<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Epilepsia Open</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsia Open</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2470-9239</journal-id>
<journal-id journal-id-type="publisher-id">EPI4</journal-id>
<journal-title-group>
<journal-title>Epilepsia Open</journal-title>
</journal-title-group>
<issn pub-type="epub">2470-9239</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32524040</article-id>
<article-id pub-id-type="pmc">7278567</article-id>
<article-id pub-id-type="doi">10.1002/epi4.12386</article-id>
<article-id pub-id-type="publisher-id">EPI412386</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Critical Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Critical Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neurodegenerative pathways as targets for acquired epilepsy therapy development</article-title>
<alt-title alt-title-type="left-running-head">CASILLAS‐ESPINOSA et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="epi412386-cr-0001">
<name>
<surname>Casillas‐Espinosa</surname>
<given-names>Pablo M.</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-6199-9415</contrib-id>
<xref ref-type="aff" rid="epi412386-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="epi412386-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="epi412386-cr-0002">
<name>
<surname>Ali</surname>
<given-names>Idrish</given-names>
</name>
<xref ref-type="aff" rid="epi412386-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="epi412386-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="epi412386-cr-0003">
<name>
<surname>O'Brien</surname>
<given-names>Terence J.</given-names>
</name>
<xref ref-type="aff" rid="epi412386-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="epi412386-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="epi412386-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="epi412386-aff-0004">
<sup>4</sup>
</xref>
<address>
<email>terence.obrien@monash.edu</email>
</address>
</contrib>
</contrib-group>
<aff id="epi412386-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Departments of Neuroscience and Medicine</named-content>
<named-content content-type="organisation-division">Central Clinical School</named-content>
<institution>Monash University</institution>
<city>Melbourne</city>
<named-content content-type="country-part">Vic.</named-content>
<country country="AU">Australia</country>
</aff>
<aff id="epi412386-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<named-content content-type="organisation-division">The Royal Melbourne Hospital</named-content>
<institution>The University of Melbourne</institution>
<city>Melbourne</city>
<named-content content-type="country-part">Vic.</named-content>
<country country="AU">Australia</country>
</aff>
<aff id="epi412386-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>The Alfred Hospital</institution>
<city>Melbourne</city>
<named-content content-type="country-part">Vic.</named-content>
<country country="AU">Australia</country>
</aff>
<aff id="epi412386-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>The Royal Melbourne Hospital</institution>
<city>Parkville</city>
<named-content content-type="country-part">Vic.</named-content>
<country country="AU">Australia</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Terence J. O'Brien, Department of Neuroscience, Central Clinical School, Monash University, Melbourne, 3004 Vic., Australia.<break></break>
Email: <email>terence.obrien@monash.edu</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2020</year>
</pub-date>
<volume>5</volume>
<issue>2</issue>
<issue-id pub-id-type="doi">10.1002/epi4.v5.2</issue-id>
<fpage>138</fpage>
<lpage>154</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>13</day>
<month>2</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>2</month>
<year>2020</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 International League Against Epilepsy <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2020 The Authors. <italic>Epilepsia Open</italic> published by Wiley Periodicals, Inc. on behalf of International League Against Epilepsy.</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:EPI4-5-138.pdf"></self-uri>
<abstract id="epi412386-abs-0001">
<title>Abstract</title>
<p>There is a growing body of clinical and experimental evidence that neurodegenerative diseases and epileptogenesis after an acquired brain insult may share common etiological mechanisms. Acquired epilepsy commonly develops as a comorbid condition in patients with neurodegenerative diseases such as Alzheimer's disease, although it is likely much under diagnosed in practice. Progressive neurodegeneration has also been described after traumatic brain injury, stroke, and other forms of brain insults. Moreover, recent evidence has shown that acquired epilepsy is often a progressive disorder that is associated with the development of drug resistance, cognitive decline, and worsening of other neuropsychiatric comorbidities. Therefore, new pharmacological therapies that target neurobiological pathways that underpin neurodegenerative diseases have potential to have both an anti‐epileptogenic and disease‐modifying effect on the seizures in patients with acquired epilepsy, and also mitigate the progressive neurocognitive and neuropsychiatric comorbidities. Here, we review the neurodegenerative pathways that are plausible targets for the development of novel therapies that could prevent the development or modify the progression of acquired epilepsy, and the supporting published experimental and clinical evidence.</p>
</abstract>
<kwd-group>
<kwd id="epi412386-kwd-0001">AMPA</kwd>
<kwd id="epi412386-kwd-0002">amyloid‐β</kwd>
<kwd id="epi412386-kwd-0003">glutamate</kwd>
<kwd id="epi412386-kwd-0004">mTOR</kwd>
<kwd id="epi412386-kwd-0005">neuroinflammation</kwd>
<kwd id="epi412386-kwd-0006">tau</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-0001">
<funding-source>Melbourne University Early Career Research Grant</funding-source>
<award-id>603834</award-id>
</award-group>
<award-group id="funding-0002">
<funding-source>Peter Doherty Early Career NHMRC Fellowship</funding-source>
<award-id>APP1166170</award-id>
</award-group>
<award-group id="funding-0003">
<funding-source>National Institute of Neurological Disorders and Stroke (NINDS) Centers without Walls</funding-source>
<award-id>U54 NS100064</award-id>
</award-group>
<award-group id="funding-0004">
<funding-source>
<institution-wrap>
<institution>National Health and Medical Research Council </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/501100000925</institution-id>
</institution-wrap>
</funding-source>
<award-id>APP1091593</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<page-count count="17"></page-count>
<word-count count="14709"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2020</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:08.06.2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="epi412386-cit-1001" publication-type="journal">
<string-name>
<surname>Casillas‐Espinosa</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>TJ</given-names>
</string-name>. <article-title>Neurodegenerative pathways as targets for acquired epilepsy therapy development</article-title>. <source xml:lang="en"/>Epilepsia Open. <year>2020</year>;<volume>5</volume>:<fpage>138</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1002/epi4.12386</pub-id>
</mixed-citation>
</p>
</notes>
</front>
<body id="epi412386-body-0001">
<p>
<boxed-text content-type="box" id="epi412386-blkfxd-0001" orientation="portrait" position="anchor"><caption><title>Key points</title></caption><p>
<list id="epi412386-list-0001" list-type="bullet"><list-item><p>Neurodegenerative diseases and epileptogenesis after an acquired brain insult may share common etiological mechanisms</p></list-item><list-item><p>Targeting neurodegenerative pathways have the potential to have both anti‐epileptogenic and disease‐modifying effects in acquired epilepsy</p></list-item><list-item><p>Modification of tau, amyloid‐β, neuroinflammation, mTOR, and AMPA pathways are plausible targets for the development of epilepsy therapies</p></list-item></list>
</p></boxed-text>
</p>
<sec id="epi412386-sec-0002">
<label>1</label>
<title>INTRODUCTION</title>
<p>Epilepsy is one of the most common and disabling neurological disorders worldwide. The etiologies of acquired epilepsy are diverse, but a causative epileptogenic brain injury, such as stroke, status epilepticus, traumatic brain injury (TBI), or infection, can be identified in a proportion of patients.<xref ref-type="ref" rid="epi412386-bib-0001">1</xref> There is increasing evidence that acquired epilepsy can be a progressive disorder, associated with cognitive decline and worsening of other neuropsychiatric comorbidities and the development of pharmacoresistance.<xref ref-type="ref" rid="epi412386-bib-0002">2</xref>, <xref ref-type="ref" rid="epi412386-bib-0003">3</xref>, <xref ref-type="ref" rid="epi412386-bib-0004">4</xref>, <xref ref-type="ref" rid="epi412386-bib-0005">5</xref>, <xref ref-type="ref" rid="epi412386-bib-0006">6</xref>, <xref ref-type="ref" rid="epi412386-bib-0007">7</xref> Clinical and experimental evidence has shown an association of epilepsy with different neurodegenerative pathways such as tau, amyloid‐β‐related, the mammalian target of rapamycin (mTOR).<xref ref-type="ref" rid="epi412386-bib-0008">8</xref>
</p>
<p>Neurodegeneration is a broad term defined as the progressive alterations of neuronal function, which often involves neuronal death, and has been described in a wide variety of brain conditions such as stroke, traumatic brain injury, multiple sclerosis, Alzheimer disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington disease, and acquired epilepsy.<xref ref-type="ref" rid="epi412386-bib-0009">9</xref>, <xref ref-type="ref" rid="epi412386-bib-0010">10</xref>, <xref ref-type="ref" rid="epi412386-bib-0011">11</xref>, <xref ref-type="ref" rid="epi412386-bib-0012">12</xref> Observations in experimental models of acquired epilepsy in animals and in vitro are providing a better understanding of different neurodegenerative pathways that may contribute to excitotoxicity, cell death, neurogenesis, and axonal sprouting, which could provide possible pharmacological targets for the development of anti‐epileptogenic or disease‐modifying therapies (Figure <xref ref-type="fig" rid="epi412386-fig-0001">1</xref>). A clear etiological link between the neurodegeneration with the development of epileptic seizures has not yet been proven, and it remains possible that the neurodegeneration observed in patients and animal models with acquired epilepsy is an incidental result of the injury or a secondary effect of the repeated epileptic seizures.<xref ref-type="ref" rid="epi412386-bib-0012">12</xref>, <xref ref-type="ref" rid="epi412386-bib-0013">13</xref>, <xref ref-type="ref" rid="epi412386-bib-0014">14</xref> Nevertheless, studies targeting neurodegenerative mechanisms have reported protective effects against epileptogenesis following an acquired brain insult and thus provide evidence linking these and promise for the future development of this approach clinically.<xref ref-type="ref" rid="epi412386-bib-0015">15</xref>, <xref ref-type="ref" rid="epi412386-bib-0016">16</xref>, <xref ref-type="ref" rid="epi412386-bib-0017">17</xref>, <xref ref-type="ref" rid="epi412386-bib-0018">18</xref>, <xref ref-type="ref" rid="epi412386-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412386-bib-0020">20</xref>, <xref ref-type="ref" rid="epi412386-bib-0021">21</xref>, <xref ref-type="ref" rid="epi412386-bib-0022">22</xref>, <xref ref-type="ref" rid="epi412386-bib-0023">23</xref>
</p>
<fig fig-type="Figure" id="epi412386-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Neurodegenerative pathways in acquired epilepsy. A brain insult triggers a cascade of mechanisms that may be involved in the development of acquired epilepsy, and five neurodegenerative pathways implicated in the development of acquired epilepsy, (1) AMPA mechanisms, (2) tau‐based mechanisms, (3) amyloid‐β pathways, (4) mTOR pathway, and (5) neuroinflammatory mediators, are reviewed in this manuscript as they represent potential targets for drug development</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="EPI4-5-138-g001"></graphic>
</fig>
<p>This review focuses on some of the neurodegenerative mediators and pathways, such as AMPA receptors, tau, amyloid, mTOR, and neuroinflammation that represent potential targets to prevent or modify acquired epilepsy, and the published experimental literature supporting this approach.</p>
</sec>
<sec id="epi412386-sec-0003">
<label>2</label>
<title>NEURODEGENERATIVE MECHANISMS RELEVANT TO ACQUIRED EPILEPSIES</title>
<p>The acquired epilepsies comprise a heterogeneous group in which a structural abnormality or metabolic condition secondary to a brain injury has been attributed to play a major role in the risk of developing epilepsy.<xref ref-type="ref" rid="epi412386-bib-0024">24</xref> TLE is the most common form of acquired epilepsy that is often resistant to drug treatment, where seizures continue to occur despite anti‐epileptic drug treatment.<xref ref-type="ref" rid="epi412386-bib-0025">25</xref> Despite decades of study of TLE, and more than 15 new anti‐epileptic drugs that have been introduced into clinical practice, at least 30% of the patients are resistant to medical treatment.<xref ref-type="ref" rid="epi412386-bib-0025">25</xref>, <xref ref-type="ref" rid="epi412386-bib-0026">26</xref> A variety of different brain insults can be the trigger of the acquired epileptogenic, such as status epilepticus (SE), febrile seizures, TBI, infection, prenatal or perinatal injuries, congenital abnormalities, brain tumors, autoimmune, or genetic disorders associated with brain malformations, with the chance of the development of epilepsy likely enhanced by genetic determinants.<xref ref-type="ref" rid="epi412386-bib-0001">1</xref>, <xref ref-type="ref" rid="epi412386-bib-0026">26</xref>, <xref ref-type="ref" rid="epi412386-bib-0027">27</xref>, <xref ref-type="ref" rid="epi412386-bib-0028">28</xref>, <xref ref-type="ref" rid="epi412386-bib-0029">29</xref>, <xref ref-type="ref" rid="epi412386-bib-0030">30</xref>, <xref ref-type="ref" rid="epi412386-bib-0031">31</xref> Epileptogenesis is a cascade of molecular, functional, and structural processes that are triggered by a brain insult and are capable of generating spontaneous seizures. During epileptogenesis, the limbic structures manifest a variety of neurodegenerative changes that may contribute to the development of acquired epilepsy. The initial insult is often followed by a latent period that comprises a cascade of molecular, morphological, functional, and structural changes.<xref ref-type="ref" rid="epi412386-bib-0032">32</xref> This latent period is variable from months to years in humans <xref ref-type="ref" rid="epi412386-bib-0033">33</xref> and continues to create a hyperexcitable network prone to develop spontaneous seizures.<xref ref-type="ref" rid="epi412386-bib-0004">4</xref>, <xref ref-type="ref" rid="epi412386-bib-0034">34</xref>, <xref ref-type="ref" rid="epi412386-bib-0035">35</xref>, <xref ref-type="ref" rid="epi412386-bib-0036">36</xref>, <xref ref-type="ref" rid="epi412386-bib-0037">37</xref>, <xref ref-type="ref" rid="epi412386-bib-0038">38</xref>, <xref ref-type="ref" rid="epi412386-bib-0039">39</xref>, <xref ref-type="ref" rid="epi412386-bib-0040">40</xref>, <xref ref-type="ref" rid="epi412386-bib-0041">41</xref>, <xref ref-type="ref" rid="epi412386-bib-0042">42</xref>
</p>
<p>Moreover, acquired epilepsy, specifically affecting the temporal lobe, is associated with an increased incidence of neuropsychiatric disturbances, including anxiety, depression, memory, and learning disabilities.<xref ref-type="ref" rid="epi412386-bib-0043">43</xref>, <xref ref-type="ref" rid="epi412386-bib-0044">44</xref>, <xref ref-type="ref" rid="epi412386-bib-0045">45</xref>, <xref ref-type="ref" rid="epi412386-bib-0046">46</xref>, <xref ref-type="ref" rid="epi412386-bib-0047">47</xref> These associated neuropsychiatric comorbidities often worsen over time, resembling in some cases a neurodegenerative condition.<xref ref-type="ref" rid="epi412386-bib-0012">12</xref> The underlying pathogenic mechanisms may relate to the progressive nature of epilepsy and its impact on the function of the different brain regions involved in cognition and the cumulative effects of therapies and epigenetic factors. Learning, cognition, verbal, and long‐term memory are often affected in acquired epilepsy, since the most common focus is located in the limbic system.<xref ref-type="ref" rid="epi412386-bib-0048">48</xref>, <xref ref-type="ref" rid="epi412386-bib-0049">49</xref>, <xref ref-type="ref" rid="epi412386-bib-0050">50</xref>, <xref ref-type="ref" rid="epi412386-bib-0051">51</xref> The duration of epilepsy has been correlated with the degree of hippocampal sclerosis, cortical atrophy, and reduced psychometric intelligence in some studies,<xref ref-type="ref" rid="epi412386-bib-0048">48</xref>, <xref ref-type="ref" rid="epi412386-bib-0049">49</xref>, <xref ref-type="ref" rid="epi412386-bib-0050">50</xref>, <xref ref-type="ref" rid="epi412386-bib-0051">51</xref> but not others.<xref ref-type="ref" rid="epi412386-bib-0052">52</xref>, <xref ref-type="ref" rid="epi412386-bib-0053">53</xref>
</p>
<p>During epileptogenesis, a wide spectrum of potentially pro‐epileptogenic neurodegenerative changes is seen in limbic structures including mossy fiber sprouting<xref ref-type="ref" rid="epi412386-bib-0004">4</xref>, <xref ref-type="ref" rid="epi412386-bib-0034">34</xref>, <xref ref-type="ref" rid="epi412386-bib-0035">35</xref>, <xref ref-type="ref" rid="epi412386-bib-0036">36</xref>, <xref ref-type="ref" rid="epi412386-bib-0037">37</xref>, <xref ref-type="ref" rid="epi412386-bib-0038">38</xref>, <xref ref-type="ref" rid="epi412386-bib-0039">39</xref>, <xref ref-type="ref" rid="epi412386-bib-0040">40</xref>, <xref ref-type="ref" rid="epi412386-bib-0041">41</xref>, <xref ref-type="ref" rid="epi412386-bib-0042">42</xref>; neuronal reorganization‐synaptic remodeling<xref ref-type="ref" rid="epi412386-bib-0054">54</xref>, <xref ref-type="ref" rid="epi412386-bib-0055">55</xref>, <xref ref-type="ref" rid="epi412386-bib-0056">56</xref>, <xref ref-type="ref" rid="epi412386-bib-0057">57</xref>; neurogenesis<xref ref-type="ref" rid="epi412386-bib-0058">58</xref>; blood‐brain barrier disruption, γ‐aminobutyric acid (GABA) receptor, and GABAergic neurons changes<xref ref-type="ref" rid="epi412386-bib-0059">59</xref>, <xref ref-type="ref" rid="epi412386-bib-0060">60</xref>, <xref ref-type="ref" rid="epi412386-bib-0061">61</xref>, <xref ref-type="ref" rid="epi412386-bib-0062">62</xref>, <xref ref-type="ref" rid="epi412386-bib-0063">63</xref>; alterations in peptide and brain‐derived neurotrophic factor (BDNF) expression<xref ref-type="ref" rid="epi412386-bib-0036">36</xref>, <xref ref-type="ref" rid="epi412386-bib-0064">64</xref>, <xref ref-type="ref" rid="epi412386-bib-0065">65</xref>; neuroinflammation<xref ref-type="ref" rid="epi412386-bib-0023">23</xref>, <xref ref-type="ref" rid="epi412386-bib-0066">66</xref>; changes in ion channels<xref ref-type="ref" rid="epi412386-bib-0067">67</xref>; alterations in axonal transport, amyloid‐β peptide, tau, and PP2A pathology<xref ref-type="ref" rid="epi412386-bib-0015">15</xref>, <xref ref-type="ref" rid="epi412386-bib-0068">68</xref>; and other cellular and functional changes.<xref ref-type="ref" rid="epi412386-bib-0054">54</xref>, <xref ref-type="ref" rid="epi412386-bib-0056">56</xref>, <xref ref-type="ref" rid="epi412386-bib-0057">57</xref>, <xref ref-type="ref" rid="epi412386-bib-0069">69</xref>, <xref ref-type="ref" rid="epi412386-bib-0070">70</xref>, <xref ref-type="ref" rid="epi412386-bib-0071">71</xref>, <xref ref-type="ref" rid="epi412386-bib-0072">72</xref>, <xref ref-type="ref" rid="epi412386-bib-0073">73</xref> These neuropathological changes are not specific of epilepsy; however, they are similar to those of neurodegenerative disorders such as Alzheimer's disease,<xref ref-type="ref" rid="epi412386-bib-0012">12</xref>, <xref ref-type="ref" rid="epi412386-bib-0074">74</xref>, <xref ref-type="ref" rid="epi412386-bib-0075">75</xref>, <xref ref-type="ref" rid="epi412386-bib-0076">76</xref>, <xref ref-type="ref" rid="epi412386-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412386-bib-0078">78</xref>, <xref ref-type="ref" rid="epi412386-bib-0079">79</xref>, <xref ref-type="ref" rid="epi412386-bib-0080">80</xref>, <xref ref-type="ref" rid="epi412386-bib-0081">81</xref>, <xref ref-type="ref" rid="epi412386-bib-0082">82</xref>, <xref ref-type="ref" rid="epi412386-bib-0083">83</xref>, <xref ref-type="ref" rid="epi412386-bib-0084">84</xref>, <xref ref-type="ref" rid="epi412386-bib-0085">85</xref>, <xref ref-type="ref" rid="epi412386-bib-0086">86</xref> even when there is no clear history of epilepsy.<xref ref-type="ref" rid="epi412386-bib-0012">12</xref> Neurodegeneration is a progressive process that evolves during acquired epileptogenesis<xref ref-type="ref" rid="epi412386-bib-0087">87</xref>; however, some studies suggest that the neurodegeneration may not directly result in the epileptogenesis, but it may induce other processes that do.<xref ref-type="ref" rid="epi412386-bib-0088">88</xref>, <xref ref-type="ref" rid="epi412386-bib-0089">89</xref> Hippocampal sclerosis is the pathological landmark of chronic drug‐resistant mesial TLE and is characterized by neuronal loss in the hippocampus, reactive gliosis, and reorganization of the synaptic connections. However, not all with TLE have hippocampal sclerosis.<xref ref-type="ref" rid="epi412386-bib-0090">90</xref>, <xref ref-type="ref" rid="epi412386-bib-0091">91</xref>, <xref ref-type="ref" rid="epi412386-bib-0092">92</xref> Neuronal cell loss is commonly seen in patients with acquired epilepsy and in different animal models, including the post‐traumatic and post‐status epilepticus models.<xref ref-type="ref" rid="epi412386-bib-0015">15</xref>, <xref ref-type="ref" rid="epi412386-bib-0022">22</xref> Neuronal death causes a cascade of changes that includes massive release of intracellular Ca<sup>2+</sup>, oxidative stress, and activation of apoptotic pathways such as caspase, P53 and Bcl,<xref ref-type="ref" rid="epi412386-bib-0070">70</xref>, <xref ref-type="ref" rid="epi412386-bib-0071">71</xref>, <xref ref-type="ref" rid="epi412386-bib-0075">75</xref>, <xref ref-type="ref" rid="epi412386-bib-0078">78</xref>, <xref ref-type="ref" rid="epi412386-bib-0084">84</xref> and others.<xref ref-type="ref" rid="epi412386-bib-0093">93</xref>, <xref ref-type="ref" rid="epi412386-bib-0094">94</xref>, <xref ref-type="ref" rid="epi412386-bib-0095">95</xref>, <xref ref-type="ref" rid="epi412386-bib-0096">96</xref>, <xref ref-type="ref" rid="epi412386-bib-0097">97</xref>, <xref ref-type="ref" rid="epi412386-bib-0098">98</xref>, <xref ref-type="ref" rid="epi412386-bib-0099">99</xref>, <xref ref-type="ref" rid="epi412386-bib-0100">100</xref>, <xref ref-type="ref" rid="epi412386-bib-0101">101</xref>, <xref ref-type="ref" rid="epi412386-bib-0102">102</xref> In response to this, there is an activation and increased presence of astrocytes and microglia, a process known as gliosis. Glial cells and microglia release pro‐inflammatory cytokines, such as interleukin 1ß (IL‐1ß) and tumor necrosis factor α (TNF‐α), which promote gliosis<xref ref-type="ref" rid="epi412386-bib-0103">103</xref>, <xref ref-type="ref" rid="epi412386-bib-0104">104</xref> and perpetuate a chronic inflammatory state that further influences the hyperexcitability and promotes aberrant neurogenesis and tissue remodeling, which further enhance epileptogenesis.<xref ref-type="ref" rid="epi412386-bib-0103">103</xref>, <xref ref-type="ref" rid="epi412386-bib-0105">105</xref>, <xref ref-type="ref" rid="epi412386-bib-0106">106</xref>
</p>
<p>Mossy fiber sprouting is another pathological landmark seen in the hippocampal formation of acquired chronic epilepsy patients, in particular those with mesial TLE, and in animal models that represents aberrant synaptic remodeling and hyperexcitable neuronal network formation.<xref ref-type="ref" rid="epi412386-bib-0105">105</xref>, <xref ref-type="ref" rid="epi412386-bib-0107">107</xref>, <xref ref-type="ref" rid="epi412386-bib-0108">108</xref>, <xref ref-type="ref" rid="epi412386-bib-0109">109</xref> The increase in interictal epileptiform spike frequency in the chronic epileptic phase in animal models of TLE correlates with the development of spontaneous seizures, neuronal loss, and mossy fiber sprouting.<xref ref-type="ref" rid="epi412386-bib-0091">91</xref>, <xref ref-type="ref" rid="epi412386-bib-0110">110</xref> The imbalance between inhibitory and excitatory mechanisms plays a role in the development of epilepsy, but also in the initiation and maintenance of spontaneous seizures.<xref ref-type="ref" rid="epi412386-bib-0071">71</xref>, <xref ref-type="ref" rid="epi412386-bib-0072">72</xref> N‐methyl‐D‐aspartate (NMDA) receptor activation might play a role for inducing the trans‐synaptic alterations that underlie TLE epileptogenesis.<xref ref-type="ref" rid="epi412386-bib-0033">33</xref> In fact, repeated seizures may lead to loss of GABAergic inhibitory interneurons in the hippocampus.<xref ref-type="ref" rid="epi412386-bib-0111">111</xref>, <xref ref-type="ref" rid="epi412386-bib-0112">112</xref>, <xref ref-type="ref" rid="epi412386-bib-0113">113</xref> In addition, regulation of inhibitory and excitatory receptors can be influenced by neuropeptides such as brain BDNF.<xref ref-type="ref" rid="epi412386-bib-0064">64</xref>, <xref ref-type="ref" rid="epi412386-bib-0114">114</xref>, <xref ref-type="ref" rid="epi412386-bib-0115">115</xref> However, the mechanisms of GABA, NMDA, BDNF, and other neuropeptide‐related neurodegeneration are out of the scope of this review and will not be discussed in the current manuscript.</p>
<p>This review will focus on the discussion of the AMPA, tau, amyloid‐β, mTOR, and neuroinflammatory pathways as potential targets for drug development.</p>
</sec>
<sec id="epi412386-sec-0004">
<label>3</label>
<title>AMPA RECEPTOR NEURODEGENERATIVE MECHANISMS</title>
<p>The majority of fast excitatory synaptic neurotransmission in the central nervous system is mediated via glutamate activation of α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA) receptors.<xref ref-type="ref" rid="epi412386-bib-0115">115</xref>, <xref ref-type="ref" rid="epi412386-bib-0116">116</xref> This neurotransmitter system not only drives abnormal hyperexcitable circuitry during an epileptic seizure but also could initiate neurodegenerative processes by excessive calcium uptake and pushing the cells toward apoptotic cell death.<xref ref-type="ref" rid="epi412386-bib-0117">117</xref>
</p>
<p>The AMPARs primarily mediate fast neurotransmission by serving as a glutamate‐gated cation channel. In addition to initiating neuronal firing, AMPARs also underlie aspects of synaptic plasticity<xref ref-type="ref" rid="epi412386-bib-0116">116</xref> such as long‐term potentiation, learning, and memory.<xref ref-type="ref" rid="epi412386-bib-0118">118</xref> Glutamate chronic neuronal excitotoxicity is a newer concept, but has linked glutamate excitotoxicity to neurodegenerative processes in Huntington's disease, Parkinson's disease, and Alzheimer's dementia.<xref ref-type="ref" rid="epi412386-bib-0009">9</xref>
</p>
<p>Similarly, excessive glutamate receptor activation has been linked epilepsy.<xref ref-type="ref" rid="epi412386-bib-0119">119</xref> In acquired epilepsy, particularly in TLE, increases in glutamate excitotoxicity have been described as an important initial mechanism for neuronal injury that leads to neuronal cell death and neurodegenerative processes that may lead to overall hyperexcitable tissue reorganization by mechanisms described earlier.<xref ref-type="ref" rid="epi412386-bib-0054">54</xref>, <xref ref-type="ref" rid="epi412386-bib-0073">73</xref> These events could in turn promote increased burst firing in reticular neurons enhancing epileptogenic circuit synchrony, promoting the development of seizures.<xref ref-type="ref" rid="epi412386-bib-0120">120</xref>, <xref ref-type="ref" rid="epi412386-bib-0121">121</xref>, <xref ref-type="ref" rid="epi412386-bib-0122">122</xref>, <xref ref-type="ref" rid="epi412386-bib-0123">123</xref>, <xref ref-type="ref" rid="epi412386-bib-0124">124</xref>
</p>
<p>The hippocampus has been identified as the seizure initiating zone in many TLE patients as well as in different animal models.<xref ref-type="ref" rid="epi412386-bib-0125">125</xref> GABAergic neurons are found primarily in the basket cells located in deep portions of the granule cell layer in the dentate gyrus.<xref ref-type="ref" rid="epi412386-bib-0026">26</xref>, <xref ref-type="ref" rid="epi412386-bib-0126">126</xref> However, repeated seizures and excitotoxicity lead to death of these interneurons that are critical to maintain the balance between excitation and inhibition in the hippocampus.<xref ref-type="ref" rid="epi412386-bib-0105">105</xref>, <xref ref-type="ref" rid="epi412386-bib-0113">113</xref>, <xref ref-type="ref" rid="epi412386-bib-0127">127</xref>
</p>
<p>Glutamate is the major excitatory neurotransmitter in the hippocampal formation.<xref ref-type="ref" rid="epi412386-bib-0073">73</xref> The mossy fiber pathway runs from the dentate gyrus granule cells to the pyramidal cells of the CA3; after excitotoxicity and neuronal cell death due to the initial brain insult or to repeated seizures, the mossy fibers are reorganized and sprout into the inner molecular layers of the dentate gyrus to form aberrant synaptic terminals with dendrites of GABAergic interneuron basket cells and with granule cells.<xref ref-type="ref" rid="epi412386-bib-0113">113</xref> This abnormal reorganization renders the hippocampus hyperexcitable and prone to the development of spontaneous seizures.<xref ref-type="ref" rid="epi412386-bib-0107">107</xref>
</p>
<p>Therefore, strategies that can inhibit the AMPA receptor activity have the potential to reduce excessive excitatory responses that could to neurodegenerative changes and may be promising targets for the development of anti‐epileptogenic and disease‐modifying drugs.<xref ref-type="ref" rid="epi412386-bib-0128">128</xref>, <xref ref-type="ref" rid="epi412386-bib-0129">129</xref>
</p>
<p>Perampanel is a non‐competitive and highly selective AMPA receptor antagonist that has recently completed phase III of clinical trials and has been approved as an adjunctive treatment for drug‐resistant partial‐onset seizures.<xref ref-type="ref" rid="epi412386-bib-0130">130</xref>, <xref ref-type="ref" rid="epi412386-bib-0131">131</xref>, <xref ref-type="ref" rid="epi412386-bib-0132">132</xref>, <xref ref-type="ref" rid="epi412386-bib-0133">133</xref> Perampanel also decreases intracellular Ca<sup>2+</sup> concentration induced by AMPA receptor activation that would have the net effect of decreasing excitability.<xref ref-type="ref" rid="epi412386-bib-0134">134</xref>, <xref ref-type="ref" rid="epi412386-bib-0135">135</xref> Perampanel has shown to reduce neuronal cell death in the hippocampus and the piriform cortex in the lithium‐pilocarpine post‐SE model,<xref ref-type="ref" rid="epi412386-bib-0136">136</xref> but does not have anti‐epileptogenic properties.<xref ref-type="ref" rid="epi412386-bib-0137">137</xref> Similar neuroprotective effects have been described with other AMPA antagonists.<xref ref-type="ref" rid="epi412386-bib-0138">138</xref>
</p>
</sec>
<sec id="epi412386-sec-0005">
<label>4</label>
<title>TAU‐BASED MECHANISMS IN EPILEPSY</title>
<p>There is building clinical and experimental evidence linking tau‐based neurodegenerative mechanisms with the epilepsy development,<xref ref-type="ref" rid="epi412386-bib-0015">15</xref>, <xref ref-type="ref" rid="epi412386-bib-0068">68</xref> suggesting for a neurodegenerative basis for acquired epilepsies. Tau, a microtubule‐associated protein, performs important physiological functions in neurons, including providing stabilization to microtubules as well as contributing to axonal transport. The binding of tau to microtubules and thereby its physiological functions are regulated by a balance in phosphorylated and non‐phosphorylated forms of tau (as reviewed by Zheng et al<xref ref-type="ref" rid="epi412386-bib-0139">139</xref> for details on tauopathies). A partially phosphorylated tau is needed for the physiological functioning, whereas a hyperphosphorylated tau can aggregate and lead to impairment of normal functions and cessation of cell survival mechanisms and contribute to neurodegeneration.<xref ref-type="ref" rid="epi412386-bib-0140">140</xref>, <xref ref-type="ref" rid="epi412386-bib-0141">141</xref>
</p>
<p>Abnormalities in the expression and phosphorylation of tau have also been described in stroke,<xref ref-type="ref" rid="epi412386-bib-0142">142</xref> epilepsy, Alzheimer's disease, frontotemporal dementia, and chronic traumatic encephalopathies.<xref ref-type="ref" rid="epi412386-bib-0143">143</xref> In clinical situations, pathological deposition of hyperphosphorylated tau has been observed in brain samples obtained from surgical resection of epileptic tissue from patients with drug‐resistant chronic TLE.<xref ref-type="ref" rid="epi412386-bib-0144">144</xref>, <xref ref-type="ref" rid="epi412386-bib-0145">145</xref>, <xref ref-type="ref" rid="epi412386-bib-0146">146</xref>, <xref ref-type="ref" rid="epi412386-bib-0147">147</xref> Similarly, brain tissue from other drug‐resistant epileptic conditions such as focal cortical dysplasia also displays hyperphosphorylated tau.<xref ref-type="ref" rid="epi412386-bib-0148">148</xref> Moreover, tau‐based pathologies are also reported acutely after traumatic brain injury, a major component for secondary injury, and is associated with neurological symptoms and cognitive decline,<xref ref-type="ref" rid="epi412386-bib-0068">68</xref>, <xref ref-type="ref" rid="epi412386-bib-0145">145</xref> as also reported in animal models of TBI.<xref ref-type="ref" rid="epi412386-bib-0068">68</xref>, <xref ref-type="ref" rid="epi412386-bib-0149">149</xref> Elevated levels of tau and hyperphosphorylated tau have also been observed in cerebrospinal fluid from epilepsy patients with partial and convulsive seizures, as well as following status epilepticus.<xref ref-type="ref" rid="epi412386-bib-0150">150</xref>, <xref ref-type="ref" rid="epi412386-bib-0151">151</xref>, <xref ref-type="ref" rid="epi412386-bib-0152">152</xref> Such changes were determinants of poor prognosis and higher risk to develop epilepsy.<xref ref-type="ref" rid="epi412386-bib-0150">150</xref> These findings in human patients suggest a possible role in targeting tau pathologies as disease‐modifying treatment, but also provide a possible biomarker for predicting epilepsy development after a brain insult that should be further investigated and validated.</p>
<p>The involvement of tau‐based mechanisms in epilepsy has been further supported by neuropathological findings from both genetic<xref ref-type="ref" rid="epi412386-bib-0153">153</xref>, <xref ref-type="ref" rid="epi412386-bib-0154">154</xref> and acquired models of epilepsy.<xref ref-type="ref" rid="epi412386-bib-0015">15</xref> Furthermore, there is evidence that genetic<xref ref-type="ref" rid="epi412386-bib-0155">155</xref>, <xref ref-type="ref" rid="epi412386-bib-0156">156</xref> or pharmacological<xref ref-type="ref" rid="epi412386-bib-0015">15</xref>, <xref ref-type="ref" rid="epi412386-bib-0157">157</xref>, <xref ref-type="ref" rid="epi412386-bib-0158">158</xref> manipulations of tau phosphorylation alter seizure induction or epilepsy development after an epileptogenic brain insult. In addition to the impact of hyperphosphorylated tau, total tau has been implicated in altering excitation/inhibition balance,<xref ref-type="ref" rid="epi412386-bib-0159">159</xref> Roberson et al, who showed that mice with tau genetic knockout display reduced seizure severity and latency to chemoconvulsant‐induced seizures.<xref ref-type="ref" rid="epi412386-bib-0159">159</xref>
</p>
<p>There is also building evidence that tau‐based mechanisms enhance neuronal excitability. An unstable microtubule assembly at axonal segments dysregulates the resting membrane potential and thereby generations of action potentials.<xref ref-type="ref" rid="epi412386-bib-0160">160</xref> Accordingly, not only pharmacological regulation or genetic manipulation of tau phosphorylation but also inhibiting total tau has shown protection against induced seizures.<xref ref-type="ref" rid="epi412386-bib-0156">156</xref>, <xref ref-type="ref" rid="epi412386-bib-0157">157</xref>, <xref ref-type="ref" rid="epi412386-bib-0161">161</xref>, <xref ref-type="ref" rid="epi412386-bib-0162">162</xref> Interestingly, tau knockout mice that underwent experimental stroke using a middle cerebral artery occlusion, developed less pentylenetetrazol evoked seizures, were protected from excitotoxic brain damage neurological deficits following stroke by site‐specific inhibition of glutamate‐induced and Ras/ERK‐mediated toxicity.<xref ref-type="ref" rid="epi412386-bib-0162">162</xref> Contrary to this, recent work has also suggested a role of tau phosphorylation in diminishing neuronal activity and attenuated seizure activity to 4‐aminopyridine induction.<xref ref-type="ref" rid="epi412386-bib-0163">163</xref>, <xref ref-type="ref" rid="epi412386-bib-0164">164</xref>
</p>
<p>These findings support a role for tauopathies in neuronal excitability, which may be dependent on the stage of the disease and may determine a compensatory mechanism to combat disease progression. Nevertheless, tau phosphorylation is evidenced to affect neuronal excitability and may alter excitation/inhibition balance providing conditions for epileptic seizures to occur. Whether these effects are relevant during the early phases of epileptogenesis after an epileptogenic insult is an important question. The activity of protein phosphatase 2A (PP2A), the main dephosphorylating enzyme, is increased, and glycogen synthase kinase‐3B (GSK‐3B) and cyclin‐dependent kinase 5 (CDK5), the primary phosphorylating enzymes, decreased, within few hours after the kainic acid‐induced status epilepticus<xref ref-type="ref" rid="epi412386-bib-0165">165</xref> as well as following a traumatic brain injury.<xref ref-type="ref" rid="epi412386-bib-0068">68</xref> This tips the balance between tau phosphorylation and dephosphorylation in favor of the former, resulting in an accumulation in the brain of hyperphosphorylated tau. This is prevented by the treatment of rats following a variety of epileptogenic brain insults with the oxidized selenium salt and sodium selenate, which specifically increases the activity and expression of the specific PP2A subunit, PR55, that is responsible for dephosphorylating hyperphosphorylated tau.<xref ref-type="ref" rid="epi412386-bib-0015">15</xref>, <xref ref-type="ref" rid="epi412386-bib-0166">166</xref>, <xref ref-type="ref" rid="epi412386-bib-0167">167</xref> Although the exact mechanism of how increased phosphorylation induces epileptogenesis is yet to be identified, it provides for an exciting target for the development of disease‐modifying therapies in established epilepsies as well as anti‐epileptogenesis treatment for inhibiting epilepsy after an epileptogenic insult.<xref ref-type="ref" rid="epi412386-bib-0015">15</xref>, <xref ref-type="ref" rid="epi412386-bib-0021">21</xref>, <xref ref-type="ref" rid="epi412386-bib-0167">167</xref>
</p>
<p>In the amygdala kindling, post‐SE and post‐TBI rat models of acquired epilepsy, treatment with sodium selenate inhibited the development of limbic epileptogenesis as well as cognitive and sensorimotor impairments.<xref ref-type="ref" rid="epi412386-bib-0068">68</xref> Moreover, sodium selenate treatment given acutely after the epileptogenic insult in these models prevented the decrease in PP2A activity and PR55 levels seen following these brain insults, as well as reducing the accumulation of hyperphosphorylated tau, mitigating neurodegenerative changes in the brain, and reducing the number of spontaneous seizures in these animal models.<xref ref-type="ref" rid="epi412386-bib-0015">15</xref>, <xref ref-type="ref" rid="epi412386-bib-0068">68</xref> Sodium selenate is currently being evaluated in human clinical trials for adult patients with prostate cancer and Alzheimer's disease.<xref ref-type="ref" rid="epi412386-bib-0168">168</xref>, <xref ref-type="ref" rid="epi412386-bib-0169">169</xref> Given all this pre‐clinical evidence, it seems plausible that targeting the tau neurodegenerative pathways with sodium selenate could be an anti‐epileptogenic therapy in human TLE.</p>
</sec>
<sec id="epi412386-sec-0006">
<label>5</label>
<title>AMYLOID‐β PATHWAY IN ACQUIRED EPILEPSY</title>
<p>The deleterious effects of overexpression and reduced clearance of the amyloid precursor protein (APP) and its proteolytic product, the amyloid‐β peptide, in Alzheimer's disease have been widely documented in the literature.<xref ref-type="ref" rid="epi412386-bib-0170">170</xref>, <xref ref-type="ref" rid="epi412386-bib-0171">171</xref>, <xref ref-type="ref" rid="epi412386-bib-0172">172</xref> Amyloid‐β can be found in different aggregates forms in the brain, as soluble monomers, oligomers, or protofibrils before aggregating into insoluble fibrils.<xref ref-type="ref" rid="epi412386-bib-0173">173</xref>, <xref ref-type="ref" rid="epi412386-bib-0174">174</xref> The amyloid‐β plaques are usually formed outside the cell and exert neurodegenerative effects influence by different pathological mechanisms.<xref ref-type="ref" rid="epi412386-bib-0171">171</xref> Patients with Alzheimer's disease have an 8‐ to 10‐fold risk of developing spontaneous seizures than the general population.<xref ref-type="ref" rid="epi412386-bib-0175">175</xref>, <xref ref-type="ref" rid="epi412386-bib-0176">176</xref>, <xref ref-type="ref" rid="epi412386-bib-0177">177</xref>, <xref ref-type="ref" rid="epi412386-bib-0178">178</xref>, <xref ref-type="ref" rid="epi412386-bib-0179">179</xref> Recently, attention has shifted to the importance of these two proteins and the mechanisms in the development of epilepsy.<xref ref-type="ref" rid="epi412386-bib-0180">180</xref>
</p>
<p>Dysregulation of APP after brain injury has been demonstrated in a number of human and animal studies; however, the effects of this APP regulation are still under debate.<xref ref-type="ref" rid="epi412386-bib-0008">8</xref>
</p>
<p>Numerous lines of evidence in both humans and in pre‐clinical transgenic models that express APP have demonstrated that an epileptogenic brain injury triggers overexpression of APP.<xref ref-type="ref" rid="epi412386-bib-0008">8</xref>, <xref ref-type="ref" rid="epi412386-bib-0180">180</xref>, <xref ref-type="ref" rid="epi412386-bib-0181">181</xref>, <xref ref-type="ref" rid="epi412386-bib-0182">182</xref>, <xref ref-type="ref" rid="epi412386-bib-0183">183</xref>, <xref ref-type="ref" rid="epi412386-bib-0184">184</xref>, <xref ref-type="ref" rid="epi412386-bib-0185">185</xref> An increase in APP immunoreactivity has been shown in neurons and astrocytes in the weight drop model of TBI.<xref ref-type="ref" rid="epi412386-bib-0186">186</xref>, <xref ref-type="ref" rid="epi412386-bib-0187">187</xref> APP protein expression is increased post‐fluid percussion injury in the cortex and hippocampus acutely 1‐h injury.<xref ref-type="ref" rid="epi412386-bib-0184">184</xref>, <xref ref-type="ref" rid="epi412386-bib-0185">185</xref> Similar results have been reported in the kainic acid‐induced post‐SE model of acquired epilepsy.<xref ref-type="ref" rid="epi412386-bib-0188">188</xref> Similarly, in patients APP can readily be detected within hours up to 2.5 years after TBI.<xref ref-type="ref" rid="epi412386-bib-0181">181</xref>, <xref ref-type="ref" rid="epi412386-bib-0182">182</xref>, <xref ref-type="ref" rid="epi412386-bib-0183">183</xref>
</p>
<p>Evidence shows that increased amyloid production and deposition contribute to the development of acquired epilepsy,<xref ref-type="ref" rid="epi412386-bib-0189">189</xref> and Tg2576 mice that overexpress human APP has been shown to be susceptible to the development of seizures in the amygdala kindling model of acquired epilepsy.<xref ref-type="ref" rid="epi412386-bib-0190">190</xref> Expression levels of APP and amyloid‐β protein significantly increased in cortex and the hippocampus of the patients with temporal lobe epilepsy refractory to medical treatment.<xref ref-type="ref" rid="epi412386-bib-0191">191</xref> Furthermore, amyloid‐β deposits start to accumulate around 10 years before the onset of clinical signs and symptoms of dementia.<xref ref-type="ref" rid="epi412386-bib-0192">192</xref> Amyloid‐β deposits have shown to increase neuronal excitability and induce hippocampal network reorganization and hyperactivation processes that have been described as epileptogenic.<xref ref-type="ref" rid="epi412386-bib-0193">193</xref>, <xref ref-type="ref" rid="epi412386-bib-0194">194</xref> Interestingly, in Alzheimer's patients, hippocampal hyperactivation only occurs in the initial stages of the disease. However, epileptiform activity and seizures can occur throughout the whole course of disease.<xref ref-type="ref" rid="epi412386-bib-0192">192</xref>, <xref ref-type="ref" rid="epi412386-bib-0193">193</xref>, <xref ref-type="ref" rid="epi412386-bib-0195">195</xref>, <xref ref-type="ref" rid="epi412386-bib-0196">196</xref>
</p>
<p>Consistently with the aforementioned evidence, different mice models that overexpress APP also show hyperexcitation in individual neurons, interictal spikes, and spontaneous seizures in cortical and hippocampal networks.<xref ref-type="ref" rid="epi412386-bib-0083">83</xref>, <xref ref-type="ref" rid="epi412386-bib-0197">197</xref>, <xref ref-type="ref" rid="epi412386-bib-0198">198</xref>, <xref ref-type="ref" rid="epi412386-bib-0199">199</xref>, <xref ref-type="ref" rid="epi412386-bib-0200">200</xref>, <xref ref-type="ref" rid="epi412386-bib-0201">201</xref>, <xref ref-type="ref" rid="epi412386-bib-0202">202</xref>, <xref ref-type="ref" rid="epi412386-bib-0203">203</xref>, <xref ref-type="ref" rid="epi412386-bib-0204">204</xref>, <xref ref-type="ref" rid="epi412386-bib-0205">205</xref>, <xref ref-type="ref" rid="epi412386-bib-0206">206</xref>, <xref ref-type="ref" rid="epi412386-bib-0207">207</xref> One of them, the APdE9 transgenic mouse model, generated by crossing transgenic mice expressing the APP human protein and the human PS1‐dE9 (deletion of exon 9),<xref ref-type="ref" rid="epi412386-bib-0208">208</xref> has been reported to have spontaneous seizures and increased neuronal excitability.<xref ref-type="ref" rid="epi412386-bib-0204">204</xref>, <xref ref-type="ref" rid="epi412386-bib-0205">205</xref>, <xref ref-type="ref" rid="epi412386-bib-0206">206</xref>, <xref ref-type="ref" rid="epi412386-bib-0207">207</xref> Similarly, another study analyzed four different lines of transgenic mice expressing familial mutant or wild‐type human APP and reported aberrant synchronous activity in cortical and hippocampal networks, as well as spontaneous seizures in the mutant mice.<xref ref-type="ref" rid="epi412386-bib-0063">63</xref> Moreover, these transgenic mice were more susceptible to develop seizures after pentylenetetrazol, pilocarpine, or kainic acid administration.<xref ref-type="ref" rid="epi412386-bib-0063">63</xref> It has been hypothesized that this aberrant excitatory neuronal activity induced by human APP and increased Amyloid‐β production could trigger compensatory inhibitory mechanisms constraining the capacity for synaptic plasticity and contributing to network dysfunction.<xref ref-type="ref" rid="epi412386-bib-0063">63</xref>, <xref ref-type="ref" rid="epi412386-bib-0205">205</xref> Other mechanisms of epileptogenicity described for amyloid‐β deposits have been related to the excessive dopamine release and activation of the dopamine 1 receptor.<xref ref-type="ref" rid="epi412386-bib-0209">209</xref>, <xref ref-type="ref" rid="epi412386-bib-0210">210</xref>, <xref ref-type="ref" rid="epi412386-bib-0211">211</xref> Excessive activation of dopamine 1 receptors disrupts the GABAergic inhibitory input by reducing GABA release from fast‐spiking interneurons.<xref ref-type="ref" rid="epi412386-bib-0210">210</xref> This leads to an excitatory/inhibitory imbalance and consequently hyperexcitability of pyramidal cells. The hyperexcitability of pyramidal cells further increases the amyloid‐β deposits creating a vicious cycle.<xref ref-type="ref" rid="epi412386-bib-0212">212</xref>, <xref ref-type="ref" rid="epi412386-bib-0213">213</xref> Furthermore, amyloid‐ß accumulation induces microglia activation and release of pro‐inflammatory mediators, which can promote the development of seizures and epilepsy.<xref ref-type="ref" rid="epi412386-bib-0008">8</xref>
</p>
<p>On the other hand, some authors have hypothesized that injured neuronal cells upregulate APP production as an attempt to repair the damage caused by injury.<xref ref-type="ref" rid="epi412386-bib-0008">8</xref>, <xref ref-type="ref" rid="epi412386-bib-0214">214</xref>, <xref ref-type="ref" rid="epi412386-bib-0215">215</xref>, <xref ref-type="ref" rid="epi412386-bib-0216">216</xref> Severe experimental TBI has shown to increase the expression of genes encoding proteins involved in amyloid‐β clearance and reduced amyloid‐β plaques in the mouse APP/PS1 model, which overexpresses APP.<xref ref-type="ref" rid="epi412386-bib-0217">217</xref> Similarly, in the PDAPP mice model, which exhibits high human APP expression, amyloid‐β deposits were reduced even 8 months after TBI, while sham animals displayed increasing amyloid burden.<xref ref-type="ref" rid="epi412386-bib-0218">218</xref>, <xref ref-type="ref" rid="epi412386-bib-0219">219</xref> Interestingly, mice lacking APP (APP‐KO) showed increased vulnerability to mild TBI compared with the wild‐type controls (WT) after a mild CCI.<xref ref-type="ref" rid="epi412386-bib-0220">220</xref> In addition, <ext-link ext-link-type="uri" xlink:href="https://www-sciencedirect-com.ezp.lib.unimelb.edu.au/topics/medicine-and-dentistry/intracerebroventricular-drug-administration">intracerebroventricular administration</ext-link> of recombinant secreted fragment APPα (sAPPα) in APP‐KO mice reduced the functional deficits observed after moderate TBI.<xref ref-type="ref" rid="epi412386-bib-0221">221</xref> This neuroprotective aspect of APP upregulation is based on the hypothesis that the sAPPα may be neuroprotective and the secreted fragment APP ß (sAPPß) is not.<xref ref-type="ref" rid="epi412386-bib-0222">222</xref>, <xref ref-type="ref" rid="epi412386-bib-0223">223</xref> However, the exact mechanism by which APP and amyloid‐β can be epileptogenic needs to be elucidated.</p>
<p>Nevertheless, the current evidence in the pre‐clinical models and in patients suggests that the modulation of APP and amyloid‐β production, the prevention of amyloid‐β aggregation, or promotion of its clearance could be potential therapeutic targets to prevent the development of epilepsy.<xref ref-type="ref" rid="epi412386-bib-0224">224</xref> The modulation of APP secretases, proteins that cleaves and prevents APP aggregation, has been explored as a therapeutic approach with conflicting evidence. Loane and colleagues show that pharmacological inhibition of γ‐secretase decreased APP and amyloid‐β production and reduced neurodegeneration and improved motor and cognitive recovery after controlled cortical impact‐induced TBI.<xref ref-type="ref" rid="epi412386-bib-0225">225</xref> In contrast, γ‐secretase inhibition failed to hypersynchronous oscillatory activity and spontaneous seizures in a APP transgenic mice model of Alzheimer's disease.<xref ref-type="ref" rid="epi412386-bib-0212">212</xref> Intracerebroventricular administration of APP96‐110, a peptide that interacts with the D1 heparin binding site, following controlled cortical impact in mice showed promising neuroprotective effects.<xref ref-type="ref" rid="epi412386-bib-0226">226</xref>, <xref ref-type="ref" rid="epi412386-bib-0227">227</xref> Furthermore, APP96‐110 administration in Sprague Dawley rats after a diffuse TBI improved cognitive outcomes and reduced axonal injury.<xref ref-type="ref" rid="epi412386-bib-0227">227</xref>
</p>
<p>Reduction of inhibition of the c‐Jun N‐terminal kinase (JNK) pathway is another potential therapeutic strategy to prevent the development of epilepsy.<xref ref-type="ref" rid="epi412386-bib-0228">228</xref> Aberrant activation of JNK intracellular signaling cascade has been reported in Alzheimer's disease patients and in mouse models, suggesting that it might be involved in a number of neurodegenerative mechanisms associated with the disease.<xref ref-type="ref" rid="epi412386-bib-0228">228</xref>, <xref ref-type="ref" rid="epi412386-bib-0229">229</xref>, <xref ref-type="ref" rid="epi412386-bib-0230">230</xref> SP600125, a specific JNK inhibitor, has been described to reduce APP expression levels and amyloid‐ß production, inhibition of inflammatory responses, and apoptotic neurodegeneration among other pathological features of after TBI. Remarkably, treatment with SP600125 also seems to redirect APP processing from the amyloidogenic to the non‐amyloidogenic pathway, without affecting amyloid‐ß clearance but suppressing its production.<xref ref-type="ref" rid="epi412386-bib-0228">228</xref>
</p>
<p>Valproic acid, one of the most commonly prescribed antiseizure drugs, has shown to affect the production of amyloid<xref ref-type="ref" rid="epi412386-bib-0231">231</xref> and to reduced epileptiform activity in mice models that overproduce amyloid‐ß; however, the effects are not sustained after treatment discontinuation.<xref ref-type="ref" rid="epi412386-bib-0232">232</xref> Similar effects have been shown with lamotrigine<xref ref-type="ref" rid="epi412386-bib-0233">233</xref> and bexarotene.<xref ref-type="ref" rid="epi412386-bib-0234">234</xref> Huperzine A, an acetylcholinesterase inhibitor, has shown promising anticonvulsant,<xref ref-type="ref" rid="epi412386-bib-0235">235</xref> reducing amyloid accumulations and synaptic deficits.<xref ref-type="ref" rid="epi412386-bib-0236">236</xref>, <xref ref-type="ref" rid="epi412386-bib-0237">237</xref> Levetiracetam reduces abnormal spike‐wave activity, and in chronic use (12 days), reverses hippocampal remodeling and cognitive deficits in mice model that overexpresses human APP.<xref ref-type="ref" rid="epi412386-bib-0238">238</xref>
</p>
<p>Although these approaches have been widely explored in the TBI and Alzheimer's disease research field, the findings can promote insights and bolster the rationale for developing an APP and amyloid target therapy as disease‐modifying or anti‐epileptogenic therapy in acquired epilepsy.<xref ref-type="ref" rid="epi412386-bib-0008">8</xref>
</p>
</sec>
<sec id="epi412386-sec-0007">
<label>6</label>
<title>MECHANISTIC TARGET OF MAMMALIAN RAPAMYCIN PATHWAY</title>
<p>The mammalian target of rapamycin (mTOR) is another pathway that can contribute to neurodegeneration in epilepsy as well established to be involved in neurodegenerative conditions such as Alzheimer's and Parkinsonism.<xref ref-type="ref" rid="epi412386-bib-0239">239</xref> mTOR is an intracellular signaling protein that belongs to the phosphatidylinositol 3‐kinase (PI3K)‐related kinase family, whose activity is mediated through a serine‐threonine protein kinase and has been recognized as one of the pivotal cellular signal pathway to control cell survival and proliferation.<xref ref-type="ref" rid="epi412386-bib-0240">240</xref> mTOR exists in two multiprotein complexes, namely mTORC1 that is rapamycin‐sensitive and mTORC2 that is rapamycin insensitive. mTOR signaling is regulated by signals from growth factors and nutrients that bind to receptors at the membrane to activate intracellular signaling mechanisms such as PI3K, and generates PIP3 to activate mTOR, which induces protein kinase B (Akt) signaling. This inhibits negative regulators of mTOR such as tuberous sclerosis complex (TSC1/2) and induces mTOR signaling to lead protein translation of key proteins involved in synaptic plasticity, learning, and memory apart from the proteins involved in cell growth mechanisms. In the brain, mTORC1 regulates neuronal excitability, memory formation, and learning, and on the other hand, mTORC2 is found to be involved in cytoskeletal integrity and cell migration.<xref ref-type="ref" rid="epi412386-bib-0241">241</xref> For a detailed review of mTOR signaling, readers are referred to Perluigi et al<xref ref-type="ref" rid="epi412386-bib-0239">239</xref>
</p>
<p>With regard to the role of mTOR pathway in neurodegeneration, a major focus of research attention has been mechanisms related to autophagy,<xref ref-type="ref" rid="epi412386-bib-0242">242</xref>, <xref ref-type="ref" rid="epi412386-bib-0243">243</xref> a self‐consuming mechanism that plays a key role in cell survival by removing toxic proteins and defunct organelles.<xref ref-type="ref" rid="epi412386-bib-0244">244</xref> Similarly, mitochondria‐mediated mechanisms of inducing apoptosis are also associated with this pathway.<xref ref-type="ref" rid="epi412386-bib-0245">245</xref> Accumulation or aggregation of pathological proteins is a common mechanism among neurodegenerative conditions and is negatively regulated by autophagy.<xref ref-type="ref" rid="epi412386-bib-0246">246</xref> mTOR pathway–mediated regulation of autophagy has been increasingly investigated and rapamycin led inhibition of this pathway has exhibited strong effects in inhibiting aggregation of the pathological misfolded proteins.<xref ref-type="ref" rid="epi412386-bib-0247">247</xref>, <xref ref-type="ref" rid="epi412386-bib-0248">248</xref> Indeed, rapamycin‐mediated inhibition of mTOR against neurodegeneration has been described to be neuroprotective in Parkinson's, Alzheimer's, and Huntington diseases.<xref ref-type="ref" rid="epi412386-bib-0248">248</xref>, <xref ref-type="ref" rid="epi412386-bib-0249">249</xref>, <xref ref-type="ref" rid="epi412386-bib-0250">250</xref>
</p>
<p>Considering neurodegenerative pathology in epilepsy, it is indeed relevant that mTOR pathway is involved in epileptogenesis and seizure‐inducing mechanisms.<xref ref-type="ref" rid="epi412386-bib-0241">241</xref> Abnormal mTOR activation has been reported in both genetic and acquired epilepsies. Mutations and genetic polymorphisms of TSC1 or TSC2 proteins that are intrinsic inhibitors of mTOR pathway leading to its over‐activation have been associated with the development of epilepsy in humans.<xref ref-type="ref" rid="epi412386-bib-0251">251</xref>, <xref ref-type="ref" rid="epi412386-bib-0252">252</xref> Similar outcomes have also been reported in transgenic TSC1 and 2 mouse models, with rapamycin showing antiseizure and anti‐epileptogenesis effects.<xref ref-type="ref" rid="epi412386-bib-0253">253</xref>, <xref ref-type="ref" rid="epi412386-bib-0254">254</xref>, <xref ref-type="ref" rid="epi412386-bib-0255">255</xref> Accordingly, other intracellular signaling mechanisms of mTOR such as phosphatase and tensin homolog deleted on chromosome ten (PTEN), Akt, and DEPDC5 have all been associated with the development of epilepsy.<xref ref-type="ref" rid="epi412386-bib-0256">256</xref>, <xref ref-type="ref" rid="epi412386-bib-0257">257</xref>, <xref ref-type="ref" rid="epi412386-bib-0258">258</xref>, <xref ref-type="ref" rid="epi412386-bib-0259">259</xref> Similarly, dysregulation of the mTOR signaling has also been observed in acquired epilepsies, including increased expression of phosphor‐mTOR patients with mesial temporal lobe epilepsy.<xref ref-type="ref" rid="epi412386-bib-0260">260</xref>, <xref ref-type="ref" rid="epi412386-bib-0261">261</xref> Further, the mTOR pathway is reported to be dysregulated after experimental epileptogenic insults in animal models, including SE and traumatic brain injury.<xref ref-type="ref" rid="epi412386-bib-0262">262</xref>, <xref ref-type="ref" rid="epi412386-bib-0263">263</xref> Inhibiting mTOR signaling by rapamycin has been reported to provide anti‐epileptogenesis effects in animal models following an epileptogenic insult,<xref ref-type="ref" rid="epi412386-bib-0264">264</xref>, <xref ref-type="ref" rid="epi412386-bib-0265">265</xref> as well as in animal models following the establishment of pharmacoresistant epileptic seizures.<xref ref-type="ref" rid="epi412386-bib-0261">261</xref>
</p>
<p>While considering the mechanisms by which mTOR pathway contributes to epilepsy, it is important to recognize the myriad of the cellular process involved and how a dysregulation of those could affect neuronal excitability and contribute to neuronal circuit reorganization to promote epileptic seizures. Apart from neurodegeneration, mTOR pathways are involved in neurogenesis, newborn cell survival and migration, axonal sprouting, neuronal plasticity, and altered expression of ion channels and receptors, all of these mechanisms have been considered to be characteristic of epileptogenesis and may contribute to an excitable brain network.<xref ref-type="ref" rid="epi412386-bib-0266">266</xref>
</p>
<p>Rapamycin inhibits mTORC1 and has been shown to have antiseizure effects.<xref ref-type="ref" rid="epi412386-bib-0017">17</xref>, <xref ref-type="ref" rid="epi412386-bib-0267">267</xref> Treatment with rapamycin during or after the initial epileptogenic injury has shown to reduce the percentage of mice that developed post‐traumatic epilepsy and the frequency of spontaneous seizures, as well as neuronal degeneration.<xref ref-type="ref" rid="epi412386-bib-0268">268</xref>, <xref ref-type="ref" rid="epi412386-bib-0269">269</xref> Similar results have also been shown in the post‐SE<xref ref-type="ref" rid="epi412386-bib-0018">18</xref>, <xref ref-type="ref" rid="epi412386-bib-0020">20</xref> and neonatal hypoxia models of acquired epilepsy.<xref ref-type="ref" rid="epi412386-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412386-bib-0270">270</xref> However, these results have not been replicated in the amygdala kindling<xref ref-type="ref" rid="epi412386-bib-0271">271</xref> and in the pilocarpine‐induced post‐SE mice model of TLE<xref ref-type="ref" rid="epi412386-bib-0016">16</xref> where rapamycin treatment was unable to reduce the occurrence of spontaneous seizures. Similarly, rapamycin did not persistently prevent mossy fiber sprouting and was unable to reduce granule cell proliferation, hilar neuron loss, or generation of ectopic granule cells.<xref ref-type="ref" rid="epi412386-bib-0016">16</xref>, <xref ref-type="ref" rid="epi412386-bib-0017">17</xref>, <xref ref-type="ref" rid="epi412386-bib-0019">19</xref>, <xref ref-type="ref" rid="epi412386-bib-0268">268</xref>, <xref ref-type="ref" rid="epi412386-bib-0272">272</xref>
</p>
</sec>
<sec id="epi412386-sec-0008">
<label>7</label>
<title>NEUROINFLAMMATION</title>
<p>Neuroinflammation plays a substantial role in promoting neurodegenerative changes in acquired epilepsies.<xref ref-type="ref" rid="epi412386-bib-0273">273</xref>, <xref ref-type="ref" rid="epi412386-bib-0274">274</xref> On the other hand, neuroinflammation could be promoted by cells undergoing death by the release of damage‐associated molecular patterns (DAMPs) such as high‐mobility group box 1 proteins, purine metabolites, or proteins released from damaged extracellular matrix due to the dying of neurons.<xref ref-type="ref" rid="epi412386-bib-0275">275</xref> These events lead to a cycle of pathways that lead to enhanced neuroinflammation and promoting further cell loss. Such events could contribute both to the pathological and functional outcomes of an epileptogenic insult. A detailed discussion of the inflammatory molecules involved in human and experimental acquired epilepsies and how such molecules may be involved in promoting seizures and epileptogenesis is discussed in another review in this special issue.<xref ref-type="ref" rid="epi412386-bib-0276">276</xref> Pharmacological target of neuroinflammation, particularly modulating interleukins, cyclooxygenase‐2, prostanoid pathways, and several chemokines are promising anti‐epileptogenic and disease‐modifying targets.<xref ref-type="ref" rid="epi412386-bib-0277">277</xref>, <xref ref-type="ref" rid="epi412386-bib-0278">278</xref> Of particular interest has been the involvement of interleukin‐1β (IL‐1β) in the pathogenesis of acquired epilepsies, with consistent reports of either its receptor blockers or inhibitors of biosynthesis providing neuroprotective, anticonvulsant, or anti‐epileptic effects as well as disease‐modifying effects in epilepsy models.<xref ref-type="ref" rid="epi412386-bib-0279">279</xref>, <xref ref-type="ref" rid="epi412386-bib-0280">280</xref>, <xref ref-type="ref" rid="epi412386-bib-0281">281</xref>, <xref ref-type="ref" rid="epi412386-bib-0282">282</xref>, <xref ref-type="ref" rid="epi412386-bib-0283">283</xref> Interestingly, an increased inflammation has also been reported in models of genetic epilepsies,<xref ref-type="ref" rid="epi412386-bib-0284">284</xref>, <xref ref-type="ref" rid="epi412386-bib-0285">285</xref> with inhibition of IL‐1β synthesis providing a seizure‐suppressant effect.<xref ref-type="ref" rid="epi412386-bib-0285">285</xref> Furthermore, blockage of purinergic receptor P<sub>2</sub>X<sub>7</sub> receptor involved in the release of pro‐inflammatory cytokines has been reported to reduce epileptic seizures or overall frequency of spontaneous recurrent seizures.<xref ref-type="ref" rid="epi412386-bib-0286">286</xref>, <xref ref-type="ref" rid="epi412386-bib-0287">287</xref>
</p>
<p>High‐mobility group box 1 protein (HMGB‐1) is another molecule that has been increasingly investigated recently, in terms of anti‐epileptic effects as well as promising findings of it providing a potential biomarker of epilepsy.<xref ref-type="ref" rid="epi412386-bib-0288">288</xref> HMGB‐1 is a DAMP and is secreted by neurons and glial cells following the formation of inflammasome and leads to the release of pro‐inflammatory cytokines after activation of its receptors—Toll‐like receptor 4 (TLR‐4) and receptor for advanced glycation end products (RAGE).<xref ref-type="ref" rid="epi412386-bib-0275">275</xref> Along with the potential of HMGB‐1 in suppressing seizures<xref ref-type="ref" rid="epi412386-bib-0289">289</xref>, <xref ref-type="ref" rid="epi412386-bib-0290">290</xref> along with reported disease‐modifying effects,<xref ref-type="ref" rid="epi412386-bib-0291">291</xref> the pathologic disulfide isoforms of HMGB‐1 have been reported to be a prospective biomarker for experimental acquired epilepsies<xref ref-type="ref" rid="epi412386-bib-0292">292</xref> as well as in human childhood and adult epilepsies.<xref ref-type="ref" rid="epi412386-bib-0288">288</xref>, <xref ref-type="ref" rid="epi412386-bib-0292">292</xref> Notably, it has also been associated with a decline in the cognitive functions,<xref ref-type="ref" rid="epi412386-bib-0293">293</xref> a major neuropsychiatric comorbidity associated with acquired epilepsies.</p>
<p>In addition to the cytokines, chemokines are other molecules contributing to the inflammatory response by mobilizing the immune cells to the site of injury. Chemokines and its receptor systems such as fractalkine/CX3CR1 and CCL2/CCR5 systems have been reported to be involved in neurodegenerative mechanisms following an epileptogenic insult.<xref ref-type="ref" rid="epi412386-bib-0273">273</xref>, <xref ref-type="ref" rid="epi412386-bib-0294">294</xref>, <xref ref-type="ref" rid="epi412386-bib-0295">295</xref>, <xref ref-type="ref" rid="epi412386-bib-0296">296</xref> Despite reports of inhibiting the signaling of these chemokines displaying neuroprotective and antiseizure effects, a disease‐modifying or anti‐epileptic effects of them are yet to be established.</p>
<p>Finally, the role of promoting anti‐inflammatory cytokines to induce neuroinflammation toward an M2 phenotype has been increasingly investigated in epilepsy models.<xref ref-type="ref" rid="epi412386-bib-0274">274</xref> This is important considering the fact that inflammation is a fairly heterogeneous process and is also involved in repair of damaged tissue. A disturbed balance in pro‐ and anti‐inflammatory response has been shown in models of acquired and genetic epilepsies.<xref ref-type="ref" rid="epi412386-bib-0297">297</xref>, <xref ref-type="ref" rid="epi412386-bib-0298">298</xref> Though, directly attempting to release anti‐inflammatory cytokines at the epileptogenic focus did not provide protective effects against epileptogenesis or neuroprotection.<xref ref-type="ref" rid="epi412386-bib-0299">299</xref> Overall, future studies are warranted to investigate the potential of other strategies modulating neuroinflammation in this manner.</p>
</sec>
<sec id="epi412386-sec-0009" sec-type="conclusions">
<label>8</label>
<title>CONCLUSIONS</title>
<p>There are significant neuropathological and neurobiological parallels between neurodegenerative diseases and acquired epileptogenesis, and both are commonly comorbid in patients and chronic animal models. All current therapies just systematically suppress seizures, but have no sustained effect to prevent the development of epilepsy, and do not mitigate its progression, or to reverse once it is established. Novel therapies targeting neurodegenerative pathways, such as tau, amyloid‐β, mTOR, and neuroinflammation, have potentially to be anti‐epileptogenic and/or disease‐modifying therapies for patients with acquired epilepsy. These therapies may not only have beneficial effects on the epilepsy itself, but also on the associated neurocognitive and neuropsychiatric comorbidities. There is promising evidence from animal models of acquired epilepsy that compounds targeting these neurodegenerative pathways may have such anti‐epileptogenic effects. However, further research is needed to validate these findings before proceeding into clinical trials.</p>
</sec>
<sec id="epi412386-sec-0011" sec-type="COI-statement">
<title>DISCLOSURES</title>
<p>Neither of the authors has any conflict of interest to disclose. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.</p>
</sec>
</body>
<back>
<ack id="epi412386-sec-0010">
<title>ACKNOWLEDGMENTS</title>
<p>PMCE and IA were funded by Melbourne University Early Career Research Grant. This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) Centers without Walls [grant number U54 NS100064], a NHMRC Program Grant to TOB (#APP1091593), and The NHMRC Peter Doherty Early Career Fellowship to PMCE (#APP1166170).</p>
</ack>
<ref-list content-type="cited-references" id="epi412386-bibl-0001">
<title>REFERENCES</title>
<ref id="epi412386-bib-0001">
<label>1</label>
<mixed-citation id="epi412386-cit-0001" publication-type="journal">
<string-name>
<surname>Berg</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>, <string-name>
<surname>Brodie</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Buchhalter</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cross</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>van Emde</surname>
<given-names>BW</given-names>
</string-name>, et al. <article-title>Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009</article-title>. <source xml:lang="en"/>Epilepsia. <year>2010</year>;<volume>51</volume>:<fpage>676</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">20196795</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0002">
<label>2</label>
<mixed-citation id="epi412386-cit-0002" publication-type="journal">
<string-name>
<surname>Leonardi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ustun</surname>
<given-names>TB</given-names>
</string-name>. <article-title>The global burden of epilepsy</article-title>. <source xml:lang="en"/>Epilepsia. <year>2002</year>;<volume>43</volume>(<issue>Suppl 6</issue>):<fpage>21</fpage>–<lpage>5</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0003">
<label>3</label>
<mixed-citation id="epi412386-cit-0003" publication-type="journal">
<string-name>
<surname>de Boer</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Mula</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sander</surname>
<given-names>JW</given-names>
</string-name>. <article-title>The global burden and stigma of epilepsy</article-title>. <source xml:lang="en"/>Epilepsy Behav. <year>2008</year>;<volume>12</volume>:<fpage>540</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">18280210</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0004">
<label>4</label>
<mixed-citation id="epi412386-cit-0004" publication-type="journal">
<string-name>
<surname>Pitkänen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sutula</surname>
<given-names>T</given-names>
</string-name>. <article-title>Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal‐lobe epilepsy</article-title>. <source xml:lang="en"/>Lancet Neurol. <year>2002</year>;<volume>1</volume>:<fpage>173</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">12849486</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0005">
<label>5</label>
<mixed-citation id="epi412386-cit-0005" publication-type="journal">
<string-name>
<surname>Kwan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Brodie</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>Refractory epilepsy: a progressive, intractable but preventable condition?</article-title>
<source xml:lang="en"/>Seizure. <year>2002</year>;<volume>11</volume>:<fpage>77</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">11945093</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0006">
<label>6</label>
<mixed-citation id="epi412386-cit-0006" publication-type="journal">
<string-name>
<surname>Coan</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Cendes</surname>
<given-names>F</given-names>
</string-name>. <article-title>Epilepsy as progressive disorders: what is the evidence that can guide our clinical decisions and how can neuroimaging help?</article-title>
<source xml:lang="en"/>Epilepsy Behav. <year>2013</year>;<volume>26</volume>:<fpage>313</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">23127969</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0007">
<label>7</label>
<mixed-citation id="epi412386-cit-0007" publication-type="journal">
<string-name>
<surname>Cole</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Is epilepsy a progressive disease? The neurobiological consequences of epilepsy</article-title>. <source xml:lang="en"/>Epilepsia.
<year>2000</year>;<volume>41</volume>(<issue>Suppl 2</issue>):<fpage>S13</fpage>–<lpage>22</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0008">
<label>8</label>
<mixed-citation id="epi412386-cit-0008" publication-type="journal">
<string-name>
<surname>Ali</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Silva</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shultz</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kwan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Targeting neurodegeneration to prevent post‐traumatic epilepsy</article-title>. <source xml:lang="en"/>Neurobiol Dis. <year>2019</year>;<volume>123</volume>:<fpage>100</fpage>–<lpage>109</lpage>.<pub-id pub-id-type="pmid">30099094</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0009">
<label>9</label>
<mixed-citation id="epi412386-cit-0009" publication-type="journal">
<string-name>
<surname>Lau</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tymianski</surname>
<given-names>M</given-names>
</string-name>. <article-title>Glutamate receptors, neurotoxicity and neurodegeneration</article-title>. <source xml:lang="en"/>Pflugers Arch. <year>2010</year>;<volume>460</volume>:<fpage>525</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">20229265</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0010">
<label>10</label>
<mixed-citation id="epi412386-cit-0010" publication-type="journal">
<string-name>
<surname>Bourdenx</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Koulakiotis</surname>
<given-names>NS</given-names>
</string-name>, <string-name>
<surname>Sanoudou</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bezard</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Dehay</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tsarbopoulos</surname>
<given-names>A</given-names>
</string-name>. <article-title>Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies</article-title>. <source xml:lang="en"/>Prog Neurobiol. <year>2017</year>;<volume>155</volume>:<fpage>171</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">26209472</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0011">
<label>11</label>
<mixed-citation id="epi412386-cit-0011" publication-type="journal">
<string-name>
<surname>Marriott</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Rojas‐Mancilla</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Morales</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Herrera‐Marschitz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tasker</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Models of progressive neurological dysfunction originating early in life</article-title>. <source xml:lang="en"/>Prog Neurobiol. <year>2017</year>;<volume>155</volume>:<fpage>2</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">26483068</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0012">
<label>12</label>
<mixed-citation id="epi412386-cit-0012" publication-type="journal">
<string-name>
<surname>Ono</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Galanopoulou</surname>
<given-names>A</given-names>
</string-name>. <article-title>Epilepsy and epileptic syndrome</article-title>. <source xml:lang="en"/>Adv Exp Med Biol. <year>2012</year>;<volume>724</volume>:<fpage>99</fpage>–<lpage>113</lpage>.<pub-id pub-id-type="pmid">22411237</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0013">
<label>13</label>
<mixed-citation id="epi412386-cit-0013" publication-type="journal">
<string-name>
<surname>Bertoglio</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Amhaoul</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Van Eetveldt</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Houbrechts</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Van De Vijver</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Kainic Acid‐induced post‐status epilepticus models of temporal lobe epilepsy with diverging seizure phenotype and neuropathology</article-title>. <source xml:lang="en"/>Front Neurol. <year>2017</year>;<volume>8</volume>:<fpage>588</fpage>–<lpage>588</lpage>.<pub-id pub-id-type="pmid">29163349</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0014">
<label>14</label>
<mixed-citation id="epi412386-cit-0014" publication-type="journal">
<string-name>
<surname>Pitkänen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kharatishvili</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Narkilahti</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lukasiuk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nissinen</surname>
<given-names>J</given-names>
</string-name>. <article-title>Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat</article-title>. <source xml:lang="en"/>Epilepsy Res. <year>2005</year>;<volume>63</volume>:<fpage>27</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">15716080</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0015">
<label>15</label>
<mixed-citation id="epi412386-cit-0015" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>S‐J</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Dezsi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Braine</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau</article-title>. <source xml:lang="en"/>Brain. <year>2016</year>;<volume>139</volume>:<fpage>1919</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">27289302</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0016">
<label>16</label>
<mixed-citation id="epi412386-cit-0016" publication-type="journal">
<string-name>
<surname>Buckmaster</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Lew</surname>
<given-names>F</given-names>
</string-name>. <article-title>Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy</article-title>. <source xml:lang="en"/>J Neurosci. <year>2011</year>;<volume>31</volume>:<fpage>2337</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">21307269</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0017">
<label>17</label>
<mixed-citation id="epi412386-cit-0017" publication-type="journal">
<string-name>
<surname>Heng</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Haney</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Buckmaster</surname>
<given-names>P</given-names>
</string-name>. <article-title>High‐dose rapamycin blocks mossy fiber sprouting but not seizures in a mouse model of temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Epilepsia. <year>2013</year>;<volume>54</volume>:<fpage>1535</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">23848506</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0018">
<label>18</label>
<mixed-citation id="epi412386-cit-0018" publication-type="journal">
<string-name>
<surname>Huang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>McMahon</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy</article-title>. <source xml:lang="en"/>Neurobiol Dis. <year>2010</year>;<volume>40</volume>:<fpage>193</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">20566381</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0019">
<label>19</label>
<mixed-citation id="epi412386-cit-0019" publication-type="journal">
<string-name>
<surname>van Vliet</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Forte</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Holtman</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>den Burger</surname>
<given-names>JCG</given-names>
</string-name>, <string-name>
<surname>Sinjewel</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>de Vries</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood‐brain barrier leakage but not microglia activation</article-title>. <source xml:lang="en"/>Epilepsia. <year>2012</year>;<volume>53</volume>:<fpage>1254</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">22612226</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0020">
<label>20</label>
<mixed-citation id="epi412386-cit-0020" publication-type="journal">
<string-name>
<surname>Zeng</surname>
<given-names>L‐H</given-names>
</string-name>, <string-name>
<surname>Rensing</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>M</given-names>
</string-name>. <article-title>The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy</article-title>. <source xml:lang="en"/>J Neurosci. <year>2009</year>;<volume>29</volume>:<fpage>6964</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">19474323</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0021">
<label>21</label>
<mixed-citation id="epi412386-cit-0021" publication-type="journal">
<string-name>
<surname>Jones</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Corcoran</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Velakoulis</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Grundy</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models</article-title>. <source xml:lang="en"/>Neurobiol Dis. <year>2012</year>;<volume>45</volume>:<fpage>897</fpage>–<lpage>901</lpage>.<pub-id pub-id-type="pmid">22182692</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0022">
<label>22</label>
<mixed-citation id="epi412386-cit-0022" publication-type="journal">
<string-name>
<surname>Shultz</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Stuchbery</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S‐J</given-names>
</string-name>, <string-name>
<surname>Sashindranath</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury</article-title>. <source xml:lang="en"/>Brain.
<year>2015</year>;<volume>138</volume>:<fpage>1297</fpage>–<lpage>313</lpage>.<pub-id pub-id-type="pmid">25771151</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0023">
<label>23</label>
<mixed-citation id="epi412386-cit-0023" publication-type="journal">
<string-name>
<surname>Semple</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Gimlin</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Casillas Espinosa</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Interleukin‐1 receptor in seizure susceptibility after traumatic injury to the pediatric brain</article-title>. <source xml:lang="en"/>J Neurosci.
<year>2017</year>;<volume>37</volume>:<fpage>7864</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">28724747</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0024">
<label>24</label>
<mixed-citation id="epi412386-cit-0024" publication-type="journal">
<string-name>
<surname>Scheffer</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>French</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hirsch</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mathern</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Moshé</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Classification of the epilepsies: new concepts for discussion and debate‐Special report of the ILAE Classification Task Force of the Commission for Classification and Terminology</article-title>. <source xml:lang="en"/>Epilepsia Open. <year>2016</year>;<volume>1</volume>:<fpage>37</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">29588927</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0025">
<label>25</label>
<mixed-citation id="epi412386-cit-0025" publication-type="journal">
<string-name>
<surname>Kwan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Schachter</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Brodie</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>Drug‐resistant epilepsy</article-title>. <source xml:lang="en"/>N Engl J Med. <year>2011</year>;<volume>365</volume>:<fpage>919</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">21899452</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0026">
<label>26</label>
<mixed-citation id="epi412386-cit-0026" publication-type="journal">
<string-name>
<surname>Sharma</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Reams</surname>
<given-names>RY</given-names>
</string-name>, <string-name>
<surname>Jordan</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Thacker</surname>
<given-names>HL</given-names>
</string-name>, <string-name>
<surname>Snyder</surname>
<given-names>PW</given-names>
</string-name>. <article-title>Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions</article-title>. <source xml:lang="en"/>Toxicol Pathol. <year>2007</year>;<volume>35</volume>:<fpage>984</fpage>–<lpage>999</lpage>. Review.<pub-id pub-id-type="pmid">18098044</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0027">
<label>27</label>
<mixed-citation id="epi412386-cit-0027" publication-type="journal">
<string-name>
<surname>Engel</surname>
<given-names>J</given-names>
<suffix>Jr</suffix>
</string-name>. <article-title>Introduction to temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Epilepsy Res. <year>1996</year>;<volume>26</volume>:<fpage>141</fpage>–<lpage>150</lpage>. Review.<pub-id pub-id-type="pmid">8985696</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0028">
<label>28</label>
<mixed-citation id="epi412386-cit-0028" publication-type="journal">
<string-name>
<surname>McNamara</surname>
<given-names>JO</given-names>
</string-name>. <article-title>Emerging insights into the genesis of epilepsy</article-title>. <source xml:lang="en"/>Nature. <year>1999</year>;<volume>399</volume>:<fpage>A15</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">10392576</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0029">
<label>29</label>
<mixed-citation id="epi412386-cit-0029" publication-type="journal">
<string-name>
<surname>Herman</surname>
<given-names>S</given-names>
</string-name>. <article-title>Epilepsy after brain insult: targeting epileptogenesis</article-title>. <source xml:lang="en"/>Neurology. <year>2002</year>;<volume>59</volume>:<fpage>S21</fpage>–<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0030">
<label>30</label>
<mixed-citation id="epi412386-cit-0030" publication-type="journal">
<string-name>
<surname>Anderson</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Temkin</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Chandler</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Winn</surname>
<given-names>HR</given-names>
</string-name>. <article-title>Effect of valproate on hemostatic function in patients with traumatic brain injury</article-title>. <source xml:lang="en"/>Epilepsy Res. <year>2003</year>;<volume>57</volume>:<fpage>111</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">15013052</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0031">
<label>31</label>
<mixed-citation id="epi412386-cit-0031" publication-type="journal">
<string-name>
<surname>McNamara</surname>
<given-names>JO</given-names>
</string-name>. <article-title>Cellular and molecular basis of epilepsy</article-title>. <source xml:lang="en"/>J Neurosci. <year>1994</year>;<volume>14</volume>:<fpage>3413</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">8207463</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0032">
<label>32</label>
<mixed-citation id="epi412386-cit-0032" publication-type="journal">
<string-name>
<surname>Powell</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lukasiuk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pitkänen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Are alterations in transmitter receptor and ion channel expression responsible for epilepsies?</article-title>
<source xml:lang="en"/>Adv Exp Med Biol. <year>2014</year>;<volume>813</volume>:<fpage>211</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">25012379</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0033">
<label>33</label>
<mixed-citation id="epi412386-cit-0033" publication-type="journal">
<string-name>
<surname>Morimoto</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fahnestock</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Racine</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Kindling and status epilepticus models of epilepsy: rewiring the brain</article-title>. <source xml:lang="en"/>Prog Neurobiol. <year>2004</year>;<volume>73</volume>:<fpage>1</fpage>–<lpage>60</lpage>. Review.<pub-id pub-id-type="pmid">15193778</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0034">
<label>34</label>
<mixed-citation id="epi412386-cit-0034" publication-type="journal">
<string-name>
<surname>Upreti</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Otero</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Partida</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Skinner</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Thakker</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Pacheco</surname>
<given-names>LF</given-names>
</string-name>, et al. <article-title>Altered neurotransmitter release, vesicle recycling and presynaptic structure in the pilocarpine model of temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Brain. <year>2012</year>;<volume>135</volume>:<fpage>869</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">22344585</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0035">
<label>35</label>
<mixed-citation id="epi412386-cit-0035" publication-type="journal">
<string-name>
<surname>Sanabria</surname>
<given-names>ER</given-names>
</string-name>, <string-name>
<surname>Su</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yaari</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Initiation of network bursts by Ca2+‐dependent intrinsic bursting in the rat pilocarpine model of temporal lobe epilepsy</article-title>. <source xml:lang="en"/>J Physiol. <year>2001</year>;<volume>532</volume>:<fpage>205</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="pmid">11283235</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0036">
<label>36</label>
<mixed-citation id="epi412386-cit-0036" publication-type="journal">
<string-name>
<surname>Binder</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Croll</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Gall</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Scharfman</surname>
<given-names>HE</given-names>
</string-name>. <article-title>BDNF and epilepsy: too much of a good thing?</article-title>
<source xml:lang="en"/>Trends Neurosci. <year>2001</year>;<volume>24</volume>:<fpage>47</fpage>–<lpage>53</lpage>. Review.<pub-id pub-id-type="pmid">11163887</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0037">
<label>37</label>
<mixed-citation id="epi412386-cit-0037" publication-type="journal">
<string-name>
<surname>Raza</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Blair</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Sombati</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Carter</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Deshpande</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>DeLorenzo</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Evidence that injury‐induced changes in hippocampal neuronal calcium dynamics during epileptogenesis cause acquired epilepsy</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA. <year>2004</year>;<volume>101</volume>:<fpage>17522</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">15583136</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0038">
<label>38</label>
<mixed-citation id="epi412386-cit-0038" publication-type="journal">
<string-name>
<surname>Blair</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Sombati</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lawrence</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>McCay</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>DeLorenzo</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Epileptogenesis causes acute and chronic increases in GABAA receptor endocytosis that contributes to the induction and maintenance of seizures in the hippocampal culture model of acquired epilepsy</article-title>. <source xml:lang="en"/>J Pharmacol Exp Ther. <year>2004</year>;<volume>310</volume>:<fpage>871</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">15084648</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0039">
<label>39</label>
<mixed-citation id="epi412386-cit-0039" publication-type="journal">
<string-name>
<surname>Tu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Timofeeva</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Jiao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nadler</surname>
<given-names>JV</given-names>
</string-name>. <article-title>Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain</article-title>. <source xml:lang="en"/>J Neurosci. <year>2005</year>;<volume>25</volume>:<fpage>1718</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">15716408</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0040">
<label>40</label>
<mixed-citation id="epi412386-cit-0040" publication-type="journal">
<string-name>
<surname>Powell</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Lukasiuk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Pitkanen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Are alterations in transmitter receptor and ion channel expression responsible for epilepsies?</article-title>
<source xml:lang="en"/>Adv Exp Med Biol. <year>2014</year>;<volume>813</volume>:<fpage>211</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">25012379</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0041">
<label>41</label>
<mixed-citation id="epi412386-cit-0041" publication-type="journal">
<string-name>
<surname>Ben</surname>
<given-names>AY</given-names>
</string-name>. <article-title>Cell death and synaptic reorganizations produced by seizures</article-title>. <source xml:lang="en"/>Epilepsia. <year>2001</year>;<volume>42</volume>(<issue>Suppl 3</issue>):<fpage>5</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">11520314</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0042">
<label>42</label>
<mixed-citation id="epi412386-cit-0042" publication-type="journal">
<string-name>
<surname>Holmes</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Sarkisian</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ben Ari</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chevassus‐Au‐Louis</surname>
<given-names>N</given-names>
</string-name>. <article-title>Mossy fiber sprouting after recurrent seizures during early development in rats</article-title>. <source xml:lang="en"/>J Comp Neurol. <year>1999</year>;<volume>404</volume>:<fpage>537</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">9987996</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0043">
<label>43</label>
<mixed-citation id="epi412386-cit-0043" publication-type="journal">
<string-name>
<surname>Stores</surname>
<given-names>G</given-names>
</string-name>. <article-title>Cognitive function in children with epilepsy</article-title>. <source xml:lang="en"/>Dev Med Child Neurol. <year>1971</year>;<volume>13</volume>:<fpage>390</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="pmid">4999207</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0044">
<label>44</label>
<mixed-citation id="epi412386-cit-0044" publication-type="journal">
<string-name>
<surname>Stafstrom</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Chronopoulos</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Thurber</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Holmes</surname>
<given-names>GL</given-names>
</string-name>. <article-title>Age‐dependent cognitive and behavioral deficits after kainic acid seizures</article-title>. <source xml:lang="en"/>Epilepsia. <year>1993</year>;<volume>34</volume>:<fpage>420</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">8504777</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0045">
<label>45</label>
<mixed-citation id="epi412386-cit-0045" publication-type="journal">
<string-name>
<surname>Kandratavicius</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lopes Aguiar</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bueno Júnior</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Romcy Pereira</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hallak</surname>
<given-names>JEC</given-names>
</string-name>, <string-name>
<surname>Leite</surname>
<given-names>J</given-names>
</string-name>. <article-title>Psychiatric comorbidities in temporal lobe epilepsy: possible relationships between psychotic disorders and involvement of limbic circuits</article-title>. <source xml:lang="en"/>Revista Brasileira de Psiquiatria. <year>2012</year>;<volume>34</volume>:<fpage>454</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">23429818</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0046">
<label>46</label>
<mixed-citation id="epi412386-cit-0046" publication-type="journal">
<string-name>
<surname>Tellez Zenteno</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Patten</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jetté</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wiebe</surname>
<given-names>S</given-names>
</string-name>. <article-title>Psychiatric comorbidity in epilepsy: a population‐based analysis</article-title>. <source xml:lang="en"/>Epilepsia. <year>2007</year>;<volume>48</volume>:<fpage>2336</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">17662062</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0047">
<label>47</label>
<mixed-citation id="epi412386-cit-0047" publication-type="journal">
<string-name>
<surname>Ott</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Siddarth</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Gurbani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Koh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tournay</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shields</surname>
<given-names>WD</given-names>
</string-name>, et al. <article-title>Behavioral disorders in pediatric epilepsy: unmet psychiatric need</article-title>. <source xml:lang="en"/>Epilepsia. <year>2003</year>;<volume>44</volume>:<fpage>591</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">12681010</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0048">
<label>48</label>
<mixed-citation id="epi412386-cit-0048" publication-type="journal">
<string-name>
<surname>Vazquez</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Devinsky</surname>
<given-names>O</given-names>
</string-name>. <article-title>Epilepsy and anxiety</article-title>. <source xml:lang="en"/>Epilepsy Behav. <year>2003</year>;<volume>4</volume>(<issue>Suppl 4</issue>):<fpage>S20</fpage>–<lpage>25</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0049">
<label>49</label>
<mixed-citation id="epi412386-cit-0049" publication-type="journal">
<string-name>
<surname>Kimiskidis</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Valeta</surname>
<given-names>T</given-names>
</string-name>. <article-title>Epilepsy and anxiety: epidemiology, classification, aetiology, and treatment</article-title>. <source xml:lang="en"/>Epileptic Disord. <year>2012</year>;<volume>14</volume>:<fpage>248</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">22947395</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0050">
<label>50</label>
<mixed-citation id="epi412386-cit-0050" publication-type="journal">
<string-name>
<surname>Hinnell</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Metcalfe</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Patten</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Parker</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wiebe</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Health status and health‐related behaviors in epilepsy compared to other chronic conditions–a national population‐based study</article-title>. <source xml:lang="en"/>Epilepsia. <year>2010</year>;<volume>51</volume>:<fpage>853</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">20067511</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0051">
<label>51</label>
<mixed-citation id="epi412386-cit-0051" publication-type="journal">
<string-name>
<surname>Valente</surname>
<given-names>KDR</given-names>
</string-name>, <string-name>
<surname>Busatto</surname>
<given-names>FG</given-names>
</string-name>. <article-title>Depression and temporal lobe epilepsy represent an epiphenomenon sharing similar neural networks: clinical and brain structural evidences</article-title>. <source xml:lang="en"/>Arq Neuropsiquiatr. <year>2013</year>;<volume>71</volume>:<fpage>183</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">23563720</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0052">
<label>52</label>
<mixed-citation id="epi412386-cit-0052" publication-type="journal">
<string-name>
<surname>Motamedi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Meador</surname>
<given-names>K</given-names>
</string-name>. <article-title>Epilepsy and cognition</article-title>. <source xml:lang="en"/>Epilepsy Behav. <year>2003</year>;<volume>4</volume>(<issue>Suppl 2</issue>):<fpage>S25</fpage>–<lpage>S38</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0053">
<label>53</label>
<mixed-citation id="epi412386-cit-0053" publication-type="journal">
<string-name>
<surname>O'Leary</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Lovell</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Sackellares</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Berent</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Giordani</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Seidenberg</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Effects of age of onset of partial and generalized seizures on neuropsychological performance in children</article-title>. <source xml:lang="en"/>J Nerv Ment Dis. <year>1983</year>;<volume>171</volume>:<fpage>624</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">6413648</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0054">
<label>54</label>
<mixed-citation id="epi412386-cit-0054" publication-type="journal">
<string-name>
<surname>Delorenzo</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Deshpande</surname>
<given-names>LS</given-names>
</string-name>. <article-title>Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintenance of epilepsy</article-title>. <source xml:lang="en"/>Pharmacol Ther. <year>2005</year>;<volume>105</volume>:<fpage>229</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">15737406</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0055">
<label>55</label>
<mixed-citation id="epi412386-cit-0055" publication-type="journal">
<string-name>
<surname>Sanabria</surname>
<given-names>ERG</given-names>
</string-name>, <string-name>
<surname>da Silva</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Spreafico</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cavalheiro</surname>
<given-names>E</given-names>
</string-name>. <article-title>Damage, reorganization, and abnormal neocortical hyperexcitability in the pilocarpine model of temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Epilepsia. <year>2002</year>;<volume>43</volume>(<issue>Suppl 5</issue>):<fpage>96</fpage>–<lpage>106</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0056">
<label>56</label>
<mixed-citation id="epi412386-cit-0056" publication-type="journal">
<string-name>
<surname>Choi</surname>
<given-names>DW</given-names>
</string-name>. <article-title>Glutamate neurotoxicity and diseases of the nervous system</article-title>. <source xml:lang="en"/>Neuron. <year>1988</year>;<volume>1</volume>:<fpage>623</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">2908446</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0057">
<label>57</label>
<mixed-citation id="epi412386-cit-0057" publication-type="journal">
<string-name>
<surname>Choi</surname>
<given-names>DW</given-names>
</string-name>. <article-title>Ionic dependence of glutamate neurotoxicity</article-title>. <source xml:lang="en"/>J Neurosci. <year>1987</year>;<volume>7</volume>:<fpage>369</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">2880938</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0058">
<label>58</label>
<mixed-citation id="epi412386-cit-0058" publication-type="journal">
<string-name>
<surname>Parent</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Leibowitz</surname>
<given-names>RT</given-names>
</string-name>, <string-name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Sloviter</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Lowenstein</surname>
<given-names>DH</given-names>
</string-name>. <article-title>Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus</article-title>. <source xml:lang="en"/>J Neurosci. <year>1997</year>;<volume>17</volume>:<fpage>3727</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">9133393</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0059">
<label>59</label>
<mixed-citation id="epi412386-cit-0059" publication-type="journal">
<string-name>
<surname>Coulter</surname>
<given-names>DA</given-names>
</string-name>. <article-title>Epilepsy‐associated plasticity in gamma‐aminobutyric acid receptor expression, function, and inhibitory synaptic properties</article-title>. <source xml:lang="en"/>Int Rev Neurobiol. <year>2001</year>;<volume>45</volume>:<fpage>237</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">11130901</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0060">
<label>60</label>
<mixed-citation id="epi412386-cit-0060" publication-type="journal">
<string-name>
<surname>Gu</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Parada</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bacci</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Graber</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Structural alterations in fast‐spiking GABAergic interneurons in a model of posttraumatic neocortical epileptogenesis</article-title>. <source xml:lang="en"/>Neurobiol Dis. <year>2017</year>;<volume>108</volume>:<fpage>100</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">28823934</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0061">
<label>61</label>
<mixed-citation id="epi412386-cit-0061" publication-type="journal">
<string-name>
<surname>Koch</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Stern</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Vasey</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Seaton</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Demers</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Harrison</surname>
<given-names>TS</given-names>
</string-name>. <article-title>Neuroendocrine and gastric myoelectrical responses to illusory self‐motion in humans</article-title>. <source xml:lang="en"/>Am J Physiol.
<year>1990</year>;<volume>258</volume>:<fpage>E304</fpage>–<lpage>310</lpage>.<pub-id pub-id-type="pmid">2137678</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0062">
<label>62</label>
<mixed-citation id="epi412386-cit-0062" publication-type="journal">
<string-name>
<surname>Olsen</surname>
<given-names>RW</given-names>
</string-name>, <string-name>
<surname>Avoli</surname>
<given-names>M</given-names>
</string-name>. <article-title>GABA and epileptogenesis</article-title>. <source xml:lang="en"/>Epilepsia. <year>1997</year>;<volume>38</volume>:<fpage>399</fpage>–<lpage>407</lpage>.<pub-id pub-id-type="pmid">9118844</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0063">
<label>63</label>
<mixed-citation id="epi412386-cit-0063" publication-type="journal">
<string-name>
<surname>Palop</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Chin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Roberson</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Thwin</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Bien‐Ly</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease</article-title>. <source xml:lang="en"/>Neuron.
<year>2007</year>;<volume>55</volume>:<fpage>697</fpage>–<lpage>711</lpage>.<pub-id pub-id-type="pmid">17785178</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0064">
<label>64</label>
<mixed-citation id="epi412386-cit-0064" publication-type="journal">
<string-name>
<surname>Scharfman</surname>
<given-names>HE</given-names>
</string-name>, <string-name>
<surname>Goodman</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Sollas</surname>
<given-names>AL</given-names>
</string-name>. <article-title>Actions of brain‐derived neurotrophic factor in slices from rats with spontaneous seizures and mossy fiber sprouting in the dentate gyrus</article-title>. <source xml:lang="en"/>J Neuroscience.
<year>1999</year>;<volume>19</volume>:<fpage>5619</fpage>–<lpage>31</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0065">
<label>65</label>
<mixed-citation id="epi412386-cit-0065" publication-type="journal">
<string-name>
<surname>Scharfman</surname>
<given-names>H</given-names>
</string-name>. <article-title>Does BDNF contribute to temporal lobe epilepsy?</article-title>
<source xml:lang="en"/>Epilepsy Curr. <year>2002</year>;<volume>2</volume>:<fpage>92</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">15309154</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0066">
<label>66</label>
<mixed-citation id="epi412386-cit-0066" publication-type="journal">
<string-name>
<surname>Curia</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lucchi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vinet</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gualtieri</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Marinelli</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Torsello</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic?</article-title>
<source xml:lang="en"/>Curr Med Chem. <year>2014</year>;<volume>21</volume>:<fpage>663</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">24251566</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0067">
<label>67</label>
<mixed-citation id="epi412386-cit-0067" publication-type="journal">
<string-name>
<surname>Casillas Espinosa</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hicks</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jeffreys</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Snutch</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Powell</surname>
<given-names>K</given-names>
</string-name>. <article-title>Z944, a Novel selective T‐type calcium channel antagonist delays the progression of seizures in the Amygdala Kindling Model</article-title>. <source xml:lang="en"/>PLoS One. <year>2015</year>;<volume>10</volume>:<elocation-id>e0130012</elocation-id>.<pub-id pub-id-type="pmid">26274319</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0068">
<label>68</label>
<mixed-citation id="epi412386-cit-0068" publication-type="journal">
<string-name>
<surname>Shultz</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Stuchbery</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Sashindranath</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury</article-title>. <source xml:lang="en"/>Brain.
<year>2015</year>;<volume>138</volume>:<fpage>1297</fpage>–<lpage>313</lpage>.<pub-id pub-id-type="pmid">25771151</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0069">
<label>69</label>
<mixed-citation id="epi412386-cit-0069" publication-type="journal">
<string-name>
<surname>Scharfman</surname>
<given-names>HE</given-names>
</string-name>. <article-title>Blockade of excitation reveals inhibition of dentate spiny hilar neurons recorded in rat hippocampal slices</article-title>. <source xml:lang="en"/>J Neurophysiol.
<year>1992</year>;<volume>68</volume>:<fpage>978</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">1359025</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0070">
<label>70</label>
<mixed-citation id="epi412386-cit-0070" publication-type="journal">
<string-name>
<surname>Scharfman</surname>
<given-names>HE</given-names>
</string-name>. <article-title>Electrophysiological diversity of pyramidal‐shaped neurons at the granule cell layer/hilus border of the rat dentate gyrus recorded in vitro</article-title>. <source xml:lang="en"/>Hippocampus.
<year>1995</year>;<volume>5</volume>:<fpage>287</fpage>–<lpage>305</lpage>.<pub-id pub-id-type="pmid">8589793</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0071">
<label>71</label>
<mixed-citation id="epi412386-cit-0071" publication-type="journal">
<string-name>
<surname>Ueda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tsuru</surname>
<given-names>N</given-names>
</string-name>. <article-title>Simultaneous monitoring of the seizure‐related changes in extracellular glutamate and gamma‐aminobutyric acid concentration in bilateral hippocampi following development of amygdaloid kindling</article-title>. <source xml:lang="en"/>Epilepsy Res.
<year>1995</year>;<volume>20</volume>:<fpage>213</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">7796793</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0072">
<label>72</label>
<mixed-citation id="epi412386-cit-0072" publication-type="journal">
<string-name>
<surname>During</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Spencer</surname>
<given-names>DD</given-names>
</string-name>. <article-title>Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain</article-title>. <source xml:lang="en"/>Lancet.
<year>1993</year>;<volume>341</volume>:<fpage>1607</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">8099987</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0073">
<label>73</label>
<mixed-citation id="epi412386-cit-0073" publication-type="journal">
<string-name>
<surname>Casillas‐Espinosa</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Powell</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>TJ</given-names>
</string-name>. <article-title>Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy</article-title>. <source xml:lang="en"/>Epilepsia.
<year>2012</year>;<volume>53</volume>(<issue>Suppl 9</issue>):<fpage>41</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="pmid">23216578</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0074">
<label>74</label>
<mixed-citation id="epi412386-cit-0074" publication-type="journal">
<string-name>
<surname>Chin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Scharfman</surname>
<given-names>HE</given-names>
</string-name>. <article-title>Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms</article-title>. <source xml:lang="en"/>Epilepsy Behav.
<year>2013</year>;<volume>26</volume>:<fpage>343</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">23321057</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0075">
<label>75</label>
<mixed-citation id="epi412386-cit-0075" publication-type="journal">
<string-name>
<surname>Costa</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Romoli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Calabresi</surname>
<given-names>P</given-names>
</string-name>. <article-title>Late onset epilepsy and Alzheimer's disease: exploring the dual pathogenic role of amyloid‐beta</article-title>. <source xml:lang="en"/>Brain.
<year>2018</year>;<volume>141</volume>:<fpage>e60</fpage>.<pub-id pub-id-type="pmid">29893897</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0076">
<label>76</label>
<mixed-citation id="epi412386-cit-0076" publication-type="journal">
<string-name>
<surname>DiFrancesco</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Tremolizzo</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Polonia</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Giussani</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bianchi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Franchi</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Adult‐onset epilepsy in presymptomatic Alzheimer's disease: a retrospective study</article-title>. <source xml:lang="en"/>J Alzheimers Dis.
<year>2017</year>;<volume>60</volume>:<fpage>1267</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">28968234</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0077">
<label>77</label>
<mixed-citation id="epi412386-cit-0077" publication-type="journal">
<string-name>
<surname>Dulla</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Coulter</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Ziburkus</surname>
<given-names>J</given-names>
</string-name>. <article-title>From molecular circuit dysfunction to disease: case studies in epilepsy, traumatic brain injury, and Alzheimer's disease</article-title>. <source xml:lang="en"/>Neuroscientist.
<year>2016</year>;<volume>22</volume>:<fpage>295</fpage>–<lpage>312</lpage>.<pub-id pub-id-type="pmid">25948650</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0078">
<label>78</label>
<mixed-citation id="epi412386-cit-0078" publication-type="journal">
<string-name>
<surname>Garg</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Joshi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Medhi</surname>
<given-names>B</given-names>
</string-name>. <article-title>Cracking novel shared targets between epilepsy and Alzheimer's disease: need of the hour</article-title>. <source xml:lang="en"/>Rev Neurosci.
<year>2018</year>;<volume>29</volume>:<fpage>425</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">29329108</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0079">
<label>79</label>
<mixed-citation id="epi412386-cit-0079" publication-type="journal">
<string-name>
<surname>Horvath</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Szucs</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hidasi</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Csukly</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Barcs</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Kamondi</surname>
<given-names>A</given-names>
</string-name>. <article-title>Prevalence, semiology, and risk factors of epilepsy in Alzheimer's disease: an ambulatory EEG study</article-title>. <source xml:lang="en"/>J Alzheimers Dis. <year>2018</year>;<volume>63</volume>:<fpage>1045</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">29710705</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0080">
<label>80</label>
<mixed-citation id="epi412386-cit-0080" publication-type="journal">
<string-name>
<surname>Jiang</surname>
<given-names>XW</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>TY</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Silico analyses for key genes and molecular genetic mechanism in epilepsy and Alzheimer's disease</article-title>. <source xml:lang="en"/>CNS Neurol Disord Drug Targets.
<year>2018</year>;<volume>17</volume>:<fpage>608</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">30047339</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0081">
<label>81</label>
<mixed-citation id="epi412386-cit-0081" publication-type="journal">
<string-name>
<surname>Lam</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Deck</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Goldman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Eskandar</surname>
<given-names>EN</given-names>
</string-name>, <string-name>
<surname>Noebels</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cole</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease</article-title>. <source xml:lang="en"/>Nat Med.
<year>2017</year>;<volume>23</volume>:<fpage>678</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">28459436</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0082">
<label>82</label>
<mixed-citation id="epi412386-cit-0082" publication-type="journal">
<string-name>
<surname>Nicastro</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Assal</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Seeck</surname>
<given-names>M</given-names>
</string-name>. <article-title>From here to epilepsy: the risk of seizure in patients with Alzheimer's disease</article-title>. <source xml:lang="en"/>Epileptic Disord.
<year>2016</year>;<volume>18</volume>:<fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0083">
<label>83</label>
<mixed-citation id="epi412386-cit-0083" publication-type="journal">
<string-name>
<surname>Palop</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Roberson</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Thwin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bien Ly</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease</article-title>. <source xml:lang="en"/>Neuron.
<year>2007</year>;<volume>55</volume>:<fpage>697</fpage>–<lpage>711</lpage>.<pub-id pub-id-type="pmid">17785178</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0084">
<label>84</label>
<mixed-citation id="epi412386-cit-0084" publication-type="journal">
<string-name>
<surname>Rapoport</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Shimshony</surname>
<given-names>A</given-names>
</string-name>. <article-title>Health hazards to the small ruminant population of the Middle East posed by the trade of sheep and goat meat</article-title>. <source xml:lang="en"/>Rev Sci Tech.
<year>1997</year>;<volume>16</volume>:<fpage>57</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">9329108</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0085">
<label>85</label>
<mixed-citation id="epi412386-cit-0085" publication-type="journal">
<string-name>
<surname>Rauramaa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Saxlin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lohvansuu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Alafuzoff</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Pitkanen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Soininen</surname>
<given-names>H</given-names>
</string-name>. <article-title>Epilepsy in neuropathologically verified Alzheimer's disease</article-title>. <source xml:lang="en"/>Seizure. <year>2018</year>;<volume>58</volume>:<fpage>9</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">29602145</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0086">
<label>86</label>
<mixed-citation id="epi412386-cit-0086" publication-type="journal">
<string-name>
<surname>Subota</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pham</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jette</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Sauro</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lorenzetti</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Holroyd‐Leduc</surname>
<given-names>J</given-names>
</string-name>. <article-title>The association between dementia and epilepsy: a systematic review and meta‐analysis</article-title>. <source xml:lang="en"/>Epilepsia.
<year>2017</year>;<volume>58</volume>:<fpage>962</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">28397967</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0087">
<label>87</label>
<mixed-citation id="epi412386-cit-0087" publication-type="journal">
<string-name>
<surname>Naegele</surname>
<given-names>J</given-names>
</string-name>. <article-title>Neuroprotective strategies to avert seizure‐induced neurodegeneration in epilepsy</article-title>. <source xml:lang="en"/>Epilepsia.
<year>2007</year>;<volume>48</volume>(<issue>Suppl 2</issue>):<fpage>107</fpage>–<lpage>17</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0088">
<label>88</label>
<mixed-citation id="epi412386-cit-0088" publication-type="journal">
<string-name>
<surname>Pitkänen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Treatment with antiepileptic drugs: Possible neuroprotective effects</article-title>. <source xml:lang="en"/>Neurology. <year>1996</year>;<volume>47</volume>:<fpage>S12</fpage>–<lpage>S16</lpage>.<pub-id pub-id-type="pmid">8677031</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0089">
<label>89</label>
<mixed-citation id="epi412386-cit-0089" publication-type="journal">
<string-name>
<surname>Nairismägi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pitkänen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kettunen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kauppinen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kubova</surname>
<given-names>H</given-names>
</string-name>. <article-title>Status epilepticus in 12‐day‐old rats leads to temporal lobe neurodegeneration and volume reduction: a histologic and MRI study</article-title>. <source xml:lang="en"/>Epilepsia. <year>2006</year>;<volume>47</volume>:<fpage>479</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">16529609</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0090">
<label>90</label>
<mixed-citation id="epi412386-cit-0090" publication-type="journal">
<string-name>
<surname>Mathern</surname>
<given-names>GW</given-names>
</string-name>, <string-name>
<surname>Babb</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Pretorius</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Melendez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Levesque</surname>
<given-names>MF</given-names>
</string-name>. <article-title>The pathophysiologic relationships between lesion pathology, intracranial ictal EEG onsets, and hippocampal neuron losses in temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Epilepsy Res.
<year>1995</year>;<volume>21</volume>:<fpage>133</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">7588588</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0091">
<label>91</label>
<mixed-citation id="epi412386-cit-0091" publication-type="journal">
<string-name>
<surname>Mathern</surname>
<given-names>GW</given-names>
</string-name>, <string-name>
<surname>Cifuentes</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Leite</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Pretorius</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Babb</surname>
<given-names>TL</given-names>
</string-name>. <article-title>Hippocampal EEG excitability and chronic spontaneous seizures are associated with aberrant synaptic reorganization in the rat intrahippocampal kainate model</article-title>. <source xml:lang="en"/>Electroencephalogr Clin Neurophysiol.
<year>1993</year>;<volume>87</volume>:<fpage>326</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">7693444</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0092">
<label>92</label>
<mixed-citation id="epi412386-cit-0092" publication-type="journal">
<string-name>
<surname>Thom</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sisodiya</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Beckett</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Martinian</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>W‐R</given-names>
</string-name>, <string-name>
<surname>Harkness</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>Cytoarchitectural abnormalities in hippocampal sclerosis</article-title>. <source xml:lang="en"/>J Neuropathol Exp Neurol.
<year>2002</year>;<volume>61</volume>:<fpage>510</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">12071634</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0093">
<label>93</label>
<mixed-citation id="epi412386-cit-0093" publication-type="journal">
<string-name>
<surname>Dragunow</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bilkey</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Lawlor</surname>
<given-names>P</given-names>
</string-name>. <article-title>Induction of immediate‐early gene proteins in dentate granule cells and somatostatin interneurons after hippocampal seizures</article-title>. <source xml:lang="en"/>Mol Brain Res.
<year>1992</year>;<volume>13</volume>:<fpage>119</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">1349720</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0094">
<label>94</label>
<mixed-citation id="epi412386-cit-0094" publication-type="journal">
<string-name>
<surname>Herdegen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sandkühler</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gass</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kiessling</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bravo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Zimmermann</surname>
<given-names>MJUN</given-names>
</string-name>, et al. <article-title>and CREB transcription factor proteins in the rat cortex: basal expression and induction by spreading depression and epileptic seizures</article-title>. <source xml:lang="en"/>J Comp Neurol. <year>1993</year>;<volume>333</volume>:<fpage>271</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">8345107</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0095">
<label>95</label>
<mixed-citation id="epi412386-cit-0095" publication-type="journal">
<string-name>
<surname>Dragunow</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hughes</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>MacGibbon</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lawlor</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Singleton</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Is c‐Jun involved in nerve cell death following status epilepticus and hypoxic‐ischaemic brain injury?</article-title>
<source xml:lang="en"/>Mol Brain Res. <year>1993</year>;<volume>18</volume>:<fpage>347</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">8326831</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0096">
<label>96</label>
<mixed-citation id="epi412386-cit-0096" publication-type="journal">
<string-name>
<surname>Gass</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bruehl</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Herdegen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kiessling</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lutzenburg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Witte</surname>
<given-names>OW</given-names>
</string-name>. <article-title>Induction of FOS and JUN proteins during focal epilepsy: congruences with and differences to [14C]deoxyglucose metabolism</article-title>. <source xml:lang="en"/>Mol Brain Res. <year>1997</year>;<volume>46</volume>:<fpage>177</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">9191092</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0097">
<label>97</label>
<mixed-citation id="epi412386-cit-0097" publication-type="journal">
<string-name>
<surname>Engel</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sanz Rodgriguez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jimenez Mateos</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Concannon</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Jimenez Pacheco</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Moran</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>CHOP regulates the p53‐MDM2 axis and is required for neuronal survival after seizures</article-title>. <source xml:lang="en"/>Brain. <year>2013</year>;<volume>136</volume>:<fpage>577</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">23361066</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0098">
<label>98</label>
<mixed-citation id="epi412386-cit-0098" publication-type="journal">
<string-name>
<surname>Jewett</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Christian</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bacos</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>N‐P</given-names>
</string-name>. <article-title>Feedback modulation of neural network synchrony and seizure susceptibility by Mdm2‐p53‐Nedd4‐2 signaling</article-title>. <source xml:lang="en"/>Mol Brain.
<year>2016</year>;<volume>9</volume>:<fpage>32</fpage>.<pub-id pub-id-type="pmid">27000207</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0099">
<label>99</label>
<mixed-citation id="epi412386-cit-0099" publication-type="journal">
<string-name>
<surname>Kilany</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Raouf</surname>
<given-names>ERA</given-names>
</string-name>, <string-name>
<surname>Gaber</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Aloush</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Aref</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Anwar</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Elevated serum Bcl‐2 in children with temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Seizure (London, England).
<year>2012</year>;<volume>21</volume>:<fpage>250</fpage>–<lpage>3</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0100">
<label>100</label>
<mixed-citation id="epi412386-cit-0100" publication-type="journal">
<string-name>
<surname>El Hodhod</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Tomoum</surname>
<given-names>HY</given-names>
</string-name>. <article-title>Abd Al‐Aziz MM, Samaan SM. Serum Fas and Bcl‐2 in patients with epilepsy</article-title>. <source xml:lang="en"/>Acta Neurol Scand. <year>2006</year>;<volume>113</volume>:<fpage>315</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">16629767</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0101">
<label>101</label>
<mixed-citation id="epi412386-cit-0101" publication-type="journal">
<string-name>
<surname>Tzeng</surname>
<given-names>T‐T</given-names>
</string-name>, <string-name>
<surname>Tsay</surname>
<given-names>H‐J</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>C‐L</given-names>
</string-name>, <string-name>
<surname>Lai</surname>
<given-names>T‐H</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>F‐L</given-names>
</string-name>, et al. <article-title>Caspase 3 involves in neuroplasticity, microglial activation and neurogenesis in the mice hippocampus after intracerebral injection of kainic acid</article-title>. <source xml:lang="en"/>J Biomed Sci. <year>2013</year>;<volume>20</volume>:<fpage>90</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">24313976</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0102">
<label>102</label>
<mixed-citation id="epi412386-cit-0102" publication-type="journal">
<string-name>
<surname>Narkilahti</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pitkänen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Caspase 6 expression in the rat hippocampus during epileptogenesis and epilepsy</article-title>. <source xml:lang="en"/>Neuroscience. <year>2005</year>;<volume>131</volume>:<fpage>887</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">15749343</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0103">
<label>103</label>
<mixed-citation id="epi412386-cit-0103" publication-type="journal">
<string-name>
<surname>Shapiro</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ribak</surname>
<given-names>C</given-names>
</string-name>. <article-title>Rapid astrocyte and microglial activation following pilocarpine‐induced seizures in rats</article-title>. <source xml:lang="en"/>Epilepsia.
<year>2008</year>;<volume>49</volume>(<issue>Suppl 2</issue>):<fpage>33</fpage>–<lpage>41</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0104">
<label>104</label>
<mixed-citation id="epi412386-cit-0104" publication-type="journal">
<string-name>
<surname>Vezzani</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ravizza</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Balosso</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aronica</surname>
<given-names>E</given-names>
</string-name>. <article-title>Glia as a source of cytokines: implications for neuronal excitability and survival</article-title>. <source xml:lang="en"/>Epilepsia.
<year>2008</year>;<volume>49</volume>(<issue>Suppl 2</issue>):<fpage>24</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">18226169</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0105">
<label>105</label>
<mixed-citation id="epi412386-cit-0105" publication-type="journal">
<string-name>
<surname>Cavazos</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cross</surname>
<given-names>D</given-names>
</string-name>. <article-title>The role of synaptic reorganization in mesial temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Epilepsy Behav.
<year>2006</year>;<volume>8</volume>:<fpage>483</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">16500154</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0106">
<label>106</label>
<mixed-citation id="epi412386-cit-0106" publication-type="journal">
<string-name>
<surname>Foresti</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Arisi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Shapiro</surname>
<given-names>L</given-names>
</string-name>. <article-title>Role of glia in epilepsy‐associated neuropathology, neuroinflammation and neurogenesis</article-title>. <source xml:lang="en"/>Brain Res Rev.
<year>2011</year>;<volume>66</volume>:<fpage>115</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">20837059</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0107">
<label>107</label>
<mixed-citation id="epi412386-cit-0107" publication-type="journal">
<string-name>
<surname>Sutula</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Cascino</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Cavazos</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Parada</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Ramirez</surname>
<given-names>L</given-names>
</string-name>. <article-title>Mossy fiber synaptic reorganization in the epileptic human temporal lobe</article-title>. <source xml:lang="en"/>Annals Neurol.
<year>1989</year>;<volume>26</volume>:<fpage>321</fpage>–<lpage>30</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0108">
<label>108</label>
<mixed-citation id="epi412386-cit-0108" publication-type="journal">
<string-name>
<surname>Cavazos</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Sutula</surname>
<given-names>TP</given-names>
</string-name>. <article-title>Progressive neuronal loss induced by kindling: a possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis</article-title>. <source xml:lang="en"/>Brain Res.
<year>1990</year>;<volume>527</volume>:<fpage>1</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">2282474</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0109">
<label>109</label>
<mixed-citation id="epi412386-cit-0109" publication-type="journal">
<string-name>
<surname>Buckmaster</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Dudek</surname>
<given-names>FE</given-names>
</string-name>. <article-title>In vivo intracellular analysis of granule cell axon reorganization in epileptic rats</article-title>. <source xml:lang="en"/>J Neurophysiol.
<year>1999</year>;<volume>81</volume>:<fpage>712</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">10036272</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0110">
<label>110</label>
<mixed-citation id="epi412386-cit-0110" publication-type="journal">
<string-name>
<surname>Tauck</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Nadler</surname>
<given-names>JV</given-names>
</string-name>. <article-title>Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid‐treated rats</article-title>. <source xml:lang="en"/>J Neurosci.
<year>1985</year>;<volume>5</volume>:<fpage>1016</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">3981241</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0111">
<label>111</label>
<mixed-citation id="epi412386-cit-0111" publication-type="journal">
<string-name>
<surname>Bouilleret</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Loup</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Kiener</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Marescaux</surname>
<given-names>C</given-names>
</string-name>. <article-title>Fritschy JM. Early loss of interneurons and delayed subunit‐specific changes in GABA(A)‐receptor expression in a mouse model of mesial temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Hippocampus. <year>2000</year>;<volume>10</volume>:<fpage>305</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">10902900</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0112">
<label>112</label>
<mixed-citation id="epi412386-cit-0112" publication-type="journal">
<string-name>
<surname>Loup</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wieser</surname>
<given-names>HG</given-names>
</string-name>, <string-name>
<surname>Yonekawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Aguzzi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fritschy</surname>
<given-names>JM</given-names>
</string-name>. <article-title>Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy</article-title>. <source xml:lang="en"/>J Neurosci.
<year>2000</year>;<volume>20</volume>:<fpage>5401</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">10884325</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0113">
<label>113</label>
<mixed-citation id="epi412386-cit-0113" publication-type="journal">
<string-name>
<surname>Cavazos</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Cross</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>Sprouting and synaptic reorganization in the subiculum and CA1 region of the hippocampus in acute and chronic models of partial‐onset epilepsy</article-title>. <source xml:lang="en"/>Neuroscience. <year>2004</year>;<volume>126</volume>:<fpage>677</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">15183517</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0114">
<label>114</label>
<mixed-citation id="epi412386-cit-0114" publication-type="journal">
<string-name>
<surname>Brooks Kayal</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Raol</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Russek</surname>
<given-names>S</given-names>
</string-name>. <article-title>Alteration of epileptogenesis genes</article-title>. <source xml:lang="en"/>Neurotherapeutics. <year>2009</year>;<volume>6</volume>:<fpage>312</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">19332325</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0115">
<label>115</label>
<mixed-citation id="epi412386-cit-0115" publication-type="journal">
<string-name>
<surname>Casillas Espinosa</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Powell</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>T</given-names>
</string-name>. <article-title>Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy</article-title>. <source xml:lang="en"/>Epilepsia.
<year>2012</year>;<volume>53</volume>(<issue>Suppl 9</issue>):<fpage>41</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="pmid">23216578</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0116">
<label>116</label>
<mixed-citation id="epi412386-cit-0116" publication-type="journal">
<string-name>
<surname>Dingledine</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Borges</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bowie</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Traynelis</surname>
<given-names>SF</given-names>
</string-name>. <article-title>The glutamate receptor ion channels</article-title>. <source xml:lang="en"/>Pharmacol Rev.
<year>1999</year>;<volume>51</volume>:<fpage>7</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">10049997</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0117">
<label>117</label>
<mixed-citation id="epi412386-cit-0117" publication-type="journal">
<string-name>
<surname>Nagarkatti</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Deshpande</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>DeLorenzo</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Development of the calcium plateau following status epilepticus: role of calcium in epileptogenesis</article-title>. <source xml:lang="en"/>Expert Rev Neurother.
<year>2009</year>;<volume>9</volume>:<fpage>813</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">19496685</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0118">
<label>118</label>
<mixed-citation id="epi412386-cit-0118" publication-type="journal">
<string-name>
<surname>Selcher</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Hanson</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Malenka</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Madison</surname>
<given-names>DV</given-names>
</string-name>. <article-title>Glutamate receptor subunit GluA1 is necessary for long‐term potentiation and synapse unsilencing, but not long‐term depression in mouse hippocampus</article-title>. <source xml:lang="en"/>Brain Res. <year>2012</year>;<volume>1435</volume>:<fpage>8</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">22197030</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0119">
<label>119</label>
<mixed-citation id="epi412386-cit-0119" publication-type="journal">
<string-name>
<surname>Sheldon</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>MB</given-names>
</string-name>. <article-title>The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention</article-title>. <source xml:lang="en"/>Neurochem Int.
<year>2007</year>;<volume>51</volume>:<fpage>333</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">17517448</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0120">
<label>120</label>
<mixed-citation id="epi412386-cit-0120" publication-type="journal">
<string-name>
<surname>Meeren</surname>
<given-names>HK</given-names>
</string-name>, <string-name>
<surname>Pijn</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Van Luijtelaar</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Coenen</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Lopes da Silva</surname>
<given-names>FH</given-names>
</string-name>. <article-title>Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats</article-title>. <source xml:lang="en"/>J Neurosci.
<year>2002</year>;<volume>22</volume>:<fpage>1480</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">11850474</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0121">
<label>121</label>
<mixed-citation id="epi412386-cit-0121" publication-type="journal">
<string-name>
<surname>Tanaka</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Grooms</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Bennett</surname>
<given-names>MV</given-names>
</string-name>. <article-title>Zukin RS. The AMPAR subunit GluR2: still front and center‐stage</article-title>. <source xml:lang="en"/>Brain Res. <year>2000</year>;<volume>886</volume>:<fpage>190</fpage>–<lpage>207</lpage>.<pub-id pub-id-type="pmid">11119696</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0122">
<label>122</label>
<mixed-citation id="epi412386-cit-0122" publication-type="journal">
<string-name>
<surname>McNamara</surname>
<given-names>JO</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>YZ</given-names>
</string-name>, <string-name>
<surname>Leonard</surname>
<given-names>AS</given-names>
</string-name>. <article-title>Molecular signaling mechanisms underlying epileptogenesis</article-title>. <source xml:lang="en"/>Sci STKE. <year>2006</year>;<volume>2006</volume>:<fpage>re12</fpage>.<pub-id pub-id-type="pmid">17033045</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0123">
<label>123</label>
<mixed-citation id="epi412386-cit-0123" publication-type="journal">
<string-name>
<surname>Krestel</surname>
<given-names>HE</given-names>
</string-name>, <string-name>
<surname>Shimshek</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Jensen</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Nevian</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Geng</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>A genetic switch for epilepsy in adult mice</article-title>. <source xml:lang="en"/>J Neurosci. <year>2004</year>;<volume>24</volume>:<fpage>10568</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">15548671</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0124">
<label>124</label>
<mixed-citation id="epi412386-cit-0124" publication-type="journal">
<string-name>
<surname>Sanchez</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Koh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rio</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lamperti</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>Sharma</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia‐induced seizures</article-title>. <source xml:lang="en"/>J Neurosci. <year>2001</year>;<volume>21</volume>:<fpage>8154</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">11588188</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0125">
<label>125</label>
<mixed-citation id="epi412386-cit-0125" publication-type="journal">
<string-name>
<surname>Sierra</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gröhn</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Pitkänen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Imaging microstructural damage and plasticity in the hippocampus during epileptogenesis</article-title>. <source xml:lang="en"/>Neuroscience.
<year>2015</year>;<volume>309</volume>:<fpage>162</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">25934032</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0126">
<label>126</label>
<mixed-citation id="epi412386-cit-0126" publication-type="journal">
<string-name>
<surname>Goldensohn</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Salazar</surname>
<given-names>AM</given-names>
</string-name>. <article-title>Temporal and spatial distribution of intracellular potentials during generation and spread of epileptogenic discharges</article-title>. <source xml:lang="en"/>Adv Neurol.
<year>1986</year>;<volume>44</volume>:<fpage>559</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">3706020</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0127">
<label>127</label>
<mixed-citation id="epi412386-cit-0127" publication-type="journal">
<string-name>
<surname>Cavazos</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Golarai</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Sutula</surname>
<given-names>TP</given-names>
</string-name>. <article-title>Mossy fiber synaptic reorganization induced by kindling: time course of development, progression, and permanence</article-title>. <source xml:lang="en"/>J Neurosci.
<year>1991</year>;<volume>11</volume>:<fpage>2795</fpage>–<lpage>803</lpage>.<pub-id pub-id-type="pmid">1880549</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0128">
<label>128</label>
<mixed-citation id="epi412386-cit-0128" publication-type="journal">
<string-name>
<surname>Meldrum</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Rogawski</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Molecular targets for antiepileptic drug development</article-title>. <source xml:lang="en"/>Neurotherapeutics. <year>2007</year>;<volume>4</volume>:<fpage>18</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">17199015</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0129">
<label>129</label>
<mixed-citation id="epi412386-cit-0129" publication-type="journal">
<string-name>
<surname>Rogawski</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Revisiting AMPA receptors as an antiepileptic drug target</article-title>. <source xml:lang="en"/>Epilepsy Curr.
<year>2011</year>;<volume>11</volume>:<fpage>56</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">21686307</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0130">
<label>130</label>
<mixed-citation id="epi412386-cit-0130" publication-type="journal">
<string-name>
<surname>Krauss</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Bar</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Biton</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Klapper</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Rektor</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Vaiciene‐Magistris</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Tolerability and safety of perampanel: two randomized dose‐escalation studies</article-title>. <source xml:lang="en"/>Acta Neurol Scand.
<year>2012</year>;<volume>125</volume>:<fpage>8</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">21883097</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0131">
<label>131</label>
<mixed-citation id="epi412386-cit-0131" publication-type="journal">
<string-name>
<surname>Trinka</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Steinhoff</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Nikanorova</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brodie</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>Perampanel for focal epilepsy: insights from early clinical experience</article-title>. <source xml:lang="en"/>Acta Neurol Scand.
<year>2016</year>;<volume>133</volume>:<fpage>160</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">26506904</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0132">
<label>132</label>
<mixed-citation id="epi412386-cit-0132" publication-type="journal">
<string-name>
<surname>Brodie</surname>
<given-names>M</given-names>
</string-name>. <article-title>Practical use of newer antiepileptic drugs as adjunctive therapy in focal epilepsy</article-title>. <source xml:lang="en"/>CNS Drugs.
<year>2015</year>;<volume>29</volume>:<fpage>893</fpage>–<lpage>904</lpage>.<pub-id pub-id-type="pmid">26507832</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0133">
<label>133</label>
<mixed-citation id="epi412386-cit-0133" publication-type="journal">
<string-name>
<surname>Glauser</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Laurenza</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fain</surname>
<given-names>R</given-names>
</string-name>. <article-title>Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post‐hoc analysis</article-title>. <source xml:lang="en"/>Epilepsy Res.
<year>2016</year>;<volume>119</volume>:<fpage>34</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">26656783</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0134">
<label>134</label>
<mixed-citation id="epi412386-cit-0134" publication-type="journal">
<string-name>
<surname>Hanada</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hashizume</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tokuhara</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Takenaka</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Kohmura</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ogasawara</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Perampanel: a novel, orally active, noncompetitive AMPA‐receptor antagonist that reduces seizure activity in rodent models of epilepsy</article-title>. <source xml:lang="en"/>Epilepsia. <year>2011</year>;<volume>52</volume>:<fpage>1331</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">21635236</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0135">
<label>135</label>
<mixed-citation id="epi412386-cit-0135" publication-type="journal">
<string-name>
<surname>Ceolin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bortolotto</surname>
<given-names>ZA</given-names>
</string-name>, <string-name>
<surname>Bannister</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Collingridge</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Lodge</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Volianskis</surname>
<given-names>A</given-names>
</string-name>. <article-title>A novel anti‐epileptic agent, perampanel, selectively inhibits AMPA receptor‐mediated synaptic transmission in the hippocampus</article-title>. <source xml:lang="en"/>Neurochem Int. <year>2012</year>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0136">
<label>136</label>
<mixed-citation id="epi412386-cit-0136" publication-type="journal">
<string-name>
<surname>Wu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ido</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Osada</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kotani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tamaoka</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hanada</surname>
<given-names>T</given-names>
</string-name>. <article-title>The neuroprotective effect of perampanel in lithium‐pilocarpine rat seizure model</article-title>. <source xml:lang="en"/>Epilepsy Res.
<year>2017</year>;<volume>137</volume>:<fpage>152</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">28624183</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0137">
<label>137</label>
<mixed-citation id="epi412386-cit-0137" publication-type="journal">
<string-name>
<surname>Twele</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bankstahl</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Römermann</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Löscher</surname>
<given-names>W</given-names>
</string-name>. <article-title>The AMPA receptor antagonist NBQX exerts anti‐seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Neuropharmacology.
<year>2015</year>;<volume>95</volume>:<fpage>234</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">25839899</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0138">
<label>138</label>
<mixed-citation id="epi412386-cit-0138" publication-type="journal">
<string-name>
<surname>Apland</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Aroniadou Anderjaska</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Figueiredo</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Green</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Swezey</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman‐exposure model without pretreatment and its pharmacokinetics after intramuscular administration</article-title>. <source xml:lang="en"/>J Pharmacol Exp Therap.
<year>2013</year>;<volume>344</volume>:<fpage>133</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">23042954</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0139">
<label>139</label>
<mixed-citation id="epi412386-cit-0139" publication-type="book">
<string-name>
<surname>Zheng</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Shultz</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hovens</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>TJ</given-names>
</string-name>. In <person-group person-group-type="editor"><name name-style="western"><surname>Pitkanen</surname><given-names>A</given-names></name></person-group>, editor. <source xml:lang="en"/>Animal Models of Acquired Epilepsy and Tauopathies. 2 ed. <publisher-name>Academic Press</publisher-name>; <year>2017</year>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0140">
<label>140</label>
<mixed-citation id="epi412386-cit-0140" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Leugers</surname>
<given-names>CJ</given-names>
</string-name>. <article-title>Tau and tauopathies</article-title>. <source xml:lang="en"/>Prog Mol Biol Transl Sci.
<year>2012</year>;<volume>107</volume>:<fpage>263</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">22482453</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0141">
<label>141</label>
<mixed-citation id="epi412386-cit-0141" publication-type="journal">
<string-name>
<surname>Morris</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Maeda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Vossel</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mucke</surname>
<given-names>L</given-names>
</string-name>. <article-title>The many faces of tau</article-title>. <source xml:lang="en"/>Neuron. <year>2011</year>;<volume>70</volume>:<fpage>410</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">21555069</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0142">
<label>142</label>
<mixed-citation id="epi412386-cit-0142" publication-type="journal">
<string-name>
<surname>Bi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gladbach</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>van Eersel</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ittner</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Przybyla</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>van Hummel</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Tau exacerbates excitotoxic brain damage in an animal model of stroke</article-title>. <source xml:lang="en"/>Nat Communicat.
<year>2017</year>;<volume>8</volume>:<fpage>473</fpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0143">
<label>143</label>
<mixed-citation id="epi412386-cit-0143" publication-type="journal">
<string-name>
<surname>Engel</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Goni‐Oliver</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Lucas</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Avila</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hernandez</surname>
<given-names>F</given-names>
</string-name>. <article-title>Chronic lithium administration to FTDP‐17 tau and GSK‐3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre‐formed neurofibrillary tangles do not revert</article-title>. <source xml:lang="en"/>J Neurochem. <year>2006</year>;<volume>99</volume>:<fpage>1445</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">17059563</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0144">
<label>144</label>
<mixed-citation id="epi412386-cit-0144" publication-type="journal">
<string-name>
<surname>Puvenna</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Engeler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Banjara</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brennan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schreiber</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Dadas</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Is phosphorylated tau unique to chronic traumatic encephalopathy? Phosphorylated tau in epileptic brain and chronic traumatic encephalopathy</article-title>. <source xml:lang="en"/>Brain Res.
<year>2016</year>;<volume>1630</volume>:<fpage>225</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">26556772</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0145">
<label>145</label>
<mixed-citation id="epi412386-cit-0145" publication-type="journal">
<string-name>
<surname>Tai</surname>
<given-names>XY</given-names>
</string-name>, <string-name>
<surname>Koepp</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Duncan</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Fox</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Baxendale</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections</article-title>. <source xml:lang="en"/>Brain.
<year>2016</year>;<volume>139</volume>:<fpage>2441</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">27497924</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0146">
<label>146</label>
<mixed-citation id="epi412386-cit-0146" publication-type="journal">
<string-name>
<surname>Thom</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Phadke</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Narkiewicz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Martinian</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post‐mortem study</article-title>. <source xml:lang="en"/>Brain.
<year>2011</year>;<volume>134</volume>:<fpage>2969</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">21903728</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0147">
<label>147</label>
<mixed-citation id="epi412386-cit-0147" publication-type="journal">
<string-name>
<surname>Sanchez</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Garcia‐Cabrero</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Sanchez‐Elexpuru</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Burgos</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Serratosa</surname>
<given-names>JM</given-names>
</string-name>. <article-title>Tau‐induced pathology in epilepsy and dementia: notions from patients and animal models</article-title>. <source xml:lang="en"/>Int J Mol Sci. <year>2018</year>;<volume>19</volume>:<fpage>E1092</fpage>
<pub-id pub-id-type="doi">10.3390/ijms19041092</pub-id>
<pub-id pub-id-type="pmid">29621183</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0148">
<label>148</label>
<mixed-citation id="epi412386-cit-0148" publication-type="journal">
<string-name>
<surname>Sen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Thom</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Martinian</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Harding</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Cross</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Nikolic</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Pathological tau tangles localize to focal cortical dysplasia in older patients</article-title>. <source xml:lang="en"/>Epilepsia.
<year>2007</year>;<volume>48</volume>:<fpage>1447</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">17441989</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0149">
<label>149</label>
<mixed-citation id="epi412386-cit-0149" publication-type="journal">
<string-name>
<surname>Hawkins</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Krishnamurthy</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Castillo‐Carranza</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Sengupta</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Prough</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>GR</given-names>
</string-name>, et al. <article-title>Rapid accumulation of endogenous tau oligomers in a rat model of traumatic brain injury</article-title>. <source xml:lang="en"/>J Biol Chem.
<year>2013</year>;<volume>288</volume>:<fpage>17042</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">23632019</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0150">
<label>150</label>
<mixed-citation id="epi412386-cit-0150" publication-type="journal">
<string-name>
<surname>Monti</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tondelli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Giovannini</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bedin</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Nichelli</surname>
<given-names>PF</given-names>
</string-name>, <string-name>
<surname>Trenti</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Cerebrospinal fluid tau proteins in status epilepticus</article-title>. <source xml:lang="en"/>Epilepsy Behav.
<year>2015</year>;<volume>49</volume>:<fpage>150</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">25958230</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0151">
<label>151</label>
<mixed-citation id="epi412386-cit-0151" publication-type="journal">
<string-name>
<surname>Palmio</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Suhonen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Keranen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hulkkonen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Peltola</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pirttila</surname>
<given-names>T</given-names>
</string-name>. <article-title>Cerebrospinal fluid tau as a marker of neuronal damage after epileptic seizure</article-title>. <source xml:lang="en"/>Seizure.
<year>2009</year>;<volume>18</volume>:<fpage>474</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">19428269</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0152">
<label>152</label>
<mixed-citation id="epi412386-cit-0152" publication-type="journal">
<string-name>
<surname>Shahim</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rejdak</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ksiazek</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Blennow</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Zetterberg</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mattsson</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Cerebrospinal fluid biomarkers of beta‐amyloid metabolism and neuronal damage in epileptic seizures</article-title>. <source xml:lang="en"/>Eur J Neurol.
<year>2014</year>;<volume>21</volume>:<fpage>486</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">24372994</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0153">
<label>153</label>
<mixed-citation id="epi412386-cit-0153" publication-type="journal">
<string-name>
<surname>Gheyara</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Ponnusamy</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Djukic</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Craft</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Ho</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>Tau reduction prevents disease in a mouse model of Dravet syndrome</article-title>. <source xml:lang="en"/>Ann Neurology.
<year>2014</year>;<volume>76</volume>:<fpage>443</fpage>–<lpage>56</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0154">
<label>154</label>
<mixed-citation id="epi412386-cit-0154" publication-type="journal">
<string-name>
<surname>Holth</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Bomben</surname>
<given-names>VC</given-names>
</string-name>, <string-name>
<surname>Reed</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Inoue</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Younkin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Younkin</surname>
<given-names>SG</given-names>
</string-name>, et al. <article-title>Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy</article-title>. <source xml:lang="en"/>J Neurosci.
<year>2013</year>;<volume>33</volume>:<fpage>1651</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">23345237</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0155">
<label>155</label>
<mixed-citation id="epi412386-cit-0155" publication-type="journal">
<string-name>
<surname>Yan</surname>
<given-names>XX</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shelton</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>XG</given-names>
</string-name>, <string-name>
<surname>Oddo</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Chronic temporal lobe epilepsy is associated with enhanced Alzheimer‐like neuropathology in 36 x Tg‐AD mice</article-title>.<source xml:lang="en"/> PloS One. <year>2012</year>;<fpage>7:</fpage>
<elocation-id>e48782</elocation-id>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0156">
<label>156</label>
<mixed-citation id="epi412386-cit-0156" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shultz</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hovens</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Adlard</surname>
<given-names>PA</given-names>
</string-name>, et al. <article-title>Accelerated kindling epileptogenesis in Tg4510 tau transgenic mice, but not in tau knockout mice</article-title>. <source xml:lang="en"/>Epilepsia. <year>2017</year>;<volume>58</volume>:<fpage>E136</fpage>–<lpage>E141</lpage>.<pub-id pub-id-type="pmid">28710841</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0157">
<label>157</label>
<mixed-citation id="epi412386-cit-0157" publication-type="journal">
<string-name>
<surname>Jones</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Corcoran</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Velakoulis</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Grundy</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models</article-title>. <source xml:lang="en"/>Neurobiol Dis.
<year>2012</year>;<volume>45</volume>:<fpage>897</fpage>–<lpage>901</lpage>.<pub-id pub-id-type="pmid">22182692</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0158">
<label>158</label>
<mixed-citation id="epi412386-cit-0158" publication-type="journal">
<string-name>
<surname>Bhowmik</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Khanam</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Saini</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Vohora</surname>
<given-names>D</given-names>
</string-name>. <article-title>Activation of AKT/GSK3beta pathway by TDZD‐8 attenuates kainic acid induced neurodegeneration but not seizures in mice</article-title>. <source xml:lang="en"/>Neurotoxicology. <year>2015</year>;<volume>46</volume>:<fpage>44</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">25453207</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0159">
<label>159</label>
<mixed-citation id="epi412386-cit-0159" publication-type="journal">
<string-name>
<surname>Roberson</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>Scearce‐Levie</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Palop</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>FR</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>IH</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Reducing endogenous tau ameliorates amyloid beta‐induced deficits in an Alzheimer's disease mouse model</article-title>. <source xml:lang="en"/>Science.
<year>2007</year>;<volume>316</volume>:<fpage>750</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">17478722</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0160">
<label>160</label>
<mixed-citation id="epi412386-cit-0160" publication-type="journal">
<string-name>
<surname>Matsumoto</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Sakai</surname>
<given-names>H</given-names>
</string-name>. <article-title>Microtubules inside the plasma membrane of squid giant axons and their possible physiological function</article-title>. <source xml:lang="en"/>J Membr Biol.
<year>1979</year>;<volume>50</volume>:<fpage>1</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">501731</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0161">
<label>161</label>
<mixed-citation id="epi412386-cit-0161" publication-type="journal">
<string-name>
<surname>DeVos</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Goncharoff</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Kebodeaux</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Stewart</surname>
<given-names>FR</given-names>
</string-name>, et al. <article-title>Antisense reduction of tau in adult mice protects against seizures</article-title>.<source xml:lang="en"/> J Neurosci. <year>2013</year>;<volume>33</volume>:<fpage>12887</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">23904623</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0162">
<label>162</label>
<mixed-citation id="epi412386-cit-0162" publication-type="journal">
<string-name>
<surname>Bi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gladbach</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>van Eersel</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ittner</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Przybyla</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>van Hummel</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Tau exacerbates excitotoxic brain damage in an animal model of stroke</article-title>. <source xml:lang="en"/>Nat Commun. <year>2017</year>;<volume>8</volume>:<fpage>473</fpage>.<pub-id pub-id-type="pmid">28883427</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0163">
<label>163</label>
<mixed-citation id="epi412386-cit-0163" publication-type="journal">
<string-name>
<surname>Hatch</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gotz</surname>
<given-names>J</given-names>
</string-name>. <article-title>Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment</article-title>. <source xml:lang="en"/>Acta Neuropathol. <year>2017</year>;<volume>133</volume>:<fpage>717</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">28091722</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0164">
<label>164</label>
<mixed-citation id="epi412386-cit-0164" publication-type="journal">
<string-name>
<surname>Mondragon Rodriguez</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Salas Gallardo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gonzalez Pereyra</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Macias</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ordaz</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Pena Ortega</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Phosphorylation of tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model</article-title>. <source xml:lang="en"/>J Biol Chem. <year>2018</year>;<volume> 293</volume>:<fpage>8462</fpage>–<lpage>8472</lpage>.<pub-id pub-id-type="pmid">29632073</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0165">
<label>165</label>
<mixed-citation id="epi412386-cit-0165" publication-type="journal">
<string-name>
<surname>Liang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Iqbal</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Grundke‐Iqbal</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Gong</surname>
<given-names>CX</given-names>
</string-name>. <article-title>Dysregulation of tau phosphorylation in mouse brain during excitotoxic damage</article-title>. <source xml:lang="en"/>J Alzheimer's Dis.
<year>2009</year>;<volume>17</volume>:<fpage>531</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">19363259</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0166">
<label>166</label>
<mixed-citation id="epi412386-cit-0166" publication-type="journal">
<string-name>
<surname>van Eersel</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ke</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Delerue</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Kril</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Götz</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA. <year>2010</year>;<volume>107</volume>:<fpage>13888</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">20643941</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0167">
<label>167</label>
<mixed-citation id="epi412386-cit-0167" publication-type="journal">
<string-name>
<surname>Corcoran</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hutter Paier</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Windisch</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nheu</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model</article-title>. <source xml:lang="en"/>J Clin Neurosci. <year>2010</year>;<volume>17</volume>:<fpage>1025</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">20537899</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0168">
<label>168</label>
<mixed-citation id="epi412386-cit-0168" publication-type="journal">
<string-name>
<surname>Corcoran</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Hovens</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Michael</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rosenthal</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Costello</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Open‐label, phase I dose‐escalation study of sodium selenate, a novel activator of PP2A, in patients with castration‐resistant prostate cancer</article-title>. <source xml:lang="en"/>Br J Cancer. <year>2010</year>;<volume>103</volume>:<fpage>462</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">20648008</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0169">
<label>169</label>
<mixed-citation id="epi412386-cit-0169" publication-type="journal">
<string-name>
<surname>Malpas</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vivash</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Genc</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Saling</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Desmond</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Steward</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>A phase IIa randomized control trial of VEL015 (sodium selenate) in mild‐moderate Alzheimer's disease</article-title>. <source xml:lang="en"/>J Alzheimers Dis. <year>2016</year>;<volume>54</volume>:<fpage>223</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">27447428</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0170">
<label>170</label>
<mixed-citation id="epi412386-cit-0170" publication-type="journal">
<string-name>
<surname>Masters</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bateman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Blennow</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Rowe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sperling</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cummings</surname>
<given-names>J</given-names>
</string-name>. <article-title>Alzheimer's disease</article-title>. <source xml:lang="en"/>Nat Rev Dis Primers.
<year>2015</year>;<volume>1</volume>:<fpage>15056</fpage>.<pub-id pub-id-type="pmid">27188934</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0171">
<label>171</label>
<mixed-citation id="epi412386-cit-0171" publication-type="journal">
<string-name>
<surname>Masters</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Selkoe</surname>
<given-names>D</given-names>
</string-name>. <article-title>Biochemistry of amyloid β‐protein and amyloid deposits in Alzheimer disease</article-title>. <source xml:lang="en"/>Cold Spring Harb Perspect Med. <year>2012</year>;<volume>2</volume>:<fpage>a006262</fpage>.<pub-id pub-id-type="pmid">22675658</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0172">
<label>172</label>
<mixed-citation id="epi412386-cit-0172" publication-type="journal">
<string-name>
<surname>Selkoe</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>. <article-title>The amyloid hypothesis of Alzheimer's disease at 25 years</article-title>. <source xml:lang="en"/>EMBO Mol Med. <year>2016</year>;<volume>8</volume>:<fpage>595</fpage>–<lpage>608</lpage>.<pub-id pub-id-type="pmid">27025652</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0173">
<label>173</label>
<mixed-citation id="epi412386-cit-0173" publication-type="journal">
<string-name>
<surname>Walsh</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Hartley</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Kusumoto</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fezoui</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Condron</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Lomakin</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Amyloid beta‐protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates</article-title>. <source xml:lang="en"/>J Biol Chem.
<year>1999</year>;<volume>274</volume>:<fpage>25945</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">10464339</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0174">
<label>174</label>
<mixed-citation id="epi412386-cit-0174" publication-type="journal">
<string-name>
<surname>Walsh</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Selkoe</surname>
<given-names>D</given-names>
</string-name>. <article-title>A beta oligomers – a decade of discovery</article-title>. <source xml:lang="en"/>J Neurochem.
<year>2007</year>;<volume>101</volume>:<fpage>1172</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">17286590</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0175">
<label>175</label>
<mixed-citation id="epi412386-cit-0175" publication-type="journal">
<string-name>
<surname>Hauser</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Heston</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>VE</given-names>
</string-name>. <article-title>Seizures and myoclonus in patients with Alzheimer's disease</article-title>. <source xml:lang="en"/>Neurology.
<year>1986</year>;<volume>36</volume>:<fpage>1226</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">3092131</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0176">
<label>176</label>
<mixed-citation id="epi412386-cit-0176" publication-type="journal">
<string-name>
<surname>Risse</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Lampe</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Bird</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Nochlin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sumi</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Keenan</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>seizures, and paratonia in Alzheimer disease</article-title>. <source xml:lang="en"/>Alzheimer Dis Assoc Disord. <year>1990</year>;<volume>4</volume>:<fpage>217</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">2264979</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0177">
<label>177</label>
<mixed-citation id="epi412386-cit-0177" publication-type="journal">
<string-name>
<surname>Friedman</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Honig</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Scarmeas</surname>
<given-names>N</given-names>
</string-name>. <article-title>Seizures and epilepsy in Alzheimer's disease</article-title>. <source xml:lang="en"/>CNS Neurosci Therap.
<year>2012</year>;<volume>18</volume>:<fpage>285</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">22070283</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0178">
<label>178</label>
<mixed-citation id="epi412386-cit-0178" publication-type="journal">
<string-name>
<surname>Scarmeas</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Honig</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Cantero</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Brandt</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Blacker</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Seizures in Alzheimer disease: who, when, and how common?</article-title>
<source xml:lang="en"/>Arch Neurol. <year>2009</year>;<volume>66</volume>:<fpage>992</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">19667221</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0179">
<label>179</label>
<mixed-citation id="epi412386-cit-0179" publication-type="journal">
<string-name>
<surname>Amatniek</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hauser</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>DelCastillo</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Jacobs</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Marder</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bell</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Incidence and predictors of seizures in patients with Alzheimer's disease</article-title>. <source xml:lang="en"/>Epilepsia.
<year>2006</year>;<volume>47</volume>:<fpage>867</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">16686651</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0180">
<label>180</label>
<mixed-citation id="epi412386-cit-0180" publication-type="journal">
<string-name>
<surname>Blennow</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zetterberg</surname>
<given-names>H</given-names>
</string-name>. <article-title>The neuropathology and neurobiology of traumatic brain injury</article-title>. <source xml:lang="en"/>Neuron.
<year>2012</year>;<volume>76</volume>:<fpage>886</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">23217738</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0181">
<label>181</label>
<mixed-citation id="epi412386-cit-0181" publication-type="journal">
<string-name>
<surname>Hayashi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ago</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nakamae</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Higo</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ogata</surname>
<given-names>M</given-names>
</string-name>. <article-title>Two different immunostaining patterns of beta‐amyloid precursor protein (APP) may distinguish traumatic from nontraumatic axonal injury</article-title>. <source xml:lang="en"/>Int J Legal Med. <year>2015</year>;<volume>129</volume>:<fpage>1085</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">26249371</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0182">
<label>182</label>
<mixed-citation id="epi412386-cit-0182" publication-type="journal">
<string-name>
<surname>Hortobágyi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Wise</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hunt</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Cary</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Djurovic</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Fegan Earl</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Traumatic axonal damage in the brain can be detected using beta‐APP immunohistochemistry within 35 min after head injury to human adults</article-title>. <source xml:lang="en"/>Neuropathol Appl Neurobiol. <year>2007</year>;<volume>33</volume>:<fpage>226</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">17359363</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0183">
<label>183</label>
<mixed-citation id="epi412386-cit-0183" publication-type="journal">
<string-name>
<surname>Ikonomovic</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Uryu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Abrahamson</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ciallella</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Trojanowski</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>VMY</given-names>
</string-name>, et al. <article-title>Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury</article-title>. <source xml:lang="en"/>Exp Neurol.
<year>2004</year>;<volume>190</volume>:<fpage>192</fpage>–<lpage>203</lpage>.<pub-id pub-id-type="pmid">15473992</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0184">
<label>184</label>
<mixed-citation id="epi412386-cit-0184" publication-type="journal">
<string-name>
<surname>Murakami</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Yamaki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Iwamoto</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sakakibara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kobori</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Fushiki</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus</article-title>. <source xml:lang="en"/>J Neurotrauma. <year>1998</year>;<volume>15</volume>:<fpage>993</fpage>–<lpage>1003</lpage>.<pub-id pub-id-type="pmid">9840772</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0185">
<label>185</label>
<mixed-citation id="epi412386-cit-0185" publication-type="journal">
<string-name>
<surname>Pierce</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</string-name>, <string-name>
<surname>Graham</surname>
<given-names>DI</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>McIntosh</surname>
<given-names>TK</given-names>
</string-name>. <article-title>Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta‐amyloid peptide after experimental brain injury in the rat</article-title>. <source xml:lang="en"/>J Neurosci.
<year>1996</year>;<volume>16</volume>:<fpage>1083</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">8558237</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0186">
<label>186</label>
<mixed-citation id="epi412386-cit-0186" publication-type="journal">
<string-name>
<surname>Lewén</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Olsson</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hillered</surname>
<given-names>L</given-names>
</string-name>. <article-title>Traumatic brain injury in rat produces changes of beta‐amyloid precursor protein immunoreactivity</article-title>. <source xml:lang="en"/>Neuroreport.
<year>1995</year>;<volume>6</volume>:<fpage>357</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">7756628</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0187">
<label>187</label>
<mixed-citation id="epi412386-cit-0187" publication-type="journal">
<string-name>
<surname>Otsuka</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Tomonaga</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ikeda</surname>
<given-names>K</given-names>
</string-name>. <article-title>Rapid appearance of beta‐amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury</article-title>. <source xml:lang="en"/>Brain Res.
<year>1991</year>;<volume>568</volume>:<fpage>335</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">1814579</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0188">
<label>188</label>
<mixed-citation id="epi412386-cit-0188" publication-type="journal">
<string-name>
<surname>Kodam</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ourdev</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Maulik</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hariharakrishnan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Banerjee</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>A role for astrocyte‐derived amyloid β peptides in the degeneration of neurons in an animal model of temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Brain Pathol. <year>2019</year>;<volume>29</volume>:<fpage>28</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">29665128</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0189">
<label>189</label>
<mixed-citation id="epi412386-cit-0189" publication-type="journal">
<string-name>
<surname>Kenney</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Iacono</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Edlow</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Katz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Diaz Arrastia</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dams O'Connor</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Dementia after moderate‐severe traumatic brain injury: coexistence of multiple proteinopathies</article-title>. <source xml:lang="en"/>J Neuropathol Experimental Neurol.
<year>2018</year>;<volume>77</volume>:<fpage>50</fpage>–<lpage>63</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0190">
<label>190</label>
<mixed-citation id="epi412386-cit-0190" publication-type="journal">
<string-name>
<surname>Chan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bush</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kwan</surname>
<given-names>P</given-names>
</string-name>. <article-title>A mouse model of Alzheimer's disease displays increased susceptibility to kindling and seizure‐associated death</article-title>. <source xml:lang="en"/>Epilepsia.
<year>2015</year>;<volume>56</volume>:<fpage>e73</fpage>–<lpage>e77</lpage>.<pub-id pub-id-type="pmid">25879152</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0191">
<label>191</label>
<mixed-citation id="epi412386-cit-0191" publication-type="journal">
<string-name>
<surname>Sima</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>You</surname>
<given-names>C</given-names>
</string-name>. <article-title>Expression of β‐amyloid precursor protein in refractory epilepsy</article-title>. <source xml:lang="en"/>Mol Med Report.
<year>2014</year>;<volume>9</volume>:<fpage>1242</fpage>–<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0192">
<label>192</label>
<mixed-citation id="epi412386-cit-0192" publication-type="journal">
<string-name>
<surname>Bakker</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Albert</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Krauss</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Speck</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gallagher</surname>
<given-names>M</given-names>
</string-name>. <article-title>Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance</article-title>. <source xml:lang="en"/>NeuroImage Clin.
<year>2015</year>;<volume>7</volume>:<fpage>688</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">25844322</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0193">
<label>193</label>
<mixed-citation id="epi412386-cit-0193" publication-type="journal">
<string-name>
<surname>Vossel</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tartaglia</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nygaard</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zeman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>B</given-names>
</string-name>. <article-title>Epileptic activity in Alzheimer's disease: causes and clinical relevance</article-title>. <source xml:lang="en"/>Lancet Neurol.
<year>2017</year>;<volume>16</volume>:<fpage>311</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">28327340</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0194">
<label>194</label>
<mixed-citation id="epi412386-cit-0194" publication-type="journal">
<string-name>
<surname>Huijbers</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Mormino</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Schultz</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wigman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ward</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Larvie</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Amyloid‐β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression</article-title>. <source xml:lang="en"/>Brain. <year>2015</year>;<volume>138</volume>:<fpage>1023</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">25678559</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0195">
<label>195</label>
<mixed-citation id="epi412386-cit-0195" publication-type="journal">
<string-name>
<surname>Vossel</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Beagle</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rabinovici</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Shu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Naasan</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Seizures and epileptiform activity in the early stages of Alzheimer disease</article-title>. <source xml:lang="en"/>JAMA Neurol.
<year>2013</year>;<volume>70</volume>:<fpage>1158</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">23835471</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0196">
<label>196</label>
<mixed-citation id="epi412386-cit-0196" publication-type="journal">
<string-name>
<surname>Villemagne</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Burnham</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bourgeat</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ellis</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Salvado</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study</article-title>. <source xml:lang="en"/>Lancet Neurol.
<year>2013</year>;<volume>12</volume>:<fpage>357</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">23477989</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0197">
<label>197</label>
<mixed-citation id="epi412386-cit-0197" publication-type="journal">
<string-name>
<surname>Kam</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Duffy</surname>
<given-names>ÁM</given-names>
</string-name>, <string-name>
<surname>Moretto</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>LaFrancois</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Scharfman</surname>
<given-names>H</given-names>
</string-name>. <article-title>Interictal spikes during sleep are an early defect in the Tg2576 mouse model of β‐amyloid neuropathology</article-title>. <source xml:lang="en"/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>20119</fpage>.<pub-id pub-id-type="pmid">26818394</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0198">
<label>198</label>
<mixed-citation id="epi412386-cit-0198" publication-type="journal">
<string-name>
<surname>Ziyatdinova</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rönnbäck</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gurevicius</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Miszczuk</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Graff</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Winblad</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Increased epileptiform EEG activity and decreased seizure threshold in arctic APP transgenic mouse model of Alzheimer's disease</article-title>. <source xml:lang="en"/>Curr Alzheimer Res.
<year>2016</year>;<volume>13</volume>:<fpage>817</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">26825094</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0199">
<label>199</label>
<mixed-citation id="epi412386-cit-0199" publication-type="journal">
<string-name>
<surname>Minkeviciene</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Rheims</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dobszay</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zilberter</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hartikainen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fülöp</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Amyloid beta‐induced neuronal hyperexcitability triggers progressive epilepsy</article-title>. <source xml:lang="en"/>J Neurosci.
<year>2009</year>;<volume>29</volume>:<fpage>3453</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">19295151</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0200">
<label>200</label>
<mixed-citation id="epi412386-cit-0200" publication-type="journal">
<string-name>
<surname>Busche</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Henning</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Reichwald</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Staufenbiel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sakmann</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Critical role of soluble amyloid‐β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci U S A. <year>2012</year>;<volume>109</volume>:<fpage>8740</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">22592800</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0201">
<label>201</label>
<mixed-citation id="epi412386-cit-0201" publication-type="journal">
<string-name>
<surname>Busche</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Eichhoff</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Adelsberger</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Abramowski</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wiederhold</surname>
<given-names>K‐H</given-names>
</string-name>, <string-name>
<surname>Haass</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease</article-title>. <source xml:lang="en"/>Science.
<year>2008</year>;<volume>321</volume>:<fpage>1686</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">18802001</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0202">
<label>202</label>
<mixed-citation id="epi412386-cit-0202" publication-type="journal">
<string-name>
<surname>Brown</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Chin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Leiser</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Pangalos</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Randall</surname>
<given-names>AD</given-names>
</string-name>. <article-title>Altered intrinsic neuronal excitability and reduced Na+ currents in a mouse model of Alzheimer's disease</article-title>. <source xml:lang="en"/>Neurobiol Aging.
<year>2011</year>;<volume>32</volume>:<fpage>e2101</fpage>–<lpage>2114</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0203">
<label>203</label>
<mixed-citation id="epi412386-cit-0203" publication-type="journal">
<string-name>
<surname>Sawada</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ichinose</surname>
<given-names>M</given-names>
</string-name>. <article-title>Amyloid beta proteins reduce the GABA‐induced Cl‐ current in identified Aplysia neurons</article-title>. <source xml:lang="en"/>Neurosci Lett.
<year>1996</year>;<volume>213</volume>:<fpage>213</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">8873152</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0204">
<label>204</label>
<mixed-citation id="epi412386-cit-0204" publication-type="journal">
<string-name>
<surname>Gurevicius</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lipponen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tanila</surname>
<given-names>H</given-names>
</string-name>. <article-title>Increased cortical and thalamic excitability in freely moving APPswe/PS1dE9 mice modeling epileptic activity associated with Alzheimer's disease</article-title>. <source xml:lang="en"/>Cereb Cortex.
<year>2013</year>;<volume>23</volume>:<fpage>1148</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="pmid">22581851</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0205">
<label>205</label>
<mixed-citation id="epi412386-cit-0205" publication-type="journal">
<string-name>
<surname>Minkeviciene</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Rheims</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dobszay</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Zilberter</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hartikainen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fulop</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Amyloid beta‐induced neuronal hyperexcitability triggers progressive epilepsy</article-title>. <source xml:lang="en"/>J Neurosci.
<year>2009</year>;<volume>29</volume>:<fpage>3453</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">19295151</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0206">
<label>206</label>
<mixed-citation id="epi412386-cit-0206" publication-type="journal">
<string-name>
<surname>Ziyatdinova</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gurevicius</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kutchiashvili</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bolkvadze</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nissinen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tanila</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels</article-title>. <source xml:lang="en"/>Epilepsy Res.
<year>2011</year>;<volume>94</volume>:<fpage>75</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">21300523</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0207">
<label>207</label>
<mixed-citation id="epi412386-cit-0207" publication-type="journal">
<string-name>
<surname>Ziyatdinova</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Viswanathan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hiltunen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tanila</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Pitkanen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Reduction of epileptiform activity by valproic acid in a mouse model of Alzheimer's disease is not long‐lasting after treatment discontinuation</article-title>. <source xml:lang="en"/>Epilepsy Res.
<year>2015</year>;<volume>112</volume>:<fpage>43</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">25847338</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0208">
<label>208</label>
<mixed-citation id="epi412386-cit-0208" publication-type="journal">
<string-name>
<surname>Jankowsky</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Fadale</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Gonzales</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Jenkins</surname>
<given-names>NA</given-names>
</string-name>, et al. <article-title>Mutant presenilins specifically elevate the levels of the 42 residue beta‐amyloid peptide in vivo: evidence for augmentation of a 42‐specific gamma secretase</article-title>. <source xml:lang="en"/>Hum Mol Genet. <year>2004</year>;<volume>13</volume>:<fpage>159</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">14645205</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0209">
<label>209</label>
<mixed-citation id="epi412386-cit-0209" publication-type="journal">
<string-name>
<surname>Costa</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Parnetti</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>D'Amelio</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tozzi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tantucci</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Romigi</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Epilepsy, amyloid‐β, and D1 dopamine receptors: a possible pathogenetic link?</article-title>
<source xml:lang="en"/>Neurobiol Aging. <year>2016</year>;<volume>48</volume>:<fpage>161</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">27701029</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0210">
<label>210</label>
<mixed-citation id="epi412386-cit-0210" publication-type="journal">
<string-name>
<surname>Ren</surname>
<given-names>S‐Q</given-names>
</string-name>, <string-name>
<surname>Yao</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>J‐Z</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>J‐J</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Amyloid β causes excitation/inhibition imbalance through dopamine receptor 1‐dependent disruption of fast‐spiking GABAergic input in anterior cingulate cortex.</article-title>
<source xml:lang="en"/>Sci Rep.
<year>2018</year>;<volume>8</volume>:<fpage>302</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">29321592</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0211">
<label>211</label>
<mixed-citation id="epi412386-cit-0211" publication-type="journal">
<string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Nichols</surname>
<given-names>R</given-names>
</string-name>. <article-title>Dopamine release in prefrontal cortex in response to beta‐amyloid activation of alpha7 * nicotinic receptors</article-title>. <source xml:lang="en"/>Brain Res. <year>2007</year>;<volume>1182</volume>:<fpage>82</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">17935702</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0212">
<label>212</label>
<mixed-citation id="epi412386-cit-0212" publication-type="journal">
<string-name>
<surname>Born</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>J‐Y</given-names>
</string-name>, <string-name>
<surname>Savjani</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Das</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Dabaghian</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>Q</given-names>
</string-name>, et al. <article-title>Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzheimer's disease</article-title>. <source xml:lang="en"/>J Neurosci.
<year>2014</year>;<volume>34</volume>:<fpage>3826</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">24623762</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0213">
<label>213</label>
<mixed-citation id="epi412386-cit-0213" publication-type="journal">
<string-name>
<surname>Cirrito</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Finn</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sloviter</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bales</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>May</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Synaptic activity regulates interstitial fluid amyloid‐beta levels in vivo</article-title>. <source xml:lang="en"/>Neuron. <year>2005</year>;<volume>48</volume>:<fpage>913</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">16364896</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0214">
<label>214</label>
<mixed-citation id="epi412386-cit-0214" publication-type="journal">
<string-name>
<surname>Yun</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Gamkrelidze</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Stine</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Sullivan</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Pasternak</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Ladu</surname>
<given-names>MJ</given-names>
</string-name>, et al. <article-title>Amyloid‐beta1‐42 reduces neuronal excitability in mouse dentate gyrus</article-title>. <source xml:lang="en"/>Neurosci Lett. <year>2006</year>;<volume>403</volume>:<fpage>162</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">16765515</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0215">
<label>215</label>
<mixed-citation id="epi412386-cit-0215" publication-type="journal">
<string-name>
<surname>Thornton</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Vink</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Blumbergs</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Van Den Heuvel</surname>
<given-names>C</given-names>
</string-name>. <article-title>Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats</article-title>. <source xml:lang="en"/>Brain Res.
<year>2006</year>;<volume>1094</volume>:<fpage>38</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">16697978</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0216">
<label>216</label>
<mixed-citation id="epi412386-cit-0216" publication-type="journal">
<string-name>
<surname>Van den Heuvel</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Blumbergs</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Finnie</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Manavis</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Reilly</surname>
<given-names>PL</given-names>
</string-name>, et al. <article-title>Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: an ovine head impact model</article-title>. <source xml:lang="en"/>Exp Neurol.
<year>1999</year>;<volume>159</volume>:<fpage>441</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">10506515</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0217">
<label>217</label>
<mixed-citation id="epi412386-cit-0217" publication-type="journal">
<string-name>
<surname>Miszczuk</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Debski</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Tanila</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lukasiuk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Pitkanen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Traumatic brain injury increases the expression of Nos1, abeta clearance, and epileptogenesis in APP/PS1 mouse model of Alzheimer's disease</article-title>. <source xml:lang="en"/>Mol Neurobiol. <year>2016</year>;<volume>53</volume>:<fpage>7010</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">26671618</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0218">
<label>218</label>
<mixed-citation id="epi412386-cit-0218" publication-type="journal">
<string-name>
<surname>Nakagawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>McIntosh</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Rodriguez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Berlin</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>DH</given-names>
</string-name>, et al. <article-title>Traumatic brain injury in young, amyloid‐beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging</article-title>. <source xml:lang="en"/>J Comp Neurol. <year>1999</year>;<volume>411</volume>:<fpage>390</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">10413774</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0219">
<label>219</label>
<mixed-citation id="epi412386-cit-0219" publication-type="journal">
<string-name>
<surname>Nakagawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Reed</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>McIntosh</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Saatman</surname>
<given-names>KE</given-names>
</string-name>, et al. <article-title>Brain trauma in aged transgenic mice induces regression of established abeta deposits</article-title>. <source xml:lang="en"/>Exp Neurol.
<year>2000</year>;<volume>163</volume>:<fpage>244</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">10785464</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0220">
<label>220</label>
<mixed-citation id="epi412386-cit-0220" publication-type="journal">
<string-name>
<surname>Corrigan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Vink</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Blumbergs</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Masters</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Cappai</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>van den Heuvel</surname>
<given-names>C</given-names>
</string-name>. <article-title>Characterisation of the effect of knockout of the amyloid precursor protein on outcome following mild traumatic brain injury</article-title>. <source xml:lang="en"/>Brain Res.
<year>2012</year>;<volume>1451</volume>:<fpage>87</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">22424792</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0221">
<label>221</label>
<mixed-citation id="epi412386-cit-0221" publication-type="journal">
<string-name>
<surname>Corrigan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Vink</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Blumbergs</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Masters</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Cappai</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>van,</surname>
</string-name>. <article-title>den Heuvel C. sAPPalpha rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury</article-title>. <source xml:lang="en"/>J Neurochem. <year>2012</year>;<volume>122</volume>:<fpage>208</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">22519988</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0222">
<label>222</label>
<mixed-citation id="epi412386-cit-0222" publication-type="journal">
<string-name>
<surname>Mockett</surname>
<given-names>BG</given-names>
</string-name>, <string-name>
<surname>Richter</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Abraham</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>UC</given-names>
</string-name>. <article-title>Therapeutic potential of secreted amyloid precursor protein APPsalpha</article-title>. <source xml:lang="en"/>Front Mol Neurosci.
<year>2017</year>;<volume>10</volume>:<fpage>30</fpage>.<pub-id pub-id-type="pmid">28223920</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0223">
<label>223</label>
<mixed-citation id="epi412386-cit-0223" publication-type="journal">
<string-name>
<surname>Muller</surname>
<given-names>UC</given-names>
</string-name>, <string-name>
<surname>Deller</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Korte</surname>
<given-names>M</given-names>
</string-name>. <article-title>Not just amyloid: physiological functions of the amyloid precursor protein family</article-title>. <source xml:lang="en"/>Nat Rev Neurosci.
<year>2017</year>;<volume>18</volume>:<fpage>281</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">28360418</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0224">
<label>224</label>
<mixed-citation id="epi412386-cit-0224" publication-type="journal">
<string-name>
<surname>Schenk</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Basi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pangalos</surname>
<given-names>M</given-names>
</string-name>. <article-title>Treatment strategies targeting amyloid β‐protein</article-title>. <source xml:lang="en"/>Cold Spring Harb Perspect Med.
<year>2012</year>;<volume>2</volume>:<fpage>a006387</fpage>.<pub-id pub-id-type="pmid">22951439</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0225">
<label>225</label>
<mixed-citation id="epi412386-cit-0225" publication-type="journal">
<string-name>
<surname>Loane</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pocivavsek</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Moussa</surname>
<given-names>CEH</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Matsuoka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Faden</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury</article-title>. <source xml:lang="en"/>Nat Med.
<year>2009</year>;<volume>15</volume>:<fpage>377</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">19287391</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0226">
<label>226</label>
<mixed-citation id="epi412386-cit-0226" publication-type="journal">
<string-name>
<surname>Corrigan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Vink</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Blumbergs</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Masters</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cappai</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>van,</surname>
</string-name>. <article-title>den Heuvel C. sAPPα rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury</article-title>. <source xml:lang="en"/>J Neurochem. <year>2012</year>;<volume>122</volume>:<fpage>208</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">22519988</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0227">
<label>227</label>
<mixed-citation id="epi412386-cit-0227" publication-type="journal">
<string-name>
<surname>Corrigan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Thornton</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Roisman</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Leonard</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Vink</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Blumbergs</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96–110</article-title>. <source xml:lang="en"/>J Neurochem. <year>2014</year>;<volume>128</volume>:<fpage>196</fpage>–<lpage>204</lpage>.<pub-id pub-id-type="pmid">23919582</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0228">
<label>228</label>
<mixed-citation id="epi412386-cit-0228" publication-type="journal">
<string-name>
<surname>Rehman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ahmad</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yoon</surname>
<given-names>G‐H</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Abid</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>M</given-names>
</string-name>. <article-title>Inhibition of c‐Jun N‐terminal kinase protects against brain damage and improves learning and memory after traumatic brain injury in adult mice</article-title>. <source xml:lang="en"/>Cereb Cortex.
<year>2018</year>;<volume>28</volume>:<fpage>2854</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">29088310</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0229">
<label>229</label>
<mixed-citation id="epi412386-cit-0229" publication-type="journal">
<string-name>
<surname>Mehan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Meena</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sharma</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sankhla</surname>
<given-names>R</given-names>
</string-name>. <article-title>JNK: a stress‐activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities</article-title>. <source xml:lang="en"/>J Mol Neurosci. <year>2011</year>;<volume>43</volume>:<fpage>376</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">20878262</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0230">
<label>230</label>
<mixed-citation id="epi412386-cit-0230" publication-type="journal">
<string-name>
<surname>Shoji</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Iwakami</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Takeuchi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Waragai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kanazawa</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>JNK activation is associated with intracellular beta‐amyloid accumulation</article-title>. <source xml:lang="en"/>Mol Brain Res.
<year>2000</year>;<volume>85</volume>:<fpage>221</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">11146125</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0231">
<label>231</label>
<mixed-citation id="epi412386-cit-0231" publication-type="journal">
<string-name>
<surname>Williams</surname>
<given-names>RSB</given-names>
</string-name>, <string-name>
<surname>Bate</surname>
<given-names>C</given-names>
</string-name>. <article-title>Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid‐β oligomers released from 7PA2 cells</article-title>. <source xml:lang="en"/>Neuropharmacology. <year>2018</year>;<volume>128</volume>:<fpage>54</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">28947378</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0232">
<label>232</label>
<mixed-citation id="epi412386-cit-0232" publication-type="journal">
<string-name>
<surname>Ziyatdinova</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Viswanathan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hiltunen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tanila</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Pitkänen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Reduction of epileptiform activity by valproic acid in a mouse model of Alzheimer's disease is not long‐lasting after treatment discontinuation</article-title>. <source xml:lang="en"/>Epilepsy Res.
<year>2015</year>;<volume>112</volume>:<fpage>43</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">25847338</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0233">
<label>233</label>
<mixed-citation id="epi412386-cit-0233" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>M‐Y</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>C‐Y</given-names>
</string-name>, <string-name>
<surname>Zou</surname>
<given-names>M‐M</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>J‐W</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP/PS1 transgenic mice</article-title>. <source xml:lang="en"/>Neurobiol Aging. <year>2014</year>;<volume>35</volume>:<fpage>2713</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">25044076</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0234">
<label>234</label>
<mixed-citation id="epi412386-cit-0234" publication-type="journal">
<string-name>
<surname>Bomben</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Holth</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Reed</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cramer</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Landreth</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Noebels</surname>
<given-names>J</given-names>
</string-name>. <article-title>Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy</article-title>. <source xml:lang="en"/>Neurobiol Aging.
<year>2014</year>;<volume>35</volume>:<fpage>2091</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">24767949</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0235">
<label>235</label>
<mixed-citation id="epi412386-cit-0235" publication-type="journal">
<string-name>
<surname>Gersner</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ekstein</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Dhamne</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Schachter</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Rotenberg</surname>
<given-names>A</given-names>
</string-name>. <article-title>Huperzine A prophylaxis against pentylenetetrazole‐induced seizures in rats is associated with increased cortical inhibition</article-title>. <source xml:lang="en"/>Epilepsy Res.
<year>2015</year>;<volume>117</volume>:<fpage>97</fpage>–<lpage>103</lpage>.<pub-id pub-id-type="pmid">26432930</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0236">
<label>236</label>
<mixed-citation id="epi412386-cit-0236" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>. <article-title>Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice</article-title>. <source xml:lang="en"/>J Neurosci Res. <year>2012</year>;<volume>90</volume>:<fpage>508</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">22002568</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0237">
<label>237</label>
<mixed-citation id="epi412386-cit-0237" publication-type="journal">
<string-name>
<surname>Peng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>DYW</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Schachter</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Lemere</surname>
<given-names>CA</given-names>
</string-name>. <article-title>Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen‐activated protein kinase pathways in neuroblastoma SK‐N‐SH cells over‐expressing wild type human amyloid precursor protein 695</article-title>. <source xml:lang="en"/>Neuroscience. <year>2007</year>;<volume>150</volume>:<fpage>386</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">17945434</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0238">
<label>238</label>
<mixed-citation id="epi412386-cit-0238" publication-type="journal">
<string-name>
<surname>Sanchez</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Verret</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Vossel</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Orr</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cirrito</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci U S A.
<year>2012</year>;<volume>109</volume>:<fpage>E2895</fpage>–<lpage>E2903</lpage>.<pub-id pub-id-type="pmid">22869752</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0239">
<label>239</label>
<mixed-citation id="epi412386-cit-0239" publication-type="journal">
<string-name>
<surname>Perluigi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Di Domenico</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Butterfield</surname>
<given-names>DA</given-names>
</string-name>. <article-title>mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy</article-title>. <source xml:lang="en"/>Neurobiol Dis. <year>2015</year>;<volume>84</volume>:<fpage>39</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="pmid">25796566</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0240">
<label>240</label>
<mixed-citation id="epi412386-cit-0240" publication-type="journal">
<string-name>
<surname>Bove</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Martinez‐Vicente</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vila</surname>
<given-names>M</given-names>
</string-name>. <article-title>Fighting neurodegeneration with rapamycin: mechanistic insights</article-title>. <source xml:lang="en"/>Nat Rev Neurosci.
<year>2011</year>;<volume>12</volume>:<fpage>437</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">21772323</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0241">
<label>241</label>
<mixed-citation id="epi412386-cit-0241" publication-type="journal">
<string-name>
<surname>Meng</surname>
<given-names>XF</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Chi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>L</given-names>
</string-name>. <article-title>Role of the mTOR signaling pathway in epilepsy</article-title>. <source xml:lang="en"/>J Neurol Sci. <year>2013</year>;<volume>332</volume>:<fpage>4</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">23773767</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0242">
<label>242</label>
<mixed-citation id="epi412386-cit-0242" publication-type="journal">
<string-name>
<surname>Yang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Klionsky</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>Mammalian autophagy: core molecular machinery and signaling regulation</article-title>. <source xml:lang="en"/>Curr Opinion Cell Biol.
<year>2010</year>;<volume>22</volume>:<fpage>124</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">20034776</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0243">
<label>243</label>
<mixed-citation id="epi412386-cit-0243" publication-type="journal">
<string-name>
<surname>Heras‐Sandoval</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Perez‐Rojas</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Hernandez‐Damian</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pedraza‐Chaverri</surname>
<given-names>J</given-names>
</string-name>. <article-title>The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration</article-title>. <source xml:lang="en"/>Cell Signal. <year>2014</year>;<volume>26</volume>:<fpage>2694</fpage>–<lpage>701</lpage>.<pub-id pub-id-type="pmid">25173700</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0244">
<label>244</label>
<mixed-citation id="epi412386-cit-0244" publication-type="journal">
<string-name>
<surname>Mizushima</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Levine</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Cuervo</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Klionsky</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>Autophagy fights disease through cellular self‐digestion</article-title>. <source xml:lang="en"/>Nature.
<year>2008</year>;<volume>451</volume>:<fpage>1069</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">18305538</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0245">
<label>245</label>
<mixed-citation id="epi412386-cit-0245" publication-type="journal">
<string-name>
<surname>Fulda</surname>
<given-names>S</given-names>
</string-name>. <article-title>Modulation of mitochondrial apoptosis by PI3K inhibitors</article-title>. <source xml:lang="en"/>Mitochondrion. <year>2013</year>;<volume>13</volume>:<fpage>195</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">22580303</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0246">
<label>246</label>
<mixed-citation id="epi412386-cit-0246" publication-type="journal">
<string-name>
<surname>Ghavami</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shojaei</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yeganeh</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ande</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Jangamreddy</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Mehrpour</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Autophagy and apoptosis dysfunction in neurodegenerative disorders</article-title>. <source xml:lang="en"/>Prog Neurobiol.
<year>2014</year>;<volume>112</volume>:<fpage>24</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="pmid">24211851</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0247">
<label>247</label>
<mixed-citation id="epi412386-cit-0247" publication-type="journal">
<string-name>
<surname>Crews</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Spencer</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Desplats</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Patrick</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Paulino</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rockenstein</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha‐synucleinopathy.</article-title>
<source xml:lang="en"/>PloS One.
<year>2010</year>;<volume>5</volume>:<elocation-id>e9313</elocation-id>.<pub-id pub-id-type="pmid">20174468</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0248">
<label>248</label>
<mixed-citation id="epi412386-cit-0248" publication-type="journal">
<string-name>
<surname>Caccamo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Majumder</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Richardson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Strong</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Oddo</surname>
<given-names>S</given-names>
</string-name>. <article-title>Molecular interplay between mammalian target of rapamycin (mTOR), amyloid‐beta, and Tau: effects on cognitive impairments</article-title>. <source xml:lang="en"/>J Biol Chem. <year>2010</year>;<volume>285</volume>:<fpage>13107</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">20178983</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0249">
<label>249</label>
<mixed-citation id="epi412386-cit-0249" publication-type="journal">
<string-name>
<surname>Ravikumar</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Vacher</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Berger</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Davies</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Oroz</surname>
<given-names>LG</given-names>
</string-name>, et al. <article-title>Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease</article-title>. <source xml:lang="en"/>Nat Genet.
<year>2004</year>;<volume>36</volume>:<fpage>585</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">15146184</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0250">
<label>250</label>
<mixed-citation id="epi412386-cit-0250" publication-type="journal">
<string-name>
<surname>Santini</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Heiman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Greengard</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Valjent</surname>
<given-names>E</given-names>
</string-name>. <article-title>Fisone G. Inhibition of mTOR signaling in Parkinson's disease prevents L‐DOPA‐induced dyskinesia</article-title>. <source xml:lang="en"/>Sci Signal.
<year>2009</year>;<volume>2</volume>:<fpage>ra36</fpage>.<pub-id pub-id-type="pmid">19622833</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0251">
<label>251</label>
<mixed-citation id="epi412386-cit-0251" publication-type="journal">
<string-name>
<surname>Jiang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Correlation between TSC1 gene polymorphism and epilepsy</article-title>. <source xml:lang="en"/>Exp Therap Med. <year>2017</year>;<volume>14</volume>:<fpage>6238</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">29285181</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0252">
<label>252</label>
<mixed-citation id="epi412386-cit-0252" publication-type="journal">
<string-name>
<surname>Rosset</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Netto</surname>
<given-names>CBO</given-names>
</string-name>, <string-name>
<surname>Ashton‐Prolla</surname>
<given-names>P</given-names>
</string-name>. <article-title>TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review</article-title>. <source xml:lang="en"/>Genet Mol Biol.
<year>2017</year>;<volume>40</volume>:<fpage>69</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">28222202</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0253">
<label>253</label>
<mixed-citation id="epi412386-cit-0253" publication-type="journal">
<string-name>
<surname>Zeng</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Rensing</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Gutmann</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Gambello</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>M</given-names>
</string-name>. <article-title>Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex</article-title>. <source xml:lang="en"/>Human Mol Genet. <year>2011</year>;<volume>20</volume>:<fpage>445</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">21062901</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0254">
<label>254</label>
<mixed-citation id="epi412386-cit-0254" publication-type="journal">
<string-name>
<surname>Zeng</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Gutmann</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>M</given-names>
</string-name>. <article-title>Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex</article-title>. <source xml:lang="en"/>Ann Neurol.
<year>2008</year>;<volume>63</volume>:<fpage>444</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">18389497</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0255">
<label>255</label>
<mixed-citation id="epi412386-cit-0255" publication-type="journal">
<string-name>
<surname>Ehninger</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shilyansky</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Kwiatkowski</surname>
<given-names>DJ</given-names>
</string-name>, et al. <article-title>Reversal of learning deficits in a Tsc2+/‐ mouse model of tuberous sclerosis</article-title>. <source xml:lang="en"/>Nat Med. <year>2008</year>;<volume>14</volume>:<fpage>843</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">18568033</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0256">
<label>256</label>
<mixed-citation id="epi412386-cit-0256" publication-type="journal">
<string-name>
<surname>Sunnen</surname>
<given-names>CN</given-names>
</string-name>, <string-name>
<surname>Brewster</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Lugo</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Vanegas</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Turcios</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mukhi</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS‐Pten conditional knockout mice</article-title>. <source xml:lang="en"/>Epilepsia. <year>2011</year>;<volume>52</volume>:<fpage>2065</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">21973019</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0257">
<label>257</label>
<mixed-citation id="epi412386-cit-0257" publication-type="journal">
<string-name>
<surname>Tokuda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mahaffey</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Monks</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Faulkner</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Birnbaum</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Danzer</surname>
<given-names>SC</given-names>
</string-name>, et al. <article-title>A novel Akt3 mutation associated with enhanced kinase activity and seizure susceptibility in mice</article-title>. <source xml:lang="en"/>Human Mol Genetics. <year>2011</year>;<volume>20</volume>:<fpage>988</fpage>–<lpage>99</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0258">
<label>258</label>
<mixed-citation id="epi412386-cit-0258" publication-type="journal">
<string-name>
<surname>D'Gama</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Woodworth</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Hossain</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Bizzotto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hatem</surname>
<given-names>NE</given-names>
</string-name>, <string-name>
<surname>LaCoursiere</surname>
<given-names>CM</given-names>
</string-name>, et al. <article-title>Somatic mutations activating the mTOR pathway in dorsal telencephalic progenitors cause a continuum of cortical dysplasias</article-title>. <source xml:lang="en"/>Cell Rep.
<year>2017</year>;<volume>21</volume>:<fpage>3754</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">29281825</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0259">
<label>259</label>
<mixed-citation id="epi412386-cit-0259" publication-type="journal">
<string-name>
<surname>D'Gama</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Geng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Couto</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Boyle</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>LaCoursiere</surname>
<given-names>CM</given-names>
</string-name>, et al. <article-title>Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia</article-title>. <source xml:lang="en"/>Ann Neurol.
<year>2015</year>;<volume>77</volume>:<fpage>720</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">25599672</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0260">
<label>260</label>
<mixed-citation id="epi412386-cit-0260" publication-type="journal">
<string-name>
<surname>Talos</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Jacobs</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Gourmaud</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Coto</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lim</surname>
<given-names>KC</given-names>
</string-name>, et al. <article-title>Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Ann Neurol. <year>2018</year>;<volume>83</volume>:<fpage>311</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">29331082</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0261">
<label>261</label>
<mixed-citation id="epi412386-cit-0261" publication-type="journal">
<string-name>
<surname>Chi</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Inhibition of mTOR pathway by rapamycin decreases P‐glycoprotein expression and spontaneous seizures in pharmacoresistant epilepsy</article-title>. <source xml:lang="en"/>J Mol Neurosci.
<year>2017</year>;<volume>61</volume>:<fpage>553</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">28229367</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0262">
<label>262</label>
<mixed-citation id="epi412386-cit-0262" publication-type="journal">
<string-name>
<surname>Park</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Qiu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Degterev</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lo</surname>
<given-names>EH</given-names>
</string-name>, et al. <article-title>Combination therapy targeting Akt and mammalian target of rapamycin improves functional outcome after controlled cortical impact in mice</article-title>. <source xml:lang="en"/>J Cereb Blood Flow Metabol
<year>2012</year>;<volume>32</volume>:<fpage>330</fpage>–<lpage>40</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0263">
<label>263</label>
<mixed-citation id="epi412386-cit-0263" publication-type="journal">
<string-name>
<surname>Nikolaeva</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Crowell</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Valenziano</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Meaney</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>D'Arcangelo</surname>
<given-names>G</given-names>
</string-name>. <article-title>Beneficial effects of early mTORC1 inhibition after traumatic brain injury</article-title>. <source xml:lang="en"/>J Neurotrauma. <year>2016</year>;<volume>33</volume>:<fpage>183</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">26122481</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0264">
<label>264</label>
<mixed-citation id="epi412386-cit-0264" publication-type="journal">
<string-name>
<surname>Zeng</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Rensing</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>M</given-names>
</string-name>. <article-title>Developing antiepileptogenic drugs for acquired epilepsy: targeting the Mammalian Target of Rapamycin (mTOR) pathway</article-title>. <source xml:lang="en"/>Mol Cell Pharmacol.
<year>2009</year>;<volume>1</volume>:<fpage>124</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">20419051</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0265">
<label>265</label>
<mixed-citation id="epi412386-cit-0265" publication-type="journal">
<string-name>
<surname>Zeng</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Rensing</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>M</given-names>
</string-name>. <article-title>The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy</article-title>. <source xml:lang="en"/>J Neurosci.
<year>2009</year>;<volume>29</volume>:<fpage>6964</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">19474323</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0266">
<label>266</label>
<mixed-citation id="epi412386-cit-0266" publication-type="journal">
<string-name>
<surname>Baulac</surname>
<given-names>S</given-names>
</string-name>. <article-title>mTOR signaling pathway genes in focal epilepsies</article-title>. <source xml:lang="en"/>Progress Brain Res. <year>2016</year>;<volume>226</volume>:<fpage>61</fpage>–<lpage>79</lpage>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0267">
<label>267</label>
<mixed-citation id="epi412386-cit-0267" publication-type="journal">
<string-name>
<surname>Muncy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Butler</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Koenig</surname>
<given-names>M</given-names>
</string-name>. <article-title>Rapamycin reduces seizure frequency in tuberous sclerosis complex</article-title>. <source xml:lang="en"/>J Child Neurol.
<year>2009</year>;<volume>24</volume>:<fpage>477</fpage>.<pub-id pub-id-type="pmid">19151365</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0268">
<label>268</label>
<mixed-citation id="epi412386-cit-0268" publication-type="journal">
<string-name>
<surname>Guo</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zeng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Brody</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>M</given-names>
</string-name>. <article-title>Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury</article-title>. <source xml:lang="en"/>PLoS One.
<year>2013</year>;<volume>8</volume>:<elocation-id>e64078</elocation-id>.<pub-id pub-id-type="pmid">23691153</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0269">
<label>269</label>
<mixed-citation id="epi412386-cit-0269" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Fang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Rapamycin provides anti‐epileptogenic effect in a rat model of post‐traumatic epilepsy via deactivation of mTOR signaling pathway</article-title>. <source xml:lang="en"/>Exp Ther Med.
<year>2018</year>;<volume>15</volume>:<fpage>4763</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">29904395</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0270">
<label>270</label>
<mixed-citation id="epi412386-cit-0270" publication-type="journal">
<string-name>
<surname>Talos</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Fitzgerald</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>The interaction between early life epilepsy and autistic‐like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway</article-title>. <source xml:lang="en"/>PLoS One. <year>2012</year>;<volume>7</volume>:<elocation-id>e35885</elocation-id>.<pub-id pub-id-type="pmid">22567115</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0271">
<label>271</label>
<mixed-citation id="epi412386-cit-0271" publication-type="journal">
<string-name>
<surname>Sliwa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Plucinska</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bednarczyk</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lukasiuk</surname>
<given-names>K</given-names>
</string-name>. <article-title>Post‐treatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Neurosci Lett.
<year>2012</year>;<volume>509</volume>:<fpage>105</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">22227620</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0272">
<label>272</label>
<mixed-citation id="epi412386-cit-0272" publication-type="journal">
<string-name>
<surname>Hester</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hosford</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Santos</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rolle</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>LaSarge</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Impact of rapamycin on status epilepticus induced hippocampal pathology and weight gain</article-title>. <source xml:lang="en"/>Exp Neurol.
<year>2016</year>;<volume>280</volume>:<fpage>1</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">26995324</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0273">
<label>273</label>
<mixed-citation id="epi412386-cit-0273" publication-type="journal">
<string-name>
<surname>Ali</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Chugh</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ekdahl</surname>
<given-names>CT</given-names>
</string-name>. <article-title>Role of fractalkine‐CX3CR1 pathway in seizure‐induced microglial activation, neurodegeneration, and neuroblast production in the adult rat brain</article-title>. <source xml:lang="en"/>Neurobiol Dis. <year>2015</year>;<volume>74</volume>:<fpage>194</fpage>–<lpage>203</lpage>.<pub-id pub-id-type="pmid">25461978</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0274">
<label>274</label>
<mixed-citation id="epi412386-cit-0274" publication-type="journal">
<string-name>
<surname>Ali</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Silva</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shultz</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Kwan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>NC</given-names>
</string-name>, et al. <article-title>Targeting neurodegeneration to prevent post‐traumatic epilepsy</article-title>. <source xml:lang="en"/>Neurobiol Dis. <year>2019</year>;<volume>123</volume>:<fpage>100</fpage>–<lpage>109</lpage>.<pub-id pub-id-type="pmid">30099094</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0275">
<label>275</label>
<mixed-citation id="epi412386-cit-0275" publication-type="journal">
<string-name>
<surname>Lotze</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Tracey</surname>
<given-names>KJ</given-names>
</string-name>. <article-title>High‐mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal</article-title>. <source xml:lang="en"/>Nat Rev Immunol. <year>2005</year>;<volume>5</volume>:<fpage>331</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">15803152</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0276">
<label>276</label>
<mixed-citation id="epi412386-cit-0276" publication-type="journal">
<string-name>
<surname>Vezzani</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Granata</surname>
<given-names>T</given-names>
</string-name>. <article-title>Brain inflammation in epilepsy: experimental and clinical evidence</article-title>. <source xml:lang="en"/>Epilepsia.
<year>2005</year>;<volume>46</volume>:<fpage>1724</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">16302852</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0277">
<label>277</label>
<mixed-citation id="epi412386-cit-0277" publication-type="journal">
<string-name>
<surname>Webster</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Crack</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Shultz</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Semple</surname>
<given-names>BD</given-names>
</string-name>. <article-title>Inflammation in epileptogenesis after traumatic brain injury</article-title>. <source xml:lang="en"/>J Neuroinflammation.
<year>2017</year>;<volume>14</volume>:<fpage>10</fpage>.<pub-id pub-id-type="pmid">28086980</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0278">
<label>278</label>
<mixed-citation id="epi412386-cit-0278" publication-type="journal">
<string-name>
<surname>Saletti</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Casillas‐Espinosa</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Semple</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Lisgaras</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Moshe</surname>
<given-names>SL</given-names>
</string-name>, et al. <article-title>In search of antiepileptogenic treatments for post‐traumatic epilepsy</article-title>. <source xml:lang="en"/>Neurobiol Dis.
<year>2019</year>;<volume>123</volume>:<fpage>86</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">29936231</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0279">
<label>279</label>
<mixed-citation id="epi412386-cit-0279" publication-type="journal">
<string-name>
<surname>Semple</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Gimlin</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Casillas‐Espinosa</surname>
<given-names>PM</given-names>
</string-name>, et al. <article-title>Interleukin‐1 receptor in seizure susceptibility after traumatic injury to the pediatric brain</article-title>. <source xml:lang="en"/>J Neurosci. <year>2017</year>;<volume>37</volume>:<fpage>7864</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">28724747</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0280">
<label>280</label>
<mixed-citation id="epi412386-cit-0280" publication-type="journal">
<string-name>
<surname>Maroso</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Balosso</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ravizza</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Iori</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>CI</given-names>
</string-name>, <string-name>
<surname>French</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Interleukin‐1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice</article-title>. <source xml:lang="en"/>Neurotherapeutics.
<year>2011</year>;<volume>8</volume>:<fpage>304</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">21431948</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0281">
<label>281</label>
<mixed-citation id="epi412386-cit-0281" publication-type="journal">
<string-name>
<surname>Ravizza</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Noe</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zardoni</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Vaghi</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Sifringer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vezzani</surname>
<given-names>A</given-names>
</string-name>. <article-title>Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL‐1beta production</article-title>. <source xml:lang="en"/>Neurobiol Dis. <year>2008</year>;<volume>31</volume>:<fpage>327</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">18632279</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0282">
<label>282</label>
<mixed-citation id="epi412386-cit-0282" publication-type="journal">
<string-name>
<surname>Noe</surname>
<given-names>FM</given-names>
</string-name>, <string-name>
<surname>Polascheck</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Frigerio</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bankstahl</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ravizza</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Marchini</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Pharmacological blockade of IL‐1beta/IL‐1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Neurobiol Dis. <year>2013</year>;<volume>59</volume>:<fpage>183</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">23938763</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0283">
<label>283</label>
<mixed-citation id="epi412386-cit-0283" publication-type="journal">
<string-name>
<surname>Iori</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Iyer</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Ravizza</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Beltrame</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Paracchini</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Marchini</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Blockade of the IL‐1R1/TLR4 pathway mediates disease‐modification therapeutic effects in a model of acquired epilepsy</article-title>. <source xml:lang="en"/>Neurobiol Dis. <year>2017</year>;<volume>99</volume>:<fpage>12</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">27939857</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0284">
<label>284</label>
<mixed-citation id="epi412386-cit-0284" publication-type="journal">
<string-name>
<surname>Chugh</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bakochi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bahonjic</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Etholm</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ekdahl</surname>
<given-names>CT</given-names>
</string-name>. <article-title>Alterations in brain inflammation, synaptic proteins, and adult hippocampal neurogenesis during epileptogenesis in mice lacking synapsin2</article-title>. <source xml:lang="en"/>PloS One.
<year>2015</year>;<volume>10</volume>:<elocation-id>e0132366</elocation-id>.<pub-id pub-id-type="pmid">26177381</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0285">
<label>285</label>
<mixed-citation id="epi412386-cit-0285" publication-type="journal">
<string-name>
<surname>Akin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ravizza</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Maroso</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Carcak</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Eryigit</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Vanzulli</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>IL‐1beta is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike‐and‐wave discharges, and contributes to their occurrence</article-title>. <source xml:lang="en"/>Neurobiol Dis.
<year>2011</year>;<volume>44</volume>:<fpage>259</fpage>–<lpage>69</lpage>.<pub-id pub-id-type="pmid">21645619</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0286">
<label>286</label>
<mixed-citation id="epi412386-cit-0286" publication-type="journal">
<string-name>
<surname>Amhaoul</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Mola</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Van Eitveldt</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Szewczyk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Missault</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>P2X7 receptor antagonism inhibits seizure severity in a chronic model of temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Neuropharmacology. <year>2016</year>.</mixed-citation>
</ref>
<ref id="epi412386-bib-0287">
<label>287</label>
<mixed-citation id="epi412386-cit-0287" publication-type="journal">
<string-name>
<surname>Jimenez‐Pacheco</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Diaz‐Hernandez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Arribas‐Blazquez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sanz‐Rodriguez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Olivos‐Ore</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Artalejo</surname>
<given-names>AR</given-names>
</string-name>, et al. <article-title>Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy</article-title>. <source xml:lang="en"/>J Neurosci. <year>2016</year>;<volume> 36</volume>:<fpage>5920</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">27251615</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0288">
<label>288</label>
<mixed-citation id="epi412386-cit-0288" publication-type="journal">
<string-name>
<surname>Zhu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>. <article-title>High Mobility Group Protein B1 (HMGB1) and Interleukin‐1beta as Prognostic Biomarkers of Epilepsy in Children</article-title>. <source xml:lang="en"/>J Child Neurol.
<year>2018</year>;<volume>33</volume>:<fpage>909</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">30303442</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0289">
<label>289</label>
<mixed-citation id="epi412386-cit-0289" publication-type="journal">
<string-name>
<surname>Fu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wake</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Teshigawara</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yoshino</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Therapeutic effects of anti‐HMGB1 monoclonal antibody on pilocarpine‐induced status epilepticus in mice</article-title>. <source xml:lang="en"/>Sci Rep.
<year>2017</year>;<volume>7</volume>:<fpage>1179</fpage>.<pub-id pub-id-type="pmid">28446773</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0290">
<label>290</label>
<mixed-citation id="epi412386-cit-0290" publication-type="journal">
<string-name>
<surname>Ito</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yano</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>YI</given-names>
</string-name>, <string-name>
<surname>Yano</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ishizaki</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>High mobility group box 1 enhances hyperthermia‐induced seizures and secondary epilepsy associated with prolonged hyperthermia‐induced seizures in developing rats</article-title>. <source xml:lang="en"/>Metab Brain Dis. <year>2017</year>;<volume>32</volume>:<fpage>2095</fpage>–<lpage>104</lpage>.<pub-id pub-id-type="pmid">28879430</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0291">
<label>291</label>
<mixed-citation id="epi412386-cit-0291" publication-type="journal">
<string-name>
<surname>Maroso</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Balosso</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ravizza</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Aronica</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Iyer</surname>
<given-names>AM</given-names>
</string-name>, et al. <article-title>Toll‐like receptor 4 and high‐mobility group box‐1 are involved in ictogenesis and can be targeted to reduce seizures</article-title>. <source xml:lang="en"/>Nat Med. <year>2010</year>;<volume>16</volume>:<fpage>413</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">20348922</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0292">
<label>292</label>
<mixed-citation id="epi412386-cit-0292" publication-type="journal">
<string-name>
<surname>Walker</surname>
<given-names>LE</given-names>
</string-name>, <string-name>
<surname>Frigerio</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Ravizza</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ricci</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tse</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Jenkins</surname>
<given-names>RE</given-names>
</string-name>, et al. <article-title>Molecular isoforms of high‐mobility group box 1 are mechanistic biomarkers for epilepsy</article-title>. <source xml:lang="en"/>J Clin Invest. <year>2017</year>;<volume>127</volume>:<fpage>2118</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">28504645</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0293">
<label>293</label>
<mixed-citation id="epi412386-cit-0293" publication-type="journal">
<string-name>
<surname>Mazarati</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Maroso</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Iori</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Vezzani</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Carli</surname>
<given-names>M</given-names>
</string-name>. <article-title>High‐mobility group box‐1 impairs memory in mice through both toll‐like receptor 4 and receptor for advanced glycation end products</article-title>. <source xml:lang="en"/>Exp Neurol. <year>2011</year>;<volume>232</volume>:<fpage>143</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">21884699</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0294">
<label>294</label>
<mixed-citation id="epi412386-cit-0294" publication-type="journal">
<string-name>
<surname>Limatola</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ransohoff</surname>
<given-names>RM</given-names>
</string-name>. <article-title>Modulating neurotoxicity through CX3CL1/CX3CR1 signaling</article-title>. <source xml:lang="en"/>Front Cell Neurosci. <year>2014</year>;<volume>8</volume>:<fpage>229</fpage>.<pub-id pub-id-type="pmid">25152714</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0295">
<label>295</label>
<mixed-citation id="epi412386-cit-0295" publication-type="journal">
<string-name>
<surname>Louboutin</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Strayer</surname>
<given-names>DS</given-names>
</string-name>. <article-title>Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy</article-title>. <source xml:lang="en"/>CNS Neurol Disord Drug Targets.
<year>2013</year>;<volume>12</volume>:<fpage>815</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">24047524</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0296">
<label>296</label>
<mixed-citation id="epi412386-cit-0296" publication-type="journal">
<string-name>
<surname>Cerri</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Caleo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bozzi</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Chemokines as new inflammatory players in the pathogenesis of epilepsy</article-title>. <source xml:lang="en"/>Epilepsy Res. <year>2017</year>;<volume>136</volume>:<fpage>77</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">28780154</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0297">
<label>297</label>
<mixed-citation id="epi412386-cit-0297" publication-type="journal">
<string-name>
<surname>Benson</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Manzanero</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Borges</surname>
<given-names>K</given-names>
</string-name>. <article-title>Complex alterations in microglial M1/M2 markers during the development of epilepsy in two mouse models</article-title>. <source xml:lang="en"/>Epilepsia. <year>2015</year>;<volume>56</volume>:<fpage>895</fpage>–<lpage>905</lpage>.<pub-id pub-id-type="pmid">25847097</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0298">
<label>298</label>
<mixed-citation id="epi412386-cit-0298" publication-type="journal">
<string-name>
<surname>Okuneva</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Korber</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Tian</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Joensuu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kopra</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Abnormal microglial activation in the Cstb(‐/‐) mouse, a model for progressive myoclonus epilepsy, EPM1</article-title>. <source xml:lang="en"/>Glia. <year>2015</year>;<volume>63</volume>:<fpage>400</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">25327891</pub-id></mixed-citation>
</ref>
<ref id="epi412386-bib-0299">
<label>299</label>
<mixed-citation id="epi412386-cit-0299" publication-type="journal">
<string-name>
<surname>Ali</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Aertgeerts</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Le Blon</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bertoglio</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hoornaert</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ponsaerts</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Intracerebral delivery of the M2 polarizing cytokine interleukin 13 using mesenchymal stem cell implants in a model of temporal lobe epilepsy in mice</article-title>. <source xml:lang="en"/>Epilepsia. <year>2017</year>;<volume>58</volume>:<fpage>1063</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">28374921</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>